Gene Set,Size,P Value,Description,Gene
GO:0006959,humoral immune response,-2.1152,<2.2e-16,MIR-9-1
GO:0002250,adaptive immune response,-2.1318,<2.2e-16,MIR-9-1
GO:0001819,positive regulation of cytokine production,-2.1575,<2.2e-16,MIR-9-1
GO:0002521,leukocyte differentiation,-2.1656,<2.2e-16,MIR-9-1
GO:0002694,regulation of leukocyte activation,-2.1677,<2.2e-16,MIR-9-1
GO:0002526,acute inflammatory response,-2.1768,<2.2e-16,MIR-9-1
GO:0032635,interleukin-6 production,-2.1784,<2.2e-16,MIR-9-1
GO:0002764,immune response-regulating signaling pathway,-2.1896,<2.2e-16,MIR-9-1
GO:0032637,interleukin-8 production,-2.2062,<2.2e-16,MIR-9-1
GO:0042116,macrophage activation,-2.2236,<2.2e-16,MIR-9-1
GO:0001525,angiogenesis,-2.2469,<2.2e-16,MIR-9-1
GO:0032609,interferon-gamma production,-2.2613,<2.2e-16,MIR-9-1
GO:0042110,T cell activation,-2.28,<2.2e-16,MIR-9-1
GO:0034340,response to type I interferon,1.9698,0.00024716,MIR-600
GO:0032633,interleukin-4 production,-1.4783,0.15110,MIR-503
GO:0045576,mast cell activation,-1.2257,0.38702,MIR-503
GO:0002448,mast cell mediated immunity,-1.2297,0.39397,MIR-503
GO:0007159,leukocyte cell-cell adhesion,2.0704,<2.2e-16,MIR-22
GO:0002250,adaptive immune response,2.0546,<2.2e-16,MIR-22
GO:0032609,interferon-gamma production,1.9964,<2.2e-16,MIR-22
GO:0002449,lymphocyte mediated immunity,1.9883,<2.2e-16,MIR-22
GO:0002448,mast cell mediated immunity,1.9682,<2.2e-16,MIR-22
GO:0032635,interleukin-6 production,1.9492,<2.2e-16,MIR-22
GO:0002285,lymphocyte activation involved in immune response,1.9492,<2.2e-16,MIR-22
GO:0002526,acute inflammatory response,1.9349,<2.2e-16,MIR-22
GO:0002694,regulation of leukocyte activation,1.9334,<2.2e-16,MIR-22
GO:0001819,positive regulation of cytokine production,1.9321,<2.2e-16,MIR-22
GO:0032615,interleukin-12 production,1.9288,<2.2e-16,MIR-22
GO:0002446,neutrophil mediated immunity,1.9187,<2.2e-16,MIR-22
GO:0002521,leukocyte differentiation,1.9153,<2.2e-16,MIR-22
GO:0002764,immune response-regulating signaling pathway,1.8986,<2.2e-16,MIR-22
GO:0002250,adaptive immune response,2.0914,<2.2e-16,MIR-155
GO:0002449,lymphocyte mediated immunity,2.0632,<2.2e-16,MIR-155
GO:0002764,immune response-regulating signaling pathway,2.0473,<2.2e-16,MIR-155
GO:0002697,regulation of immune effector process,2.0333,<2.2e-16,MIR-155
GO:0002694,regulation of leukocyte activation,2.0333,<2.2e-16,MIR-155
GO:0007159,leukocyte cell-cell adhesion,2.0328,<2.2e-16,MIR-155
GO:0002285,lymphocyte activation involved in immune response,2.023,<2.2e-16,MIR-155
GO:0001819,positive regulation of cytokine production,2.0111,<2.2e-16,MIR-155
GO:0002440,production of molecular mediator of immune response,1.9577,<2.2e-16,MIR-155
GO:0001818,negative regulation of cytokine production,1.953,<2.2e-16,MIR-155
GO:0002521,leukocyte differentiation,1.9472,<2.2e-16,MIR-155
GO:0002446,neutrophil mediated immunity,1.9228,<2.2e-16,MIR-155
GO:0002683,negative regulation of immune system process,1.9209,<2.2e-16,MIR-155
GO:0002526,acute inflammatory response,1.8863,<2.2e-16,MIR-155
GO:0006959,humoral immune response,1.8849,<2.2e-16,MIR-155
GO:0002269,leukocyte activation involved in inflammatory response,1.8325,<2.2e-16,MIR-155
GO:0001773,myeloid dendritic cell activation,1.7826,<2.2e-16,MIR-155
GO:0002437,inflammatory response to antigenic stimulus,2.3435,0.53936,MIR-1-1
GO:0032616,interleukin-13 production,2.4205,0.57773,MIR-1-1
GO:0002507,tolerance induction,2.5201,0.63529,MIR-1-1
GO:0042092,type 2 immune response,2.4234,0.63728,MIR-1-1
GO:0032634,interleukin-5 production,2.5469,0.67089,MIR-1-1
GO:0002446,neutrophil mediated immunity,-2.0196,0.026018,MIR-124-1
GO:0032623,interleukin-2 production,-1.942,0.041628,MIR-124-1
GO:0036230,granulocyte activation,-2.0366,0.04403,MIR-124-1
GO:0042116,macrophage activation,-1.8725,0.08339,MIR-124-1
GO:0006959,humoral immune response,-1.8243,0.096565,MIR-124-1
GO:0032609,interferon-gamma production,-1.649,0.12737,MIR-124-1
GO:0002250,adaptive immune response,-1.6512,0.13594,MIR-124-1
GO:0007159,leukocyte cell-cell adhesion,-1.6096,0.13998,MIR-124-1
GO:0070555,response to interleukin-1,-1.7251,0.14038,MIR-124-1
GO:0034341,response to interferon-gamma,-2.5194,<2.2e-16,MIR-7-3
GO:0034340,response to type I interferon,-2.6025,<2.2e-16,MIR-7-3
GO:0035456,response to interferon-beta,-2.1113,0.0034898,MIR-7-3
GO:0035455,response to interferon-alpha,-2.0365,0.0065434,MIR-7-3
GO:0002507,tolerance induction,-1.9174,0.0098150,MIR-7-3
GO:0032615,interleukin-12 production,-1.8813,0.013801,MIR-7-3
GO:0001773,myeloid dendritic cell activation,-1.8382,0.023757,MIR-7-3
GO:0042110,T cell activation,-1.8223,0.025475,MIR-7-3
GO:0032633,interleukin-4 production,-1.8118,0.026173,MIR-7-3
GO:0032609,interferon-gamma production,-1.7966,0.028945,MIR-7-3
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.7644,0.033240,MIR-7-3
GO:0002250,adaptive immune response,-1.7698,0.033612,MIR-7-3
GO:0002250,adaptive immune response,2.517,<2.2e-16,MIR-23A
GO:0007159,leukocyte cell-cell adhesion,2.4176,<2.2e-16,MIR-23A
GO:0002764,immune response-regulating signaling pathway,2.3925,<2.2e-16,MIR-23A
GO:0002694,regulation of leukocyte activation,2.3324,<2.2e-16,MIR-23A
GO:0001819,positive regulation of cytokine production,2.3116,<2.2e-16,MIR-23A
GO:0002449,lymphocyte mediated immunity,2.3071,<2.2e-16,MIR-23A
GO:0002697,regulation of immune effector process,2.2812,<2.2e-16,MIR-23A
GO:0032609,interferon-gamma production,2.239,<2.2e-16,MIR-23A
GO:0032606,type I interferon production,2.1974,<2.2e-16,MIR-23A
GO:0032635,interleukin-6 production,2.1936,<2.2e-16,MIR-23A
GO:0002285,lymphocyte activation involved in immune response,2.178,<2.2e-16,MIR-23A
GO:0001818,negative regulation of cytokine production,2.1769,<2.2e-16,MIR-23A
GO:0032615,interleukin-12 production,2.1549,<2.2e-16,MIR-23A
GO:0032637,interleukin-8 production,2.1528,<2.2e-16,MIR-23A
GO:0002521,leukocyte differentiation,2.1179,<2.2e-16,MIR-23A
GO:0034340,response to type I interferon,-2.1894,0.00063314,MIR-381
GO:0035456,response to interferon-beta,-2.2055,0.00071228,MIR-381
GO:0048536,spleen development,-1.6152,0.12162,MIR-99A
GO:0150076,neuroinflammatory response,1.4895,0.33362,MIR-99A
GO:0035455,response to interferon-alpha,1.4213,0.41803,MIR-99A
GO:0032606,type I interferon production,1.3773,0.49890,MIR-99A
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.1721,<2.2e-16,MIR-1915
GO:0002526,acute inflammatory response,-2.1926,<2.2e-16,MIR-1915
GO:0032602,chemokine production,-2.195,<2.2e-16,MIR-1915
GO:0050663,cytokine secretion,-2.2127,<2.2e-16,MIR-1915
GO:0050900,leukocyte migration,-2.2456,<2.2e-16,MIR-1915
GO:0032637,interleukin-8 production,-2.1117,0.00045229,MIR-1915
GO:0007159,leukocyte cell-cell adhesion,-2.1117,0.00051690,MIR-1915
GO:0032613,interleukin-10 production,-2.1368,0.00060305,MIR-1915
GO:0034341,response to interferon-gamma,-2.0876,0.00072366,MIR-1915
GO:1990868,response to chemokine,-2.0278,0.00096488,MIR-1915
GO:0032615,interleukin-12 production,-2.0347,0.0010338,MIR-1915
GO:0050727,regulation of inflammatory response,-2.0081,0.0010642,MIR-1915
GO:0006959,humoral immune response,-1.996,0.0014071,MIR-1915
GO:0042110,T cell activation,-1.9915,0.0014473,MIR-1915
GO:0070661,leukocyte proliferation,-1.9927,0.0015235,MIR-1915
GO:0035455,response to interferon-alpha,1.7513,0.016430,MIR-1915
GO:0002251,organ or tissue specific immune response,-1.9236,0.0026538,MIR-100
GO:0071559,response to transforming growth factor beta,1.9288,0.0034574,MIR-100
GO:0002251,organ or tissue specific immune response,2.1515,0.906,MIR-137
GO:0032606,type I interferon production,0.13549,0.97227,MIR-137
GO:0007159,leukocyte cell-cell adhesion,2.5489,<2.2e-16,LET-7B
GO:0001819,positive regulation of cytokine production,2.3412,<2.2e-16,LET-7B
GO:0002764,immune response-regulating signaling pathway,2.3152,<2.2e-16,LET-7B
GO:0002694,regulation of leukocyte activation,2.3074,<2.2e-16,LET-7B
GO:0001525,angiogenesis,2.2871,<2.2e-16,LET-7B
GO:0002446,neutrophil mediated immunity,2.2665,<2.2e-16,LET-7B
GO:0002250,adaptive immune response,2.2557,<2.2e-16,LET-7B
GO:0002683,negative regulation of immune system process,2.2408,<2.2e-16,LET-7B
GO:0002532,production of molecular mediator involved in inflammatory response,2.2237,<2.2e-16,LET-7B
GO:0002521,leukocyte differentiation,2.2126,<2.2e-16,LET-7B
GO:0002526,acute inflammatory response,2.1938,<2.2e-16,LET-7B
GO:0001818,negative regulation of cytokine production,2.1295,<2.2e-16,LET-7B
GO:0002449,lymphocyte mediated immunity,2.0948,<2.2e-16,LET-7B
GO:0007159,leukocyte cell-cell adhesion,2.5653,<2.2e-16,LET-7A-2
GO:0002764,immune response-regulating signaling pathway,2.396,<2.2e-16,LET-7A-2
GO:0002250,adaptive immune response,2.3507,<2.2e-16,LET-7A-2
GO:0002694,regulation of leukocyte activation,2.3414,<2.2e-16,LET-7A-2
GO:0001819,positive regulation of cytokine production,2.3329,<2.2e-16,LET-7A-2
GO:0001525,angiogenesis,2.3073,<2.2e-16,LET-7A-2
GO:0002526,acute inflammatory response,2.2268,<2.2e-16,LET-7A-2
GO:0002521,leukocyte differentiation,2.2249,<2.2e-16,LET-7A-2
GO:0002683,negative regulation of immune system process,2.2149,<2.2e-16,LET-7A-2
GO:0002446,neutrophil mediated immunity,2.2093,<2.2e-16,LET-7A-2
GO:0002449,lymphocyte mediated immunity,2.0859,<2.2e-16,LET-7A-2
GO:0007159,leukocyte cell-cell adhesion,2.5659,<2.2e-16,LET-7A-3
GO:0002764,immune response-regulating signaling pathway,2.4008,<2.2e-16,LET-7A-3
GO:0002250,adaptive immune response,2.3603,<2.2e-16,LET-7A-3
GO:0002694,regulation of leukocyte activation,2.3592,<2.2e-16,LET-7A-3
GO:0032635,interleukin-6 production,2.3487,<2.2e-16,LET-7A-3
GO:0001819,positive regulation of cytokine production,2.3311,<2.2e-16,LET-7A-3
GO:0001525,angiogenesis,2.3251,<2.2e-16,LET-7A-3
GO:0032609,interferon-gamma production,2.3072,<2.2e-16,LET-7A-3
GO:0032637,interleukin-8 production,2.2668,<2.2e-16,LET-7A-3
GO:0002446,neutrophil mediated immunity,2.231,<2.2e-16,LET-7A-3
GO:0002683,negative regulation of immune system process,2.2248,<2.2e-16,LET-7A-3
GO:0002526,acute inflammatory response,2.2242,<2.2e-16,LET-7A-3
GO:0002521,leukocyte differentiation,2.2179,<2.2e-16,LET-7A-3
GO:0007159,leukocyte cell-cell adhesion,2.5489,<2.2e-16,LET-7B
GO:0001819,positive regulation of cytokine production,2.3412,<2.2e-16,LET-7B
GO:0002764,immune response-regulating signaling pathway,2.3152,<2.2e-16,LET-7B
GO:0002694,regulation of leukocyte activation,2.3074,<2.2e-16,LET-7B
GO:0001525,angiogenesis,2.2871,<2.2e-16,LET-7B
GO:0002446,neutrophil mediated immunity,2.2665,<2.2e-16,LET-7B
GO:0002250,adaptive immune response,2.2557,<2.2e-16,LET-7B
GO:0002683,negative regulation of immune system process,2.2408,<2.2e-16,LET-7B
GO:0002532,production of molecular mediator involved in inflammatory response,2.2237,<2.2e-16,LET-7B
GO:0002521,leukocyte differentiation,2.2126,<2.2e-16,LET-7B
GO:0002526,acute inflammatory response,2.1938,<2.2e-16,LET-7B
GO:0001818,negative regulation of cytokine production,2.1295,<2.2e-16,LET-7B
GO:0002449,lymphocyte mediated immunity,2.0948,<2.2e-16,LET-7B
GO:0002251,organ or tissue specific immune response,-1.85,0.090626,LET-7C
GO:0001773,myeloid dendritic cell activation,-1.7785,0.13202,LET-7C
GO:0036230,granulocyte activation,-1.6377,0.16481,LET-7C
GO:0019882,antigen processing and presentation,-1.5636,0.17584,LET-7C
GO:0002446,neutrophil mediated immunity,-1.6477,0.18797,LET-7C
GO:0035455,response to interferon-alpha,1.6907,0.19486,LET-7C
GO:0033028,myeloid cell apoptotic process,1.4736,0.335,LET-7C
GO:0007159,leukocyte cell-cell adhesion,2.6082,<2.2e-16,LET-7D
GO:0002250,adaptive immune response,2.4341,<2.2e-16,LET-7D
GO:0002764,immune response-regulating signaling pathway,2.3514,<2.2e-16,LET-7D
GO:0002446,neutrophil mediated immunity,2.3141,<2.2e-16,LET-7D
GO:0001819,positive regulation of cytokine production,2.2646,<2.2e-16,LET-7D
GO:0002694,regulation of leukocyte activation,2.2397,<2.2e-16,LET-7D
GO:0002449,lymphocyte mediated immunity,2.2335,<2.2e-16,LET-7D
GO:0002532,production of molecular mediator involved in inflammatory response,2.1454,<2.2e-16,LET-7D
GO:0002285,lymphocyte activation involved in immune response,2.1396,<2.2e-16,LET-7D
GO:0006959,humoral immune response,2.1331,<2.2e-16,LET-7D
GO:0002697,regulation of immune effector process,2.115,<2.2e-16,LET-7D
GO:0002521,leukocyte differentiation,2.1049,<2.2e-16,LET-7D
GO:0002683,negative regulation of immune system process,2.0944,<2.2e-16,LET-7D
GO:0001525,angiogenesis,2.2686,<2.2e-16,LET-7E
GO:0002250,adaptive immune response,2.697,<2.2e-16,LET-7F-1
GO:0007159,leukocyte cell-cell adhesion,2.6856,<2.2e-16,LET-7F-1
GO:0002449,lymphocyte mediated immunity,2.6176,<2.2e-16,LET-7F-1
GO:0002446,neutrophil mediated immunity,2.55,<2.2e-16,LET-7F-1
GO:0002764,immune response-regulating signaling pathway,2.5478,<2.2e-16,LET-7F-1
GO:0002285,lymphocyte activation involved in immune response,2.5338,<2.2e-16,LET-7F-1
GO:0001819,positive regulation of cytokine production,2.5171,<2.2e-16,LET-7F-1
GO:0002694,regulation of leukocyte activation,2.5139,<2.2e-16,LET-7F-1
GO:0002697,regulation of immune effector process,2.4799,<2.2e-16,LET-7F-1
GO:0002532,production of molecular mediator involved in inflammatory response,2.3611,<2.2e-16,LET-7F-1
GO:0002683,negative regulation of immune system process,2.3554,<2.2e-16,LET-7F-1
GO:0002521,leukocyte differentiation,2.3413,<2.2e-16,LET-7F-1
GO:0006959,humoral immune response,2.3309,<2.2e-16,LET-7F-1
GO:0001818,negative regulation of cytokine production,2.3278,<2.2e-16,LET-7F-1
GO:0002526,acute inflammatory response,2.2815,<2.2e-16,LET-7F-1
GO:0002507,tolerance induction,2.1933,<2.2e-16,LET-7F-1
GO:0007159,leukocyte cell-cell adhesion,2.4609,<2.2e-16,LET-7F-2
GO:0002250,adaptive immune response,2.4333,<2.2e-16,LET-7F-2
GO:0002764,immune response-regulating signaling pathway,2.427,<2.2e-16,LET-7F-2
GO:0001819,positive regulation of cytokine production,2.3411,<2.2e-16,LET-7F-2
GO:0002694,regulation of leukocyte activation,2.278,<2.2e-16,LET-7F-2
GO:0002449,lymphocyte mediated immunity,2.2538,<2.2e-16,LET-7F-2
GO:0032609,interferon-gamma production,2.2522,<2.2e-16,LET-7F-2
GO:0002526,acute inflammatory response,2.2497,<2.2e-16,LET-7F-2
GO:0002697,regulation of immune effector process,2.2299,<2.2e-16,LET-7F-2
GO:0002532,production of molecular mediator involved in inflammatory response,2.2223,<2.2e-16,LET-7F-2
GO:0032637,interleukin-8 production,2.2028,<2.2e-16,LET-7F-2
GO:0002446,neutrophil mediated immunity,2.1898,<2.2e-16,LET-7F-2
GO:0032635,interleukin-6 production,2.1684,<2.2e-16,LET-7F-2
GO:0032623,interleukin-2 production,2.1547,<2.2e-16,LET-7F-2
GO:0002285,lymphocyte activation involved in immune response,2.1422,<2.2e-16,LET-7F-2
GO:0002683,negative regulation of immune system process,2.0954,<2.2e-16,LET-7F-2
GO:0002521,leukocyte differentiation,2.0631,<2.2e-16,LET-7F-2
GO:0002764,immune response-regulating signaling pathway,2.5919,<2.2e-16,LET-7G
GO:0002250,adaptive immune response,2.5745,<2.2e-16,LET-7G
GO:0001819,positive regulation of cytokine production,2.4431,<2.2e-16,LET-7G
GO:0007159,leukocyte cell-cell adhesion,2.4417,<2.2e-16,LET-7G
GO:0032609,interferon-gamma production,2.4279,<2.2e-16,LET-7G
GO:0032606,type I interferon production,2.3719,<2.2e-16,LET-7G
GO:0002694,regulation of leukocyte activation,2.3424,<2.2e-16,LET-7G
GO:0002697,regulation of immune effector process,2.342,<2.2e-16,LET-7G
GO:0002449,lymphocyte mediated immunity,2.3005,<2.2e-16,LET-7G
GO:0002532,production of molecular mediator involved in inflammatory response,2.282,<2.2e-16,LET-7G
GO:0002526,acute inflammatory response,2.2275,<2.2e-16,LET-7G
GO:0002285,lymphocyte activation involved in immune response,2.1666,<2.2e-16,LET-7G
GO:0030101,natural killer cell activation,2.1632,<2.2e-16,LET-7G
GO:0002446,neutrophil mediated immunity,2.0986,<2.2e-16,LET-7G
GO:0002250,adaptive immune response,2.2518,<2.2e-16,LET-7I
GO:0007159,leukocyte cell-cell adhesion,2.1765,<2.2e-16,LET-7I
GO:0002449,lymphocyte mediated immunity,2.1677,<2.2e-16,LET-7I
GO:0002764,immune response-regulating signaling pathway,2.1326,<2.2e-16,LET-7I
GO:0001819,positive regulation of cytokine production,2.1324,<2.2e-16,LET-7I
GO:0002697,regulation of immune effector process,2.1317,<2.2e-16,LET-7I
GO:0002694,regulation of leukocyte activation,2.1279,<2.2e-16,LET-7I
GO:0002285,lymphocyte activation involved in immune response,2.1101,<2.2e-16,LET-7I
GO:0002683,negative regulation of immune system process,2.068,<2.2e-16,LET-7I
GO:0002532,production of molecular mediator involved in inflammatory response,2.0375,<2.2e-16,LET-7I
GO:0001818,negative regulation of cytokine production,2.0362,<2.2e-16,LET-7I
GO:0002440,production of molecular mediator of immune response,2.0293,<2.2e-16,LET-7I
GO:0002521,leukocyte differentiation,2.0009,<2.2e-16,LET-7I
GO:0006959,humoral immune response,1.9821,<2.2e-16,LET-7I
GO:0002446,neutrophil mediated immunity,1.9705,<2.2e-16,LET-7I
GO:0002448,mast cell mediated immunity,1.9559,<2.2e-16,LET-7I
GO:0002269,leukocyte activation involved in inflammatory response,1.9395,<2.2e-16,LET-7I
GO:0001773,myeloid dendritic cell activation,1.9182,<2.2e-16,LET-7I
GO:0002251,organ or tissue specific immune response,-1.9236,0.0026538,MIR-100
GO:0071559,response to transforming growth factor beta,1.9288,0.0034574,MIR-100
GO:0034341,response to interferon-gamma,2.5728,<2.2e-16,MIR-101-1
GO:0034340,response to type I interferon,2.5475,<2.2e-16,MIR-101-1
GO:0002764,immune response-regulating signaling pathway,2.4683,<2.2e-16,MIR-101-1
GO:0032606,type I interferon production,2.4484,<2.2e-16,MIR-101-1
GO:0002250,adaptive immune response,2.3312,<2.2e-16,MIR-101-1
GO:0001819,positive regulation of cytokine production,2.2332,<2.2e-16,MIR-101-1
GO:0032635,interleukin-6 production,2.229,<2.2e-16,MIR-101-1
GO:0002697,regulation of immune effector process,2.2137,<2.2e-16,MIR-101-1
GO:0032609,interferon-gamma production,2.1685,<2.2e-16,MIR-101-1
GO:0002449,lymphocyte mediated immunity,2.1504,<2.2e-16,MIR-101-1
GO:0007159,leukocyte cell-cell adhesion,2.1041,<2.2e-16,MIR-101-1
GO:0002526,acute inflammatory response,2.0913,<2.2e-16,MIR-101-1
GO:0032637,interleukin-8 production,2.0844,<2.2e-16,MIR-101-1
GO:0035456,response to interferon-beta,2.0825,<2.2e-16,MIR-101-1
GO:0001818,negative regulation of cytokine production,2.0525,<2.2e-16,MIR-101-1
GO:0006925,inflammatory cell apoptotic process,2.0472,<2.2e-16,MIR-101-1
GO:0042110,T cell activation,2.0379,<2.2e-16,MIR-101-1
GO:0034340,response to type I interferon,2.62,<2.2e-16,MIR-101-2
GO:0001525,angiogenesis,-2.012,0.00042812,MIR-101-2
GO:0035456,response to interferon-beta,2.2116,0.0030438,MIR-101-2
GO:0035455,response to interferon-alpha,2.0521,0.011034,MIR-101-2
GO:0032606,type I interferon production,1.8176,0.040331,MIR-101-2
GO:0034341,response to interferon-gamma,1.6787,0.071631,MIR-101-2
GO:0032637,interleukin-8 production,-2.1486,<2.2e-16,MIR-105-1
GO:0032635,interleukin-6 production,-2.1864,<2.2e-16,MIR-105-1
GO:0034341,response to interferon-gamma,-2.2031,<2.2e-16,MIR-105-1
GO:0042116,macrophage activation,-2.0196,0.0091439,MIR-105-1
GO:0002764,immune response-regulating signaling pathway,-1.9334,0.010134,MIR-105-1
GO:0050900,leukocyte migration,-1.9337,0.010858,MIR-105-1
GO:0002532,production of molecular mediator involved in inflammatory response,-1.9126,0.011112,MIR-105-1
GO:0032615,interleukin-12 production,-1.9541,0.011335,MIR-105-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.8999,0.011370,MIR-105-1
GO:0007159,leukocyte cell-cell adhesion,-1.9351,0.011694,MIR-105-1
GO:0001819,positive regulation of cytokine production,-1.8384,0.015694,MIR-105-1
GO:0042116,macrophage activation,-2.1507,<2.2e-16,MIR-105-2
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.171,<2.2e-16,MIR-105-2
GO:0032637,interleukin-8 production,-2.1732,<2.2e-16,MIR-105-2
GO:0034341,response to interferon-gamma,-2.2233,<2.2e-16,MIR-105-2
GO:0032635,interleukin-6 production,-2.2372,<2.2e-16,MIR-105-2
GO:0032615,interleukin-12 production,-2.0295,0.0059089,MIR-105-2
GO:0034612,response to tumor necrosis factor,-1.9951,0.0075971,MIR-105-2
GO:0007159,leukocyte cell-cell adhesion,-1.9742,0.0088633,MIR-105-2
GO:0002532,production of molecular mediator involved in inflammatory response,-1.9648,0.0094173,MIR-105-2
GO:0050727,regulation of inflammatory response,-1.909,0.010072,MIR-105-2
GO:0002446,neutrophil mediated immunity,-2.4252,<2.2e-16,MIR-106A
GO:0036230,granulocyte activation,-2.49,<2.2e-16,MIR-106A
GO:0050727,regulation of inflammatory response,-1.9409,0.0059888,MIR-106A
GO:0002200,somatic diversification of immune receptors,1.8561,0.00055842,MIR-106B
GO:0034340,response to type I interferon,2.5766,<2.2e-16,MIR-107
GO:0032606,type I interferon production,2.0007,0.00069823,MIR-107
GO:0035455,response to interferon-alpha,1.9037,0.0019950,MIR-107
GO:0035456,response to interferon-beta,1.8739,0.0022343,MIR-107
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.8195,0.012647,MIR-107
GO:0048536,spleen development,2.4523,0.25665,MIR-10A
GO:1903706,regulation of hemopoiesis,1.4998,0.36507,MIR-10A
GO:0002697,regulation of immune effector process,1.5275,0.36615,MIR-10A
GO:0019882,antigen processing and presentation,1.4999,0.36865,MIR-10A
GO:0030101,natural killer cell activation,1.5026,0.37004,MIR-10A
GO:0033028,myeloid cell apoptotic process,1.4908,0.37070,MIR-10A
GO:0002694,regulation of leukocyte activation,1.5327,0.37326,MIR-10A
GO:0035456,response to interferon-beta,1.6045,0.15978,MIR-10B
GO:0002437,inflammatory response to antigenic stimulus,2.3435,0.53936,MIR-1-1
GO:0032616,interleukin-13 production,2.4205,0.57773,MIR-1-1
GO:0002507,tolerance induction,2.5201,0.63529,MIR-1-1
GO:0042092,type 2 immune response,2.4234,0.63728,MIR-1-1
GO:0032634,interleukin-5 production,2.5469,0.67089,MIR-1-1
GO:0001525,angiogenesis,2.069,0.00023875,MIR-1-2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.9804,0.00023875,MIR-1-2
GO:0034340,response to type I interferon,-2.0647,0.0012662,MIR-122
GO:0035456,response to interferon-beta,-1.9978,0.0026860,MIR-122
GO:0034341,response to interferon-gamma,-1.8413,0.025061,MIR-122
GO:0002446,neutrophil mediated immunity,-2.0196,0.026018,MIR-124-1
GO:0032623,interleukin-2 production,-1.942,0.041628,MIR-124-1
GO:0036230,granulocyte activation,-2.0366,0.04403,MIR-124-1
GO:0042116,macrophage activation,-1.8725,0.08339,MIR-124-1
GO:0006959,humoral immune response,-1.8243,0.096565,MIR-124-1
GO:0032609,interferon-gamma production,-1.649,0.12737,MIR-124-1
GO:0002250,adaptive immune response,-1.6512,0.13594,MIR-124-1
GO:0007159,leukocyte cell-cell adhesion,-1.6096,0.13998,MIR-124-1
GO:0070555,response to interleukin-1,-1.7251,0.14038,MIR-124-1
GO:0002446,neutrophil mediated immunity,-1.459,0.43272,MIR-124-2
GO:0098760,response to interleukin-7,0.40562,0.99874,MIR-124-2
GO:0036230,granulocyte activation,-2.0669,0.0014674,MIR-124-3
GO:0002446,neutrophil mediated immunity,-2.0533,0.0019566,MIR-124-3
GO:0032623,interleukin-2 production,-1.9795,0.0035218,MIR-124-3
GO:0007159,leukocyte cell-cell adhesion,-1.8714,0.012326,MIR-124-3
GO:0042116,macrophage activation,-1.8108,0.017264,MIR-124-3
GO:0006959,humoral immune response,-1.767,0.024146,MIR-124-3
GO:0071559,response to transforming growth factor beta,1.9235,0.00015410,MIR-125A
GO:0019882,antigen processing and presentation,-2.304,<2.2e-16,MIR-125B-1
GO:0002446,neutrophil mediated immunity,-2.5268,<2.2e-16,MIR-125B-1
GO:0002507,tolerance induction,-2.0376,0.0012992,MIR-125B-1
GO:0071559,response to transforming growth factor beta,1.873,0.0021358,MIR-125B-1
GO:0002250,adaptive immune response,-1.9914,0.0021398,MIR-125B-1
GO:0002449,lymphocyte mediated immunity,-1.9263,0.0055576,MIR-125B-1
GO:0036230,granulocyte activation,-1.7068,0.088568,MIR-125B-2
GO:0002446,neutrophil mediated immunity,-1.7277,0.10093,MIR-125B-2
GO:0035455,response to interferon-alpha,1.6484,0.11398,MIR-125B-2
GO:0001773,myeloid dendritic cell activation,-1.6222,0.12042,MIR-125B-2
GO:0034340,response to type I interferon,1.5758,0.23640,MIR-125B-2
GO:0002250,adaptive immune response,2.4657,<2.2e-16,MIR-126
GO:0007159,leukocyte cell-cell adhesion,2.3494,<2.2e-16,MIR-126
GO:0002449,lymphocyte mediated immunity,2.2094,<2.2e-16,MIR-126
GO:0001819,positive regulation of cytokine production,2.2059,<2.2e-16,MIR-126
GO:0002764,immune response-regulating signaling pathway,2.1792,<2.2e-16,MIR-126
GO:0002446,neutrophil mediated immunity,2.1636,<2.2e-16,MIR-126
GO:0019882,antigen processing and presentation,2.137,<2.2e-16,MIR-126
GO:0002526,acute inflammatory response,2.1344,<2.2e-16,MIR-126
GO:0002697,regulation of immune effector process,2.1239,<2.2e-16,MIR-126
GO:0001818,negative regulation of cytokine production,2.0957,<2.2e-16,MIR-126
GO:0002694,regulation of leukocyte activation,2.0891,<2.2e-16,MIR-126
GO:0002285,lymphocyte activation involved in immune response,2.0756,<2.2e-16,MIR-126
GO:0001525,angiogenesis,2.0088,<2.2e-16,MIR-126
GO:0002521,leukocyte differentiation,1.9735,<2.2e-16,MIR-126
GO:0035456,response to interferon-beta,-2.2861,<2.2e-16,MIR-127
GO:0034340,response to type I interferon,-2.3188,<2.2e-16,MIR-127
GO:0042116,macrophage activation,-1.7872,0.023711,MIR-128-1
GO:0032635,interleukin-6 production,-1.7667,0.031854,MIR-128-1
GO:0032634,interleukin-5 production,-1.6916,0.049437,MIR-128-1
GO:0032602,chemokine production,-1.6161,0.085145,MIR-128-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.6239,0.086809,MIR-128-1
GO:0034340,response to type I interferon,1.8224,0.021659,MIR-128-2
GO:0032602,chemokine production,-1.6408,0.064791,MIR-128-2
GO:0050727,regulation of inflammatory response,-1.6107,0.078572,MIR-128-2
GO:0002507,tolerance induction,-2.0385,<2.2e-16,MIR-129-1
GO:0001773,myeloid dendritic cell activation,-2.111,<2.2e-16,MIR-129-1
GO:0002285,lymphocyte activation involved in immune response,-2.1114,<2.2e-16,MIR-129-1
GO:0006959,humoral immune response,-2.1586,<2.2e-16,MIR-129-1
GO:0002532,production of molecular mediator involved in inflammatory response,-2.1946,<2.2e-16,MIR-129-1
GO:0002683,negative regulation of immune system process,-2.2015,<2.2e-16,MIR-129-1
GO:0001818,negative regulation of cytokine production,-2.2059,<2.2e-16,MIR-129-1
GO:0002449,lymphocyte mediated immunity,-2.2595,<2.2e-16,MIR-129-1
GO:0002697,regulation of immune effector process,-2.2774,<2.2e-16,MIR-129-1
GO:0002694,regulation of leukocyte activation,-2.3446,<2.2e-16,MIR-129-1
GO:0002521,leukocyte differentiation,-2.3496,<2.2e-16,MIR-129-1
GO:0002526,acute inflammatory response,-2.4154,<2.2e-16,MIR-129-1
GO:0001525,angiogenesis,-2.4163,<2.2e-16,MIR-129-1
GO:0002764,immune response-regulating signaling pathway,-2.4969,<2.2e-16,MIR-129-1
GO:0002250,adaptive immune response,-2.5085,<2.2e-16,MIR-129-1
GO:0002446,neutrophil mediated immunity,-2.5362,<2.2e-16,MIR-129-1
GO:0032613,interleukin-10 production,-2.1299,<2.2e-16,MIR-129-2
GO:0002449,lymphocyte mediated immunity,-2.1512,<2.2e-16,MIR-129-2
GO:0032612,interleukin-1 production,-2.1555,<2.2e-16,MIR-129-2
GO:0002532,production of molecular mediator involved in inflammatory response,-2.2112,<2.2e-16,MIR-129-2
GO:0002697,regulation of immune effector process,-2.2215,<2.2e-16,MIR-129-2
GO:0032615,interleukin-12 production,-2.2521,<2.2e-16,MIR-129-2
GO:0002764,immune response-regulating signaling pathway,-2.2605,<2.2e-16,MIR-129-2
GO:0002521,leukocyte differentiation,-2.3041,<2.2e-16,MIR-129-2
GO:0032609,interferon-gamma production,-2.3373,<2.2e-16,MIR-129-2
GO:0002526,acute inflammatory response,-2.3491,<2.2e-16,MIR-129-2
GO:0002250,adaptive immune response,-2.3495,<2.2e-16,MIR-129-2
GO:0001525,angiogenesis,-2.3754,<2.2e-16,MIR-129-2
GO:0002446,neutrophil mediated immunity,-2.4709,<2.2e-16,MIR-129-2
GO:0032637,interleukin-8 production,-2.1238,<2.2e-16,MIR-130A
GO:0050900,leukocyte migration,-2.1572,<2.2e-16,MIR-130A
GO:0002526,acute inflammatory response,-2.1671,<2.2e-16,MIR-130A
GO:0002446,neutrophil mediated immunity,-2.6428,<2.2e-16,MIR-130A
GO:0036230,granulocyte activation,-2.6428,<2.2e-16,MIR-130A
GO:0045576,mast cell activation,-2.0612,0.00049383,MIR-130A
GO:0001525,angiogenesis,-1.998,0.0018855,MIR-130A
GO:0042092,type 2 immune response,-2.0015,0.0019753,MIR-130A
GO:0050727,regulation of inflammatory response,-1.9688,0.0020513,MIR-130A
GO:0032637,interleukin-8 production,-2.2845,<2.2e-16,MIR-130B
GO:0034340,response to type I interferon,-2.295,<2.2e-16,MIR-130B
GO:0034341,response to interferon-gamma,-2.3578,<2.2e-16,MIR-130B
GO:0035456,response to interferon-beta,-2.106,0.0030658,MIR-130B
GO:0035455,response to interferon-alpha,-2.0619,0.0036789,MIR-130B
GO:0032635,interleukin-6 production,-1.9882,0.0045986,MIR-130B
GO:0002526,acute inflammatory response,-2.0134,0.0051096,MIR-130B
GO:0032612,interleukin-1 production,-1.9968,0.0052556,MIR-130B
GO:0042092,type 2 immune response,-1.9317,0.0055741,MIR-130B
GO:0002764,immune response-regulating signaling pathway,-1.9063,0.0070748,MIR-130B
GO:0032633,interleukin-4 production,-1.8815,0.0081754,MIR-130B
GO:0032602,chemokine production,-1.8048,0.016862,MIR-130B
GO:0032620,interleukin-17 production,-1.8148,0.017032,MIR-130B
GO:0007159,leukocyte cell-cell adhesion,1.7873,<2.2e-16,MIR-132
GO:0032623,interleukin-2 production,1.7768,<2.2e-16,MIR-132
GO:0050900,leukocyte migration,1.7747,<2.2e-16,MIR-132
GO:1990868,response to chemokine,1.7548,<2.2e-16,MIR-132
GO:0032635,interleukin-6 production,1.7504,<2.2e-16,MIR-132
GO:0032615,interleukin-12 production,1.7385,<2.2e-16,MIR-132
GO:0032609,interferon-gamma production,1.7344,<2.2e-16,MIR-132
GO:0002250,adaptive immune response,1.7316,<2.2e-16,MIR-132
GO:0002694,regulation of leukocyte activation,1.7118,0.000073193,MIR-132
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7691,<2.2e-16,MIR-133A-1
GO:0001525,angiogenesis,1.7637,<2.2e-16,MIR-133A-1
GO:0050900,leukocyte migration,1.736,0.00048386,MIR-133A-1
GO:0001525,angiogenesis,1.942,<2.2e-16,MIR-133A-2
GO:0035456,response to interferon-beta,-2.2728,<2.2e-16,MIR-134
GO:0034340,response to type I interferon,-2.5616,<2.2e-16,MIR-134
GO:0032606,type I interferon production,-1.9049,0.0080945,MIR-134
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.6539,0.0085407,MIR-134
GO:0001525,angiogenesis,1.6056,0.0088352,MIR-134
GO:0001818,negative regulation of cytokine production,-2.1001,<2.2e-16,MIR-135A-1
GO:0002507,tolerance induction,-2.1009,<2.2e-16,MIR-135A-1
GO:0001773,myeloid dendritic cell activation,-2.1625,<2.2e-16,MIR-135A-1
GO:0002285,lymphocyte activation involved in immune response,-2.2189,<2.2e-16,MIR-135A-1
GO:0002697,regulation of immune effector process,-2.2495,<2.2e-16,MIR-135A-1
GO:0002532,production of molecular mediator involved in inflammatory response,-2.2738,<2.2e-16,MIR-135A-1
GO:0002521,leukocyte differentiation,-2.3115,<2.2e-16,MIR-135A-1
GO:0002683,negative regulation of immune system process,-2.3397,<2.2e-16,MIR-135A-1
GO:0002526,acute inflammatory response,-2.3614,<2.2e-16,MIR-135A-1
GO:0006959,humoral immune response,-2.3614,<2.2e-16,MIR-135A-1
GO:0001819,positive regulation of cytokine production,-2.4226,<2.2e-16,MIR-135A-1
GO:0002694,regulation of leukocyte activation,-2.4333,<2.2e-16,MIR-135A-1
GO:0002449,lymphocyte mediated immunity,-2.5379,<2.2e-16,MIR-135A-1
GO:0002764,immune response-regulating signaling pathway,-2.5025,<2.2e-16,MIR-135A-1
GO:0002446,neutrophil mediated immunity,-2.6201,<2.2e-16,MIR-135A-1
GO:0002250,adaptive immune response,-2.195,<2.2e-16,MIR-135A-2
GO:0007159,leukocyte cell-cell adhesion,-2.2193,<2.2e-16,MIR-135A-2
GO:0019882,antigen processing and presentation,-2.2411,<2.2e-16,MIR-135A-2
GO:0050900,leukocyte migration,-2.2548,<2.2e-16,MIR-135A-2
GO:0036230,granulocyte activation,-2.4663,<2.2e-16,MIR-135A-2
GO:0002446,neutrophil mediated immunity,-2.4969,<2.2e-16,MIR-135A-2
GO:1990868,response to chemokine,-2.0872,0.00033030,MIR-135A-2
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0946,0.00035570,MIR-135A-2
GO:0002449,lymphocyte mediated immunity,-2.1174,0.00038534,MIR-135A-2
GO:0034341,response to interferon-gamma,-2.1175,0.00042038,MIR-135A-2
GO:0042110,T cell activation,-2.0277,0.00048675,MIR-135A-2
GO:0002526,acute inflammatory response,-2.0588,0.00054402,MIR-135A-2
GO:0032606,type I interferon production,-2.1809,<2.2e-16,MIR-136
GO:0034340,response to type I interferon,-2.5441,<2.2e-16,MIR-136
GO:0035456,response to interferon-beta,-2.562,<2.2e-16,MIR-136
GO:0002449,lymphocyte mediated immunity,-1.7898,0.041695,MIR-136
GO:0035455,response to interferon-alpha,-1.7203,0.058456,MIR-136
GO:0034341,response to interferon-gamma,-1.6967,0.064848,MIR-136
GO:0032633,interleukin-4 production,-1.6559,0.083222,MIR-136
GO:0019882,antigen processing and presentation,-1.6074,0.11256,MIR-136
GO:0002251,organ or tissue specific immune response,2.1515,0.906,MIR-137
GO:0032606,type I interferon production,0.13549,0.97227,MIR-137
GO:0035456,response to interferon-beta,-2.1445,0.0017143,MIR-138-1
GO:0034341,response to interferon-gamma,-2.0209,0.0037402,MIR-138-1
GO:0032637,interleukin-8 production,-2.0366,0.0041142,MIR-138-1
GO:0035455,response to interferon-alpha,-1.9312,0.0085713,MIR-138-1
GO:0034340,response to type I interferon,-1.9028,0.011428,MIR-138-1
GO:0032612,interleukin-1 production,-1.7725,0.023376,MIR-138-1
GO:0032633,interleukin-4 production,-1.8586,0.035035,MIR-138-2
GO:0042116,macrophage activation,-1.9369,0.036704,MIR-138-2
GO:0032637,interleukin-8 production,-1.8376,0.041470,MIR-138-2
GO:0032612,interleukin-1 production,-1.8181,0.043794,MIR-138-2
GO:0002526,acute inflammatory response,-1.7843,0.048048,MIR-138-2
GO:0032635,interleukin-6 production,-1.7988,0.048382,MIR-138-2
GO:0002251,organ or tissue specific immune response,-1.7171,0.079663,MIR-138-2
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.6394,0.088773,MIR-138-2
GO:0050727,regulation of inflammatory response,-1.6531,0.091563,MIR-138-2
GO:0001819,positive regulation of cytokine production,-1.6434,0.092037,MIR-138-2
GO:0002269,leukocyte activation involved in inflammatory response,-1.5439,0.11641,MIR-138-2
GO:0001525,angiogenesis,1.791,0.0071823,MIR-139
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7369,0.0096513,MIR-139
GO:0007159,leukocyte cell-cell adhesion,1.8748,<2.2e-16,MIR-140
GO:0002250,adaptive immune response,1.8439,<2.2e-16,MIR-140
GO:0070661,leukocyte proliferation,1.8331,<2.2e-16,MIR-140
GO:0002269,leukocyte activation involved in inflammatory response,1.8311,<2.2e-16,MIR-140
GO:0050900,leukocyte migration,1.8249,<2.2e-16,MIR-140
GO:0002694,regulation of leukocyte activation,1.8246,<2.2e-16,MIR-140
GO:0150076,neuroinflammatory response,1.8243,<2.2e-16,MIR-140
GO:1990868,response to chemokine,1.8139,<2.2e-16,MIR-140
GO:0042116,macrophage activation,1.813,<2.2e-16,MIR-140
GO:0042110,T cell activation,1.8033,<2.2e-16,MIR-140
GO:0032635,interleukin-6 production,1.7985,<2.2e-16,MIR-140
GO:0034340,response to type I interferon,2.3049,<2.2e-16,MIR-141
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.0409,<2.2e-16,MIR-141
GO:0001525,angiogenesis,-2.2339,<2.2e-16,MIR-141
GO:0032606,type I interferon production,1.9383,0.0095521,MIR-141
GO:0045088,regulation of innate immune response,1.7119,0.10115,MIR-141
GO:0035455,response to interferon-alpha,1.599,0.11411,MIR-141
GO:0002250,adaptive immune response,1.9759,<2.2e-16,MIR-142
GO:0002449,lymphocyte mediated immunity,1.9653,<2.2e-16,MIR-142
GO:0002285,lymphocyte activation involved in immune response,1.919,<2.2e-16,MIR-142
GO:0007159,leukocyte cell-cell adhesion,1.8909,<2.2e-16,MIR-142
GO:0002764,immune response-regulating signaling pathway,1.8786,<2.2e-16,MIR-142
GO:0002694,regulation of leukocyte activation,1.8698,<2.2e-16,MIR-142
GO:0002521,leukocyte differentiation,1.8514,<2.2e-16,MIR-142
GO:0001819,positive regulation of cytokine production,1.8176,<2.2e-16,MIR-142
GO:0019882,antigen processing and presentation,1.8129,<2.2e-16,MIR-142
GO:0002697,regulation of immune effector process,1.8065,<2.2e-16,MIR-142
GO:0002446,neutrophil mediated immunity,1.8002,<2.2e-16,MIR-142
GO:0002440,production of molecular mediator of immune response,1.7939,<2.2e-16,MIR-142
GO:0001773,myeloid dendritic cell activation,1.7897,<2.2e-16,MIR-142
GO:0001818,negative regulation of cytokine production,1.7826,<2.2e-16,MIR-142
GO:0002683,negative regulation of immune system process,1.7811,<2.2e-16,MIR-142
GO:0002448,mast cell mediated immunity,1.7769,<2.2e-16,MIR-142
GO:0002526,acute inflammatory response,1.7689,<2.2e-16,MIR-142
GO:0001525,angiogenesis,2.1242,<2.2e-16,MIR-143
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.9829,<2.2e-16,MIR-143
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1.9603,<2.2e-16,MIR-143
GO:0042116,macrophage activation,1.9549,<2.2e-16,MIR-143
GO:0032612,interleukin-1 production,1.9374,<2.2e-16,MIR-143
GO:0007159,leukocyte cell-cell adhesion,1.9476,<2.2e-16,MIR-143
GO:0050900,leukocyte migration,2.4593,<2.2e-16,MIR-144
GO:0007159,leukocyte cell-cell adhesion,2.2939,0.00059051,MIR-144
GO:1990868,response to chemokine,2.3894,0.00068893,MIR-144
GO:0050727,regulation of inflammatory response,2.2996,0.00068893,MIR-144
GO:0002250,adaptive immune response,2.2565,0.0012401,MIR-144
GO:0032609,interferon-gamma production,2.2172,0.0013373,MIR-144
GO:0032615,interleukin-12 production,2.2412,0.0013779,MIR-144
GO:0032602,chemokine production,2.2146,0.0013779,MIR-144
GO:0032637,interleukin-8 production,2.2204,0.0014209,MIR-144
GO:0050663,cytokine secretion,2.2244,0.0015157,MIR-144
GO:0001819,positive regulation of cytokine production,2.2377,0.0015898,MIR-144
GO:0002449,lymphocyte mediated immunity,2.1832,0.0022844,MIR-144
GO:0042110,T cell activation,2.1446,0.0032350,MIR-144
GO:0001525,angiogenesis,1.6303,0.0078008,MIR-145
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.6458,0.0090835,MIR-145
GO:0002250,adaptive immune response,1.944,<2.2e-16,MIR-146A
GO:0002449,lymphocyte mediated immunity,1.9183,<2.2e-16,MIR-146A
GO:0002285,lymphocyte activation involved in immune response,1.9157,<2.2e-16,MIR-146A
GO:0007159,leukocyte cell-cell adhesion,1.8962,<2.2e-16,MIR-146A
GO:0002764,immune response-regulating signaling pathway,1.8771,<2.2e-16,MIR-146A
GO:0002694,regulation of leukocyte activation,1.861,<2.2e-16,MIR-146A
GO:0002697,regulation of immune effector process,1.838,<2.2e-16,MIR-146A
GO:0001819,positive regulation of cytokine production,1.8368,<2.2e-16,MIR-146A
GO:0002521,leukocyte differentiation,1.8128,<2.2e-16,MIR-146A
GO:0006959,humoral immune response,1.8059,<2.2e-16,MIR-146A
GO:0002446,neutrophil mediated immunity,1.7987,<2.2e-16,MIR-146A
GO:0001818,negative regulation of cytokine production,1.7895,<2.2e-16,MIR-146A
GO:0002532,production of molecular mediator involved in inflammatory response,1.7781,<2.2e-16,MIR-146A
GO:0002683,negative regulation of immune system process,1.7739,<2.2e-16,MIR-146A
GO:0002440,production of molecular mediator of immune response,1.7684,<2.2e-16,MIR-146A
GO:0002448,mast cell mediated immunity,1.7665,<2.2e-16,MIR-146A
GO:0002526,acute inflammatory response,1.7473,<2.2e-16,MIR-146A
GO:0001773,myeloid dendritic cell activation,1.7468,<2.2e-16,MIR-146A
GO:0034341,response to interferon-gamma,2.3835,<2.2e-16,MIR-148A
GO:0002250,adaptive immune response,2.3531,<2.2e-16,MIR-148A
GO:0034340,response to type I interferon,2.3415,<2.2e-16,MIR-148A
GO:0002449,lymphocyte mediated immunity,2.2778,<2.2e-16,MIR-148A
GO:0007159,leukocyte cell-cell adhesion,2.1438,<2.2e-16,MIR-148A
GO:0042110,T cell activation,2.1334,<2.2e-16,MIR-148A
GO:0019882,antigen processing and presentation,2.1028,<2.2e-16,MIR-148A
GO:0032609,interferon-gamma production,2.0862,<2.2e-16,MIR-148A
GO:0070661,leukocyte proliferation,2.0831,<2.2e-16,MIR-148A
GO:0045088,regulation of innate immune response,2.076,<2.2e-16,MIR-148A
GO:0002697,regulation of immune effector process,2.0755,<2.2e-16,MIR-148A
GO:0002694,regulation of leukocyte activation,2.0746,<2.2e-16,MIR-148A
GO:0002764,immune response-regulating signaling pathway,2.0656,<2.2e-16,MIR-148A
GO:0035456,response to interferon-beta,2.0297,<2.2e-16,MIR-148A
GO:0006959,humoral immune response,2.0185,<2.2e-16,MIR-148A
GO:0050727,regulation of inflammatory response,1.9681,<2.2e-16,MIR-148A
GO:0001818,negative regulation of cytokine production,-2.1493,<2.2e-16,MIR-149
GO:0002446,neutrophil mediated immunity,-2.1545,<2.2e-16,MIR-149
GO:0002532,production of molecular mediator involved in inflammatory response,-2.1628,<2.2e-16,MIR-149
GO:0002683,negative regulation of immune system process,-2.2014,<2.2e-16,MIR-149
GO:0002285,lymphocyte activation involved in immune response,-2.2253,<2.2e-16,MIR-149
GO:0030101,natural killer cell activation,-2.2902,<2.2e-16,MIR-149
GO:0019882,antigen processing and presentation,-2.3629,<2.2e-16,MIR-149
GO:0002526,acute inflammatory response,-2.3733,<2.2e-16,MIR-149
GO:0002694,regulation of leukocyte activation,-2.4362,<2.2e-16,MIR-149
GO:0007159,leukocyte cell-cell adhesion,-2.4768,<2.2e-16,MIR-149
GO:0002697,regulation of immune effector process,-2.5224,<2.2e-16,MIR-149
GO:0032606,type I interferon production,-2.5468,<2.2e-16,MIR-149
GO:0032609,interferon-gamma production,-2.6053,<2.2e-16,MIR-149
GO:0002449,lymphocyte mediated immunity,-2.7458,<2.2e-16,MIR-149
GO:0002764,immune response-regulating signaling pathway,-2.7248,<2.2e-16,MIR-149
GO:0002250,adaptive immune response,-2.8212,<2.2e-16,MIR-149
GO:0032615,interleukin-12 production,1.7081,<2.2e-16,MIR-150
GO:0002250,adaptive immune response,1.707,<2.2e-16,MIR-150
GO:0032633,interleukin-4 production,1.6987,<2.2e-16,MIR-150
GO:0032623,interleukin-2 production,1.6985,<2.2e-16,MIR-150
GO:0042110,T cell activation,1.6974,<2.2e-16,MIR-150
GO:0032609,interferon-gamma production,1.6892,<2.2e-16,MIR-150
GO:0002449,lymphocyte mediated immunity,1.6819,<2.2e-16,MIR-150
GO:0007159,leukocyte cell-cell adhesion,1.6776,<2.2e-16,MIR-150
GO:0001773,myeloid dendritic cell activation,1.6771,<2.2e-16,MIR-150
GO:1990868,response to chemokine,1.6713,<2.2e-16,MIR-150
GO:0070661,leukocyte proliferation,1.6705,<2.2e-16,MIR-150
GO:0032613,interleukin-10 production,1.6643,<2.2e-16,MIR-150
GO:0002285,lymphocyte activation involved in immune response,1.664,<2.2e-16,MIR-150
GO:0071887,leukocyte apoptotic process,1.6622,<2.2e-16,MIR-150
GO:0032637,interleukin-8 production,1.6599,<2.2e-16,MIR-150
GO:0045576,mast cell activation,1.6534,<2.2e-16,MIR-150
GO:0002694,regulation of leukocyte activation,1.6476,<2.2e-16,MIR-150
GO:0002521,leukocyte differentiation,1.6474,<2.2e-16,MIR-150
GO:0002764,immune response-regulating signaling pathway,1.6469,<2.2e-16,MIR-150
GO:0050900,leukocyte migration,1.736,0.00020020,MIR-152
GO:0001525,angiogenesis,1.7461,0.00022523,MIR-152
GO:0007159,leukocyte cell-cell adhesion,1.729,0.00025740,MIR-152
GO:0032615,interleukin-12 production,1.7316,0.00030030,MIR-152
GO:0002250,adaptive immune response,1.6869,0.00062370,MIR-152
GO:0035455,response to interferon-alpha,-2.0356,0.0029295,MIR-153-1
GO:0035456,response to interferon-beta,-1.8923,0.009765,MIR-153-1
GO:0070670,response to interleukin-4,-1.9271,0.009765,MIR-153-1
GO:0034340,response to type I interferon,-1.8269,0.021092,MIR-153-1
GO:0060759,regulation of response to cytokine stimulus,-1.5679,0.15201,MIR-153-1
GO:0036230,granulocyte activation,-2.2067,<2.2e-16,MIR-153-2
GO:0002446,neutrophil mediated immunity,-2.1251,0.0026450,MIR-153-2
GO:0002764,immune response-regulating signaling pathway,-1.9687,0.017986,MIR-153-2
GO:0002250,adaptive immune response,-1.8528,0.035443,MIR-153-2
GO:0002449,lymphocyte mediated immunity,-1.8541,0.038793,MIR-153-2
GO:0045576,mast cell activation,-1.7324,0.058190,MIR-153-2
GO:0002526,acute inflammatory response,-1.7255,0.059582,MIR-153-2
GO:0034341,response to interferon-gamma,-1.7095,0.060835,MIR-153-2
GO:0002683,negative regulation of immune system process,-1.6667,0.072839,MIR-153-2
GO:0035456,response to interferon-beta,-2.285,<2.2e-16,MIR-154
GO:0034340,response to type I interferon,-2.3624,<2.2e-16,MIR-154
GO:0002250,adaptive immune response,2.0914,<2.2e-16,MIR-155
GO:0002449,lymphocyte mediated immunity,2.0632,<2.2e-16,MIR-155
GO:0002764,immune response-regulating signaling pathway,2.0473,<2.2e-16,MIR-155
GO:0002697,regulation of immune effector process,2.0333,<2.2e-16,MIR-155
GO:0002694,regulation of leukocyte activation,2.0333,<2.2e-16,MIR-155
GO:0007159,leukocyte cell-cell adhesion,2.0328,<2.2e-16,MIR-155
GO:0002285,lymphocyte activation involved in immune response,2.023,<2.2e-16,MIR-155
GO:0001819,positive regulation of cytokine production,2.0111,<2.2e-16,MIR-155
GO:0002440,production of molecular mediator of immune response,1.9577,<2.2e-16,MIR-155
GO:0001818,negative regulation of cytokine production,1.953,<2.2e-16,MIR-155
GO:0002521,leukocyte differentiation,1.9472,<2.2e-16,MIR-155
GO:0002446,neutrophil mediated immunity,1.9228,<2.2e-16,MIR-155
GO:0002683,negative regulation of immune system process,1.9209,<2.2e-16,MIR-155
GO:0002526,acute inflammatory response,1.8863,<2.2e-16,MIR-155
GO:0006959,humoral immune response,1.8849,<2.2e-16,MIR-155
GO:0002269,leukocyte activation involved in inflammatory response,1.8325,<2.2e-16,MIR-155
GO:0001773,myeloid dendritic cell activation,1.7826,<2.2e-16,MIR-155
GO:0002250,adaptive immune response,2.4023,<2.2e-16,MIR-15A
GO:0007159,leukocyte cell-cell adhesion,2.2995,<2.2e-16,MIR-15A
GO:0002449,lymphocyte mediated immunity,2.2638,<2.2e-16,MIR-15A
GO:0032609,interferon-gamma production,2.2598,<2.2e-16,MIR-15A
GO:0002694,regulation of leukocyte activation,2.2463,<2.2e-16,MIR-15A
GO:0002764,immune response-regulating signaling pathway,2.2044,<2.2e-16,MIR-15A
GO:0001819,positive regulation of cytokine production,2.1776,<2.2e-16,MIR-15A
GO:0002697,regulation of immune effector process,2.1762,<2.2e-16,MIR-15A
GO:0032615,interleukin-12 production,2.173,<2.2e-16,MIR-15A
GO:0002285,lymphocyte activation involved in immune response,2.1723,<2.2e-16,MIR-15A
GO:0032613,interleukin-10 production,2.0863,<2.2e-16,MIR-15A
GO:0030101,natural killer cell activation,2.0634,<2.2e-16,MIR-15A
GO:0002521,leukocyte differentiation,2.042,<2.2e-16,MIR-15A
GO:0002507,tolerance induction,2.0186,<2.2e-16,MIR-15A
GO:0002526,acute inflammatory response,2.0115,<2.2e-16,MIR-15A
GO:0034340,response to type I interferon,2.2163,<2.2e-16,MIR-15B
GO:0032606,type I interferon production,2.1877,<2.2e-16,MIR-15B
GO:0019882,antigen processing and presentation,2.1538,<2.2e-16,MIR-15B
GO:0034341,response to interferon-gamma,2.1249,<2.2e-16,MIR-15B
GO:0071559,response to transforming growth factor beta,-1.6636,0.078694,MIR-15B
GO:0002250,adaptive immune response,2.4432,<2.2e-16,MIR-16-1
GO:0002764,immune response-regulating signaling pathway,2.3281,<2.2e-16,MIR-16-1
GO:0032606,type I interferon production,2.327,<2.2e-16,MIR-16-1
GO:0032609,interferon-gamma production,2.2893,<2.2e-16,MIR-16-1
GO:0007159,leukocyte cell-cell adhesion,2.2792,<2.2e-16,MIR-16-1
GO:0001819,positive regulation of cytokine production,2.2618,<2.2e-16,MIR-16-1
GO:0002449,lymphocyte mediated immunity,2.2404,<2.2e-16,MIR-16-1
GO:0002285,lymphocyte activation involved in immune response,2.2391,<2.2e-16,MIR-16-1
GO:0002697,regulation of immune effector process,2.2098,<2.2e-16,MIR-16-1
GO:0002694,regulation of leukocyte activation,2.2009,<2.2e-16,MIR-16-1
GO:0032615,interleukin-12 production,2.1502,<2.2e-16,MIR-16-1
GO:0019882,antigen processing and presentation,2.1128,<2.2e-16,MIR-16-1
GO:0030101,natural killer cell activation,2.1111,<2.2e-16,MIR-16-1
GO:0002250,adaptive immune response,2.3249,<2.2e-16,MIR-16-2
GO:0034340,response to type I interferon,2.1747,<2.2e-16,MIR-16-2
GO:0007159,leukocyte cell-cell adhesion,2.1659,<2.2e-16,MIR-16-2
GO:0032606,type I interferon production,2.1586,<2.2e-16,MIR-16-2
GO:0042110,T cell activation,2.1516,<2.2e-16,MIR-16-2
GO:0002449,lymphocyte mediated immunity,2.1422,<2.2e-16,MIR-16-2
GO:0002285,lymphocyte activation involved in immune response,2.1125,<2.2e-16,MIR-16-2
GO:0002697,regulation of immune effector process,2.0895,<2.2e-16,MIR-16-2
GO:0032609,interferon-gamma production,2.0878,<2.2e-16,MIR-16-2
GO:0002694,regulation of leukocyte activation,2.0812,<2.2e-16,MIR-16-2
GO:0032615,interleukin-12 production,2.0436,<2.2e-16,MIR-16-2
GO:0002764,immune response-regulating signaling pathway,2.043,<2.2e-16,MIR-16-2
GO:0036230,granulocyte activation,-2.291,<2.2e-16,MIR-17
GO:0002446,neutrophil mediated immunity,-2.3026,<2.2e-16,MIR-17
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.9607,0.0016332,MIR-17
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-1.9598,0.0020324,MIR-17
GO:0001525,angiogenesis,-1.9284,0.0036293,MIR-17
GO:0050663,cytokine secretion,-2.101,<2.2e-16,MIR-18A
GO:0034341,response to interferon-gamma,-2.1536,<2.2e-16,MIR-18A
GO:0032637,interleukin-8 production,-2.2982,<2.2e-16,MIR-18A
GO:0032635,interleukin-6 production,-2.0492,0.0022097,MIR-18A
GO:0002764,immune response-regulating signaling pathway,-1.999,0.0023830,MIR-18A
GO:0045576,mast cell activation,-2.0076,0.0025320,MIR-18A
GO:0032620,interleukin-17 production,-2.0109,0.0028937,MIR-18A
GO:0050727,regulation of inflammatory response,-2.0184,0.0033760,MIR-18A
GO:0007159,leukocyte cell-cell adhesion,-1.9664,0.0042644,MIR-18A
GO:0002446,neutrophil mediated immunity,-1.9462,0.0051560,MIR-18A
GO:0002269,leukocyte activation involved in inflammatory response,-2.027,<2.2e-16,MIR-181A-2
GO:0002507,tolerance induction,-2.0294,<2.2e-16,MIR-181A-2
GO:0001818,negative regulation of cytokine production,-2.1729,<2.2e-16,MIR-181A-2
GO:0002440,production of molecular mediator of immune response,-2.2172,<2.2e-16,MIR-181A-2
GO:0002285,lymphocyte activation involved in immune response,-2.2648,<2.2e-16,MIR-181A-2
GO:0002521,leukocyte differentiation,-2.2685,<2.2e-16,MIR-181A-2
GO:0002683,negative regulation of immune system process,-2.2791,<2.2e-16,MIR-181A-2
GO:0001773,myeloid dendritic cell activation,-2.3025,<2.2e-16,MIR-181A-2
GO:0002532,production of molecular mediator involved in inflammatory response,-2.3668,<2.2e-16,MIR-181A-2
GO:0002694,regulation of leukocyte activation,-2.4463,<2.2e-16,MIR-181A-2
GO:0002526,acute inflammatory response,-2.4975,<2.2e-16,MIR-181A-2
GO:0002446,neutrophil mediated immunity,-2.509,<2.2e-16,MIR-181A-2
GO:0006959,humoral immune response,-2.5139,<2.2e-16,MIR-181A-2
GO:0002449,lymphocyte mediated immunity,-2.5906,<2.2e-16,MIR-181A-2
GO:0002764,immune response-regulating signaling pathway,-2.5266,<2.2e-16,MIR-181A-2
GO:0002250,adaptive immune response,-2.7442,<2.2e-16,MIR-181A-2
GO:0034340,response to type I interferon,-2.1989,<2.2e-16,MIR-181B-1
GO:0019882,antigen processing and presentation,-2.3431,<2.2e-16,MIR-181B-1
GO:0002526,acute inflammatory response,-2.0538,0.00046954,MIR-181B-1
GO:0034341,response to interferon-gamma,-2.0654,0.00052171,MIR-181B-1
GO:0002251,organ or tissue specific immune response,-2.0877,0.00058692,MIR-181B-1
GO:0036230,granulocyte activation,-2.1524,0.00078256,MIR-181B-1
GO:0002446,neutrophil mediated immunity,-2.1856,0.00093908,MIR-181B-1
GO:0006959,humoral immune response,-1.9892,0.0018059,MIR-181B-1
GO:0002532,production of molecular mediator involved in inflammatory response,-1.976,0.0023477,MIR-181B-1
GO:0035456,response to interferon-beta,-1.8702,0.0087200,MIR-181B-1
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.8761,<2.2e-16,MIR-181B-2
GO:0035456,response to interferon-beta,-2.2533,<2.2e-16,MIR-181B-2
GO:0034340,response to type I interferon,-2.3456,<2.2e-16,MIR-181B-2
GO:0001525,angiogenesis,1.8309,0.00033097,MIR-181B-2
GO:0035455,response to interferon-alpha,-2.0467,0.00091599,MIR-181B-2
GO:0002507,tolerance induction,-2.0797,<2.2e-16,MIR-181C
GO:0002697,regulation of immune effector process,-2.0952,<2.2e-16,MIR-181C
GO:0001773,myeloid dendritic cell activation,-2.1551,<2.2e-16,MIR-181C
GO:0001525,angiogenesis,-2.1754,<2.2e-16,MIR-181C
GO:0002683,negative regulation of immune system process,-2.2081,<2.2e-16,MIR-181C
GO:0002764,immune response-regulating signaling pathway,-2.2125,<2.2e-16,MIR-181C
GO:0002449,lymphocyte mediated immunity,-2.2276,<2.2e-16,MIR-181C
GO:0001819,positive regulation of cytokine production,-2.2399,<2.2e-16,MIR-181C
GO:0002285,lymphocyte activation involved in immune response,-2.3263,<2.2e-16,MIR-181C
GO:0002526,acute inflammatory response,-2.3351,<2.2e-16,MIR-181C
GO:0002532,production of molecular mediator involved in inflammatory response,-2.3484,<2.2e-16,MIR-181C
GO:0006959,humoral immune response,-2.376,<2.2e-16,MIR-181C
GO:0002694,regulation of leukocyte activation,-2.4047,<2.2e-16,MIR-181C
GO:0002521,leukocyte differentiation,-2.3966,<2.2e-16,MIR-181C
GO:0002446,neutrophil mediated immunity,-2.6761,<2.2e-16,MIR-181C
GO:0001525,angiogenesis,-2.1482,<2.2e-16,MIR-182
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.9835,0.00062097,MIR-182
GO:0050727,regulation of inflammatory response,-2.0343,0.00070968,MIR-182
GO:0002532,production of molecular mediator involved in inflammatory response,-2.0143,<2.2e-16,MIR-183
GO:0001525,angiogenesis,-2.0183,<2.2e-16,MIR-183
GO:0032637,interleukin-8 production,-2.0399,<2.2e-16,MIR-183
GO:0002269,leukocyte activation involved in inflammatory response,-2.0511,<2.2e-16,MIR-183
GO:0042110,T cell activation,-2.0533,<2.2e-16,MIR-183
GO:0032635,interleukin-6 production,-2.0591,<2.2e-16,MIR-183
GO:0050900,leukocyte migration,-2.062,<2.2e-16,MIR-183
GO:0070661,leukocyte proliferation,-2.0668,<2.2e-16,MIR-183
GO:0007159,leukocyte cell-cell adhesion,-2.085,<2.2e-16,MIR-183
GO:0002526,acute inflammatory response,-2.1092,<2.2e-16,MIR-183
GO:0002250,adaptive immune response,-2.1095,<2.2e-16,MIR-183
GO:0034341,response to interferon-gamma,-2.1096,<2.2e-16,MIR-183
GO:0002694,regulation of leukocyte activation,-2.1283,<2.2e-16,MIR-183
GO:0050727,regulation of inflammatory response,-2.1455,<2.2e-16,MIR-183
GO:0002507,tolerance induction,-2.1976,<2.2e-16,MIR-184
GO:0002532,production of molecular mediator involved in inflammatory response,-2.248,<2.2e-16,MIR-184
GO:0001818,negative regulation of cytokine production,-2.3181,<2.2e-16,MIR-184
GO:0002440,production of molecular mediator of immune response,-2.3227,<2.2e-16,MIR-184
GO:0002526,acute inflammatory response,-2.3457,<2.2e-16,MIR-184
GO:0002683,negative regulation of immune system process,-2.3844,<2.2e-16,MIR-184
GO:0002521,leukocyte differentiation,-2.4484,<2.2e-16,MIR-184
GO:0002697,regulation of immune effector process,-2.5134,<2.2e-16,MIR-184
GO:0002446,neutrophil mediated immunity,-2.5555,<2.2e-16,MIR-184
GO:0002285,lymphocyte activation involved in immune response,-2.5729,<2.2e-16,MIR-184
GO:0001819,positive regulation of cytokine production,-2.5966,<2.2e-16,MIR-184
GO:0002449,lymphocyte mediated immunity,-2.6394,<2.2e-16,MIR-184
GO:0007159,leukocyte cell-cell adhesion,-2.7011,<2.2e-16,MIR-184
GO:0002694,regulation of leukocyte activation,-2.6695,<2.2e-16,MIR-184
GO:0002764,immune response-regulating signaling pathway,-2.7532,<2.2e-16,MIR-184
GO:0002250,adaptive immune response,-2.9524,<2.2e-16,MIR-184
GO:0002250,adaptive immune response,2.5951,<2.2e-16,MIR-185
GO:0007159,leukocyte cell-cell adhesion,2.4875,<2.2e-16,MIR-185
GO:0002449,lymphocyte mediated immunity,2.46,<2.2e-16,MIR-185
GO:0002694,regulation of leukocyte activation,2.3649,<2.2e-16,MIR-185
GO:0002764,immune response-regulating signaling pathway,2.3156,<2.2e-16,MIR-185
GO:0001819,positive regulation of cytokine production,2.3081,<2.2e-16,MIR-185
GO:0002521,leukocyte differentiation,2.2981,<2.2e-16,MIR-185
GO:0002285,lymphocyte activation involved in immune response,2.2967,<2.2e-16,MIR-185
GO:0002446,neutrophil mediated immunity,2.2604,<2.2e-16,MIR-185
GO:0002697,regulation of immune effector process,2.2307,<2.2e-16,MIR-185
GO:0002683,negative regulation of immune system process,2.1873,<2.2e-16,MIR-185
GO:0002440,production of molecular mediator of immune response,2.0995,<2.2e-16,MIR-185
GO:0002526,acute inflammatory response,2.0653,<2.2e-16,MIR-185
GO:0002532,production of molecular mediator involved in inflammatory response,1.9848,<2.2e-16,MIR-185
GO:0002269,leukocyte activation involved in inflammatory response,1.981,<2.2e-16,MIR-185
GO:0002250,adaptive immune response,2.7193,<2.2e-16,MIR-186
GO:0002449,lymphocyte mediated immunity,2.5319,<2.2e-16,MIR-186
GO:0001819,positive regulation of cytokine production,2.4713,<2.2e-16,MIR-186
GO:0002697,regulation of immune effector process,2.4431,<2.2e-16,MIR-186
GO:0002764,immune response-regulating signaling pathway,2.4271,<2.2e-16,MIR-186
GO:0007159,leukocyte cell-cell adhesion,2.42,<2.2e-16,MIR-186
GO:0002526,acute inflammatory response,2.4004,<2.2e-16,MIR-186
GO:0002446,neutrophil mediated immunity,2.3489,<2.2e-16,MIR-186
GO:0002694,regulation of leukocyte activation,2.297,<2.2e-16,MIR-186
GO:0002285,lymphocyte activation involved in immune response,2.2913,<2.2e-16,MIR-186
GO:0019882,antigen processing and presentation,2.2039,<2.2e-16,MIR-186
GO:0002532,production of molecular mediator involved in inflammatory response,2.177,<2.2e-16,MIR-186
GO:0006959,humoral immune response,2.1578,<2.2e-16,MIR-186
GO:0001818,negative regulation of cytokine production,2.1516,<2.2e-16,MIR-186
GO:0034340,response to type I interferon,1.932,0.0024383,MIR-187
GO:0001525,angiogenesis,-1.8265,0.0024574,MIR-187
GO:0035456,response to interferon-beta,1.9518,0.0030189,MIR-187
GO:0034340,response to type I interferon,2.2621,<2.2e-16,MIR-188
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.7773,0.018469,MIR-188
GO:0035456,response to interferon-beta,1.7987,0.11408,MIR-188
GO:0002251,organ or tissue specific immune response,1.6081,0.13558,MIR-188
GO:0032606,type I interferon production,1.8188,0.13752,MIR-188
GO:0001525,angiogenesis,-1.9695,<2.2e-16,MIR-191
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.1062,<2.2e-16,MIR-191
GO:0034340,response to type I interferon,1.9092,0.0012633,MIR-191
GO:0034340,response to type I interferon,2.1474,<2.2e-16,MIR-192
GO:0035456,response to interferon-beta,1.8525,0.010479,MIR-192
GO:0032606,type I interferon production,1.7083,0.021376,MIR-192
GO:0007159,leukocyte cell-cell adhesion,2.4022,<2.2e-16,MIR-193A
GO:0002764,immune response-regulating signaling pathway,2.3549,<2.2e-16,MIR-193A
GO:0002250,adaptive immune response,2.3227,<2.2e-16,MIR-193A
GO:0001819,positive regulation of cytokine production,2.3149,<2.2e-16,MIR-193A
GO:0002521,leukocyte differentiation,2.2517,<2.2e-16,MIR-193A
GO:0002694,regulation of leukocyte activation,2.2498,<2.2e-16,MIR-193A
GO:0002449,lymphocyte mediated immunity,2.2349,<2.2e-16,MIR-193A
GO:0002285,lymphocyte activation involved in immune response,2.2007,<2.2e-16,MIR-193A
GO:0002697,regulation of immune effector process,2.1965,<2.2e-16,MIR-193A
GO:0002448,mast cell mediated immunity,2.1766,<2.2e-16,MIR-193A
GO:0002507,tolerance induction,2.1263,<2.2e-16,MIR-193A
GO:0001525,angiogenesis,2.123,<2.2e-16,MIR-193A
GO:0002683,negative regulation of immune system process,2.0798,<2.2e-16,MIR-193A
GO:0034340,response to type I interferon,2.0899,<2.2e-16,MIR-194-1
GO:0001525,angiogenesis,-1.9943,0.00081318,MIR-194-1
GO:0070670,response to interleukin-4,1.9881,0.0013519,MIR-194-1
GO:0035456,response to interferon-beta,1.7149,0.032175,MIR-194-1
GO:0032606,type I interferon production,1.6413,0.055041,MIR-194-1
GO:0001525,angiogenesis,-2.0224,0.00054432,MIR-194-2
GO:0034340,response to type I interferon,1.7257,0.043402,MIR-194-2
GO:0070670,response to interleukin-4,1.5813,0.11427,MIR-194-2
GO:0032606,type I interferon production,1.4768,0.12447,MIR-194-2
GO:0050900,leukocyte migration,2.2101,<2.2e-16,MIR-195
GO:0050727,regulation of inflammatory response,2.1486,<2.2e-16,MIR-195
GO:0032637,interleukin-8 production,2.11,<2.2e-16,MIR-195
GO:0007159,leukocyte cell-cell adhesion,2.0984,<2.2e-16,MIR-195
GO:0032635,interleukin-6 production,2.0977,<2.2e-16,MIR-195
GO:0071706,tumor necrosis factor superfamily cytokine production,2.0887,<2.2e-16,MIR-195
GO:0032609,interferon-gamma production,2.0832,<2.2e-16,MIR-195
GO:0002250,adaptive immune response,2.0726,<2.2e-16,MIR-195
GO:0042116,macrophage activation,2.0707,<2.2e-16,MIR-195
GO:0002526,acute inflammatory response,2.0452,<2.2e-16,MIR-195
GO:0001525,angiogenesis,2.0048,<2.2e-16,MIR-195
GO:0002532,production of molecular mediator involved in inflammatory response,1.9989,<2.2e-16,MIR-195
GO:0034341,response to interferon-gamma,1.9964,<2.2e-16,MIR-195
GO:0001819,positive regulation of cytokine production,1.9942,<2.2e-16,MIR-195
GO:0035455,response to interferon-alpha,-2.1265,<2.2e-16,MIR-196A-1
GO:0035456,response to interferon-beta,-1.7686,0.015182,MIR-196A-1
GO:0035455,response to interferon-alpha,-2.088,<2.2e-16,MIR-196A-2
GO:0035456,response to interferon-beta,-1.8528,0.065291,MIR-196A-2
GO:0034340,response to type I interferon,-1.7986,0.081538,MIR-196A-2
GO:0071887,leukocyte apoptotic process,-1.5627,0.26306,MIR-196A-2
GO:0098760,response to interleukin-7,-1.4715,0.33405,MIR-196A-2
GO:0034341,response to interferon-gamma,-1.4836,0.34128,MIR-196A-2
GO:0050663,cytokine secretion,2.0755,0.00015259,MIR-197
GO:0007159,leukocyte cell-cell adhesion,2.0921,0.00016212,MIR-197
GO:0002526,acute inflammatory response,2.1082,0.00017293,MIR-197
GO:0071706,tumor necrosis factor superfamily cytokine production,2.109,0.00018528,MIR-197
GO:1990868,response to chemokine,2.1229,0.00019954,MIR-197
GO:0050900,leukocyte migration,2.1235,0.00021616,MIR-197
GO:0001525,angiogenesis,2.1414,0.00028822,MIR-197
GO:0002446,neutrophil mediated immunity,2.167,0.00037057,MIR-197
GO:0050727,regulation of inflammatory response,2.177,0.00043233,MIR-197
GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.0629,0.00043233,MIR-197
GO:0036230,granulocyte activation,2.1942,0.00051879,MIR-197
GO:0001819,positive regulation of cytokine production,2.0427,0.00068262,MIR-197
GO:0034341,response to interferon-gamma,2.0232,0.00074113,MIR-197
GO:0002764,immune response-regulating signaling pathway,1.9789,0.00074113,MIR-197
GO:0002446,neutrophil mediated immunity,0.10756,0.93991,MIR-198
GO:0036230,granulocyte activation,0.10852,0.93999,MIR-198
GO:0001819,positive regulation of cytokine production,0.090373,0.94148,MIR-198
GO:0001525,angiogenesis,1.6767,0.0021088,MIR-199A-1
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7325,0.0010645,MIR-199A-2
GO:0001525,angiogenesis,1.7063,0.0018850,MIR-199A-2
GO:0050900,leukocyte migration,1.6779,0.0020107,MIR-199A-2
GO:0001525,angiogenesis,1.7589,0.00058620,MIR-199B
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7498,0.00058620,MIR-199B
GO:0050900,leukocyte migration,1.7318,0.00065134,MIR-199B
GO:0001525,angiogenesis,-2.3367,<2.2e-16,MIR-19B-1
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.0796,0.00053770,MIR-19B-1
GO:0002446,neutrophil mediated immunity,-1.9681,0.00056108,MIR-19B-1
GO:0002446,neutrophil mediated immunity,-2.3533,<2.2e-16,MIR-19B-2
GO:0036230,granulocyte activation,-2.3705,<2.2e-16,MIR-19B-2
GO:0019882,antigen processing and presentation,-1.9817,0.0028258,MIR-19B-2
GO:0019882,antigen processing and presentation,-1.9502,0.012233,MIR-20A
GO:0002251,organ or tissue specific immune response,-1.7502,0.069464,MIR-20A
GO:0001525,angiogenesis,-2.0851,<2.2e-16,MIR-200A
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.924,0.00039123,MIR-200A
GO:0001525,angiogenesis,-1.8197,0.0012655,MIR-200B
GO:0034340,response to type I interferon,1.5255,0.30278,MIR-200B
GO:0032606,type I interferon production,1.5671,0.31918,MIR-200B
GO:1990823,response to leukemia inhibitory factor,1.4871,0.33288,MIR-200B
GO:0001525,angiogenesis,-2.0606,<2.2e-16,MIR-200C
GO:0034340,response to type I interferon,1.8902,0.015541,MIR-200C
GO:0032606,type I interferon production,1.6381,0.11494,MIR-200C
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7661,0.010689,MIR-204
GO:1990868,response to chemokine,1.762,0.010689,MIR-204
GO:0002446,neutrophil mediated immunity,1.9499,0.0046714,MIR-205
GO:0036230,granulocyte activation,1.932,0.0046714,MIR-205
GO:0032602,chemokine production,1.8239,0.022356,MIR-205
GO:0042092,type 2 immune response,1.8059,0.027153,MIR-205
GO:0002250,adaptive immune response,1.7395,0.045713,MIR-205
GO:0007159,leukocyte cell-cell adhesion,1.7454,0.045996,MIR-205
GO:0006959,humoral immune response,1.7047,0.047715,MIR-205
GO:0034612,response to tumor necrosis factor,1.6926,0.053297,MIR-205
GO:0008356,asymmetric cell division,-1.1488,0.79104,MIR-205
GO:0001818,negative regulation of cytokine production,-2.1145,<2.2e-16,MIR-206
GO:0002269,leukocyte activation involved in inflammatory response,-2.1252,<2.2e-16,MIR-206
GO:0002507,tolerance induction,-2.242,<2.2e-16,MIR-206
GO:0001773,myeloid dendritic cell activation,-2.2447,<2.2e-16,MIR-206
GO:0002532,production of molecular mediator involved in inflammatory response,-2.3774,<2.2e-16,MIR-206
GO:0006959,humoral immune response,-2.4079,<2.2e-16,MIR-206
GO:0002697,regulation of immune effector process,-2.4244,<2.2e-16,MIR-206
GO:0002285,lymphocyte activation involved in immune response,-2.4445,<2.2e-16,MIR-206
GO:0019882,antigen processing and presentation,-2.4519,<2.2e-16,MIR-206
GO:0002683,negative regulation of immune system process,-2.4727,<2.2e-16,MIR-206
GO:0002526,acute inflammatory response,-2.4756,<2.2e-16,MIR-206
GO:0002694,regulation of leukocyte activation,-2.4982,<2.2e-16,MIR-206
GO:0002521,leukocyte differentiation,-2.5402,<2.2e-16,MIR-206
GO:0001819,positive regulation of cytokine production,-2.5414,<2.2e-16,MIR-206
GO:0002764,immune response-regulating signaling pathway,-2.5424,<2.2e-16,MIR-206
GO:0002449,lymphocyte mediated immunity,-2.6385,<2.2e-16,MIR-206
GO:0002446,neutrophil mediated immunity,-2.6833,<2.2e-16,MIR-206
GO:0002250,adaptive immune response,-2.8189,<2.2e-16,MIR-206
GO:0002448,mast cell mediated immunity,-2.1472,<2.2e-16,MIR-208A
GO:0002507,tolerance induction,-2.1892,<2.2e-16,MIR-208A
GO:0001773,myeloid dendritic cell activation,-2.2035,<2.2e-16,MIR-208A
GO:0002532,production of molecular mediator involved in inflammatory response,-2.2267,<2.2e-16,MIR-208A
GO:0002440,production of molecular mediator of immune response,-2.2938,<2.2e-16,MIR-208A
GO:0002446,neutrophil mediated immunity,-2.3416,<2.2e-16,MIR-208A
GO:0002683,negative regulation of immune system process,-2.3525,<2.2e-16,MIR-208A
GO:0001818,negative regulation of cytokine production,-2.3666,<2.2e-16,MIR-208A
GO:0002521,leukocyte differentiation,-2.4289,<2.2e-16,MIR-208A
GO:0002285,lymphocyte activation involved in immune response,-2.4336,<2.2e-16,MIR-208A
GO:0002697,regulation of immune effector process,-2.523,<2.2e-16,MIR-208A
GO:0001819,positive regulation of cytokine production,-2.5819,<2.2e-16,MIR-208A
GO:0002449,lymphocyte mediated immunity,-2.6075,<2.2e-16,MIR-208A
GO:0002694,regulation of leukocyte activation,-2.6262,<2.2e-16,MIR-208A
GO:0002764,immune response-regulating signaling pathway,-2.6878,<2.2e-16,MIR-208A
GO:0007159,leukocyte cell-cell adhesion,2.3774,<2.2e-16,MIR-21
GO:0002250,adaptive immune response,2.3768,<2.2e-16,MIR-21
GO:0002449,lymphocyte mediated immunity,2.3044,<2.2e-16,MIR-21
GO:0002764,immune response-regulating signaling pathway,2.2833,<2.2e-16,MIR-21
GO:0001819,positive regulation of cytokine production,2.2815,<2.2e-16,MIR-21
GO:0002694,regulation of leukocyte activation,2.2565,<2.2e-16,MIR-21
GO:0002446,neutrophil mediated immunity,2.227,<2.2e-16,MIR-21
GO:0002285,lymphocyte activation involved in immune response,2.2016,<2.2e-16,MIR-21
GO:0002697,regulation of immune effector process,2.2013,<2.2e-16,MIR-21
GO:0002521,leukocyte differentiation,2.1932,<2.2e-16,MIR-21
GO:0002526,acute inflammatory response,2.168,<2.2e-16,MIR-21
GO:0002683,negative regulation of immune system process,2.1164,<2.2e-16,MIR-21
GO:0006959,humoral immune response,2.1036,<2.2e-16,MIR-21
GO:0001818,negative regulation of cytokine production,2.0752,<2.2e-16,MIR-21
GO:0002532,production of molecular mediator involved in inflammatory response,2.0576,<2.2e-16,MIR-21
GO:0002440,production of molecular mediator of immune response,2.0294,<2.2e-16,MIR-21
GO:0002507,tolerance induction,2.0028,<2.2e-16,MIR-21
GO:0001525,angiogenesis,2.0029,<2.2e-16,MIR-21
GO:0098760,response to interleukin-7,-1.4828,0.10976,MIR-210
GO:0032634,interleukin-5 production,-1.651,0.16288,MIR-211
GO:0034612,response to tumor necrosis factor,1.2139,0.57093,MIR-211
GO:0006925,inflammatory cell apoptotic process,1.2404,0.57215,MIR-211
GO:0008356,asymmetric cell division,1.251,0.57263,MIR-211
GO:0002251,organ or tissue specific immune response,1.2251,0.57301,MIR-211
GO:0001818,negative regulation of cytokine production,1.1636,0.5748,MIR-211
GO:0007159,leukocyte cell-cell adhesion,1.9855,<2.2e-16,MIR-212
GO:0002250,adaptive immune response,1.9448,<2.2e-16,MIR-212
GO:0032609,interferon-gamma production,1.9374,<2.2e-16,MIR-212
GO:0001525,angiogenesis,1.9271,<2.2e-16,MIR-212
GO:0032635,interleukin-6 production,1.8981,<2.2e-16,MIR-212
GO:0032615,interleukin-12 production,1.8924,<2.2e-16,MIR-212
GO:0002526,acute inflammatory response,1.8887,<2.2e-16,MIR-212
GO:0032612,interleukin-1 production,1.8838,<2.2e-16,MIR-212
GO:0002449,lymphocyte mediated immunity,1.8794,<2.2e-16,MIR-212
GO:0002694,regulation of leukocyte activation,1.8689,<2.2e-16,MIR-212
GO:0001819,positive regulation of cytokine production,1.8509,<2.2e-16,MIR-212
GO:0002521,leukocyte differentiation,1.8403,<2.2e-16,MIR-212
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.9484,<2.2e-16,MIR-181A-1
GO:0034340,response to type I interferon,-1.6667,0.043957,MIR-181A-1
GO:0001525,angiogenesis,1.642,0.0034735,MIR-214
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.8165,0.027433,MIR-215
GO:0006959,humoral immune response,2.0529,0.73625,MIR-215
GO:1990868,response to chemokine,1.0176,0.82715,MIR-215
GO:0071706,tumor necrosis factor superfamily cytokine production,1.0265,0.82856,MIR-215
GO:0032606,type I interferon production,0.94619,0.83197,MIR-215
GO:0007159,leukocyte cell-cell adhesion,0.96931,0.83212,MIR-215
GO:0150076,neuroinflammatory response,1.0203,0.83269,MIR-215
GO:0050900,leukocyte migration,2.0353,0.0023043,MIR-216A
GO:1990868,response to chemokine,2.0442,0.0034565,MIR-216A
GO:0050727,regulation of inflammatory response,1.8091,0.016673,MIR-216A
GO:0032615,interleukin-12 production,1.9295,<2.2e-16,MIR-217
GO:0050900,leukocyte migration,1.8924,<2.2e-16,MIR-217
GO:0001525,angiogenesis,1.8828,<2.2e-16,MIR-217
GO:0002250,adaptive immune response,1.8724,<2.2e-16,MIR-217
GO:1990868,response to chemokine,1.8654,<2.2e-16,MIR-217
GO:0032609,interferon-gamma production,1.838,<2.2e-16,MIR-217
GO:0034340,response to type I interferon,-1.8629,0.0093512,MIR-218-1
GO:0001818,negative regulation of cytokine production,-2.2278,<2.2e-16,MIR-218-2
GO:0002440,production of molecular mediator of immune response,-2.2394,<2.2e-16,MIR-218-2
GO:0006959,humoral immune response,-2.2899,<2.2e-16,MIR-218-2
GO:0002521,leukocyte differentiation,-2.2933,<2.2e-16,MIR-218-2
GO:0001773,myeloid dendritic cell activation,-2.3287,<2.2e-16,MIR-218-2
GO:0002285,lymphocyte activation involved in immune response,-2.407,<2.2e-16,MIR-218-2
GO:0002697,regulation of immune effector process,-2.4951,<2.2e-16,MIR-218-2
GO:0002526,acute inflammatory response,-2.4953,<2.2e-16,MIR-218-2
GO:0001819,positive regulation of cytokine production,-2.5048,<2.2e-16,MIR-218-2
GO:0002449,lymphocyte mediated immunity,-2.5186,<2.2e-16,MIR-218-2
GO:0002532,production of molecular mediator involved in inflammatory response,-2.5419,<2.2e-16,MIR-218-2
GO:0002694,regulation of leukocyte activation,-2.5718,<2.2e-16,MIR-218-2
GO:0007159,leukocyte cell-cell adhesion,-2.6373,<2.2e-16,MIR-218-2
GO:0002250,adaptive immune response,-2.6393,<2.2e-16,MIR-218-2
GO:0002446,neutrophil mediated immunity,-2.8163,<2.2e-16,MIR-218-2
GO:0007159,leukocyte cell-cell adhesion,2.0704,<2.2e-16,MIR-22
GO:0002250,adaptive immune response,2.0546,<2.2e-16,MIR-22
GO:0032609,interferon-gamma production,1.9964,<2.2e-16,MIR-22
GO:0002449,lymphocyte mediated immunity,1.9883,<2.2e-16,MIR-22
GO:0002448,mast cell mediated immunity,1.9682,<2.2e-16,MIR-22
GO:0032635,interleukin-6 production,1.9492,<2.2e-16,MIR-22
GO:0002285,lymphocyte activation involved in immune response,1.9492,<2.2e-16,MIR-22
GO:0002526,acute inflammatory response,1.9349,<2.2e-16,MIR-22
GO:0002694,regulation of leukocyte activation,1.9334,<2.2e-16,MIR-22
GO:0001819,positive regulation of cytokine production,1.9321,<2.2e-16,MIR-22
GO:0032615,interleukin-12 production,1.9288,<2.2e-16,MIR-22
GO:0002446,neutrophil mediated immunity,1.9187,<2.2e-16,MIR-22
GO:0002521,leukocyte differentiation,1.9153,<2.2e-16,MIR-22
GO:0002764,immune response-regulating signaling pathway,1.8986,<2.2e-16,MIR-22
GO:0007159,leukocyte cell-cell adhesion,2.5232,<2.2e-16,MIR-221
GO:0002250,adaptive immune response,2.4807,<2.2e-16,MIR-221
GO:0002764,immune response-regulating signaling pathway,2.3945,<2.2e-16,MIR-221
GO:0002449,lymphocyte mediated immunity,2.3292,<2.2e-16,MIR-221
GO:0001819,positive regulation of cytokine production,2.3243,<2.2e-16,MIR-221
GO:0002694,regulation of leukocyte activation,2.3163,<2.2e-16,MIR-221
GO:0002697,regulation of immune effector process,2.3015,<2.2e-16,MIR-221
GO:0002521,leukocyte differentiation,2.284,<2.2e-16,MIR-221
GO:0002683,negative regulation of immune system process,2.2353,<2.2e-16,MIR-221
GO:0002285,lymphocyte activation involved in immune response,2.1965,<2.2e-16,MIR-221
GO:0001818,negative regulation of cytokine production,2.1456,<2.2e-16,MIR-221
GO:0002532,production of molecular mediator involved in inflammatory response,2.142,<2.2e-16,MIR-221
GO:0002526,acute inflammatory response,2.1031,<2.2e-16,MIR-221
GO:0006959,humoral immune response,2.0944,<2.2e-16,MIR-221
GO:0001525,angiogenesis,2.0941,<2.2e-16,MIR-221
GO:0001773,myeloid dendritic cell activation,1.9725,<2.2e-16,MIR-221
GO:0002446,neutrophil mediated immunity,2.049,<2.2e-16,MIR-221
GO:0007159,leukocyte cell-cell adhesion,2.4271,<2.2e-16,MIR-222
GO:0002250,adaptive immune response,2.398,<2.2e-16,MIR-222
GO:0002764,immune response-regulating signaling pathway,2.3182,<2.2e-16,MIR-222
GO:0002694,regulation of leukocyte activation,2.273,<2.2e-16,MIR-222
GO:0002449,lymphocyte mediated immunity,2.2633,<2.2e-16,MIR-222
GO:0002697,regulation of immune effector process,2.2471,<2.2e-16,MIR-222
GO:0002285,lymphocyte activation involved in immune response,2.2206,<2.2e-16,MIR-222
GO:0001819,positive regulation of cytokine production,2.2187,<2.2e-16,MIR-222
GO:0002521,leukocyte differentiation,2.2186,<2.2e-16,MIR-222
GO:0002532,production of molecular mediator involved in inflammatory response,2.1744,<2.2e-16,MIR-222
GO:0006959,humoral immune response,2.1722,<2.2e-16,MIR-222
GO:0001818,negative regulation of cytokine production,2.1543,<2.2e-16,MIR-222
GO:0002683,negative regulation of immune system process,2.1539,<2.2e-16,MIR-222
GO:0002526,acute inflammatory response,2.1096,<2.2e-16,MIR-222
GO:0002446,neutrophil mediated immunity,2.0952,<2.2e-16,MIR-222
GO:0001525,angiogenesis,2.0301,<2.2e-16,MIR-222
GO:0007159,leukocyte cell-cell adhesion,1.8336,<2.2e-16,MIR-223
GO:0002250,adaptive immune response,1.8219,<2.2e-16,MIR-223
GO:0002449,lymphocyte mediated immunity,1.808,<2.2e-16,MIR-223
GO:0002269,leukocyte activation involved in inflammatory response,1.8034,<2.2e-16,MIR-223
GO:0002764,immune response-regulating signaling pathway,1.7885,<2.2e-16,MIR-223
GO:0002694,regulation of leukocyte activation,1.7774,<2.2e-16,MIR-223
GO:0006959,humoral immune response,1.7763,<2.2e-16,MIR-223
GO:0002526,acute inflammatory response,1.7752,<2.2e-16,MIR-223
GO:0001773,myeloid dendritic cell activation,1.7733,<2.2e-16,MIR-223
GO:0002285,lymphocyte activation involved in immune response,1.7696,<2.2e-16,MIR-223
GO:0001819,positive regulation of cytokine production,1.7641,<2.2e-16,MIR-223
GO:0002507,tolerance induction,1.7571,<2.2e-16,MIR-223
GO:0002532,production of molecular mediator involved in inflammatory response,1.7528,<2.2e-16,MIR-223
GO:0002446,neutrophil mediated immunity,1.7522,<2.2e-16,MIR-223
GO:0002250,adaptive immune response,2.6004,<2.2e-16,MIR-224
GO:0007159,leukocyte cell-cell adhesion,2.486,<2.2e-16,MIR-224
GO:0002449,lymphocyte mediated immunity,2.4642,<2.2e-16,MIR-224
GO:0002446,neutrophil mediated immunity,2.4277,<2.2e-16,MIR-224
GO:0002694,regulation of leukocyte activation,2.4099,<2.2e-16,MIR-224
GO:0002764,immune response-regulating signaling pathway,2.3996,<2.2e-16,MIR-224
GO:0002285,lymphocyte activation involved in immune response,2.3536,<2.2e-16,MIR-224
GO:0001819,positive regulation of cytokine production,2.3497,<2.2e-16,MIR-224
GO:0002526,acute inflammatory response,2.3339,<2.2e-16,MIR-224
GO:0002697,regulation of immune effector process,2.3296,<2.2e-16,MIR-224
GO:0019882,antigen processing and presentation,2.3242,<2.2e-16,MIR-224
GO:0002521,leukocyte differentiation,2.2765,<2.2e-16,MIR-224
GO:0006959,humoral immune response,2.2721,<2.2e-16,MIR-224
GO:0002532,production of molecular mediator involved in inflammatory response,2.2347,<2.2e-16,MIR-224
GO:0002683,negative regulation of immune system process,2.1499,<2.2e-16,MIR-224
GO:0001818,negative regulation of cytokine production,2.1228,<2.2e-16,MIR-224
GO:0001773,myeloid dendritic cell activation,2.1041,<2.2e-16,MIR-224
GO:0002250,adaptive immune response,2.517,<2.2e-16,MIR-23A
GO:0007159,leukocyte cell-cell adhesion,2.4176,<2.2e-16,MIR-23A
GO:0002764,immune response-regulating signaling pathway,2.3925,<2.2e-16,MIR-23A
GO:0002694,regulation of leukocyte activation,2.3324,<2.2e-16,MIR-23A
GO:0001819,positive regulation of cytokine production,2.3116,<2.2e-16,MIR-23A
GO:0002449,lymphocyte mediated immunity,2.3071,<2.2e-16,MIR-23A
GO:0002697,regulation of immune effector process,2.2812,<2.2e-16,MIR-23A
GO:0032609,interferon-gamma production,2.239,<2.2e-16,MIR-23A
GO:0032606,type I interferon production,2.1974,<2.2e-16,MIR-23A
GO:0032635,interleukin-6 production,2.1936,<2.2e-16,MIR-23A
GO:0002285,lymphocyte activation involved in immune response,2.178,<2.2e-16,MIR-23A
GO:0001818,negative regulation of cytokine production,2.1769,<2.2e-16,MIR-23A
GO:0032615,interleukin-12 production,2.1549,<2.2e-16,MIR-23A
GO:0032637,interleukin-8 production,2.1528,<2.2e-16,MIR-23A
GO:0002521,leukocyte differentiation,2.1179,<2.2e-16,MIR-23A
GO:0001525,angiogenesis,2.1466,<2.2e-16,MIR-23B
GO:0007159,leukocyte cell-cell adhesion,2.136,<2.2e-16,MIR-23B
GO:0032637,interleukin-8 production,2.1104,<2.2e-16,MIR-23B
GO:0002764,immune response-regulating signaling pathway,2.1062,<2.2e-16,MIR-23B
GO:0002250,adaptive immune response,2.1035,<2.2e-16,MIR-23B
GO:0032635,interleukin-6 production,2.0501,<2.2e-16,MIR-23B
GO:0032623,interleukin-2 production,2.0466,<2.2e-16,MIR-23B
GO:0001819,positive regulation of cytokine production,2.0446,<2.2e-16,MIR-23B
GO:0002285,lymphocyte activation involved in immune response,2.0362,<2.2e-16,MIR-23B
GO:0002521,leukocyte differentiation,1.9918,<2.2e-16,MIR-23B
GO:0007159,leukocyte cell-cell adhesion,2.1815,<2.2e-16,MIR-24-1
GO:0001525,angiogenesis,2.1554,<2.2e-16,MIR-24-1
GO:0050900,leukocyte migration,2.0897,<2.2e-16,MIR-24-1
GO:0034341,response to interferon-gamma,2.0549,<2.2e-16,MIR-24-1
GO:0042110,T cell activation,2.0368,0.00015198,MIR-24-1
GO:0002250,adaptive immune response,2.4169,<2.2e-16,MIR-24-2
GO:0002764,immune response-regulating signaling pathway,2.3816,<2.2e-16,MIR-24-2
GO:0034340,response to type I interferon,2.3387,<2.2e-16,MIR-24-2
GO:0007159,leukocyte cell-cell adhesion,2.3359,<2.2e-16,MIR-24-2
GO:0002449,lymphocyte mediated immunity,2.2773,<2.2e-16,MIR-24-2
GO:0001819,positive regulation of cytokine production,2.2507,<2.2e-16,MIR-24-2
GO:0002694,regulation of leukocyte activation,2.2135,<2.2e-16,MIR-24-2
GO:0002697,regulation of immune effector process,2.1933,<2.2e-16,MIR-24-2
GO:0002285,lymphocyte activation involved in immune response,2.1875,<2.2e-16,MIR-24-2
GO:0032609,interferon-gamma production,2.157,<2.2e-16,MIR-24-2
GO:0032606,type I interferon production,2.1303,<2.2e-16,MIR-24-2
GO:0032623,interleukin-2 production,2.1155,<2.2e-16,MIR-24-2
GO:0032635,interleukin-6 production,2.0881,<2.2e-16,MIR-24-2
GO:0002521,leukocyte differentiation,2.0699,<2.2e-16,MIR-24-2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.1445,<2.2e-16,MIR-25
GO:0050900,leukocyte migration,-2.2094,<2.2e-16,MIR-25
GO:0001525,angiogenesis,-2.2426,<2.2e-16,MIR-25
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-2.0221,0.00021005,MIR-25
GO:0032637,interleukin-8 production,-2.1811,<2.2e-16,MIR-26A-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.2793,<2.2e-16,MIR-26A-1
GO:0002764,immune response-regulating signaling pathway,-2.0859,0.0042803,MIR-26A-1
GO:0034341,response to interferon-gamma,-2.0322,0.0042803,MIR-26A-1
GO:0032635,interleukin-6 production,-2.0343,0.0053504,MIR-26A-1
GO:0002526,acute inflammatory response,-1.9535,0.0073932,MIR-26A-1
GO:0036230,granulocyte activation,-1.9682,0.0074905,MIR-26A-1
GO:0042116,macrophage activation,-1.9367,0.0078472,MIR-26A-1
GO:0032612,interleukin-1 production,-1.957,0.0081326,MIR-26A-1
GO:0050663,cytokine secretion,-1.9634,0.0085606,MIR-26A-1
GO:0032633,interleukin-4 production,-1.8932,0.0094166,MIR-26A-1
GO:0032609,interferon-gamma production,-1.896,0.0094778,MIR-26A-1
GO:0002446,neutrophil mediated immunity,-1.9023,0.0095483,MIR-26A-1
GO:0045088,regulation of innate immune response,-1.8529,0.014743,MIR-26A-1
GO:0002250,adaptive immune response,-1.8165,0.018619,MIR-26A-1
GO:0001818,negative regulation of cytokine production,-1.7873,0.019689,MIR-26A-1
GO:0002250,adaptive immune response,2.4335,<2.2e-16,MIR-26A-2
GO:0002764,immune response-regulating signaling pathway,2.3969,<2.2e-16,MIR-26A-2
GO:0034341,response to interferon-gamma,2.364,<2.2e-16,MIR-26A-2
GO:0045088,regulation of innate immune response,2.3485,<2.2e-16,MIR-26A-2
GO:0032606,type I interferon production,2.3364,<2.2e-16,MIR-26A-2
GO:0002697,regulation of immune effector process,2.3,<2.2e-16,MIR-26A-2
GO:0034340,response to type I interferon,2.2771,<2.2e-16,MIR-26A-2
GO:0032609,interferon-gamma production,2.2372,<2.2e-16,MIR-26A-2
GO:0007159,leukocyte cell-cell adhesion,2.2204,<2.2e-16,MIR-26A-2
GO:0070661,leukocyte proliferation,2.2139,<2.2e-16,MIR-26A-2
GO:0002449,lymphocyte mediated immunity,2.2131,<2.2e-16,MIR-26A-2
GO:0001819,positive regulation of cytokine production,2.2117,<2.2e-16,MIR-26A-2
GO:0042110,T cell activation,2.2056,<2.2e-16,MIR-26A-2
GO:0002285,lymphocyte activation involved in immune response,2.0969,0.000083206,MIR-26A-2
GO:0032612,interleukin-1 production,2.1,0.000086988,MIR-26A-2
GO:0071706,tumor necrosis factor superfamily cytokine production,2.1022,0.000091130,MIR-26A-2
GO:0002694,regulation of leukocyte activation,2.1731,0.00011257,MIR-26A-2
GO:0150076,neuroinflammatory response,2.0466,0.00014176,MIR-26A-2
GO:0034340,response to type I interferon,2.3194,<2.2e-16,MIR-26B
GO:0032606,type I interferon production,2.1955,<2.2e-16,MIR-26B
GO:0035455,response to interferon-alpha,2.0126,0.0031493,MIR-26B
GO:0008356,asymmetric cell division,1.8806,0.014397,MIR-26B
GO:0045088,regulation of innate immune response,1.8578,0.015460,MIR-26B
GO:0035456,response to interferon-beta,1.8165,0.021803,MIR-26B
GO:0070670,response to interleukin-4,1.784,0.026874,MIR-26B
GO:0150076,neuroinflammatory response,1.737,0.032985,MIR-26B
GO:0032620,interleukin-17 production,1.758,0.033264,MIR-26B
GO:0002764,immune response-regulating signaling pathway,1.7121,0.037941,MIR-26B
GO:0034341,response to interferon-gamma,1.6826,0.044484,MIR-26B
GO:0001819,positive regulation of cytokine production,1.6741,0.044696,MIR-26B
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.5479,0.13332,MIR-26B
GO:0007159,leukocyte cell-cell adhesion,2.4752,<2.2e-16,MIR-27A
GO:0001819,positive regulation of cytokine production,2.4479,<2.2e-16,MIR-27A
GO:0002250,adaptive immune response,2.4394,<2.2e-16,MIR-27A
GO:0002764,immune response-regulating signaling pathway,2.4164,<2.2e-16,MIR-27A
GO:0002697,regulation of immune effector process,2.3916,<2.2e-16,MIR-27A
GO:0032606,type I interferon production,2.3634,<2.2e-16,MIR-27A
GO:0002449,lymphocyte mediated immunity,2.323,<2.2e-16,MIR-27A
GO:0002694,regulation of leukocyte activation,2.2884,<2.2e-16,MIR-27A
GO:0002440,production of molecular mediator of immune response,2.2676,<2.2e-16,MIR-27A
GO:0032609,interferon-gamma production,2.2483,<2.2e-16,MIR-27A
GO:0002285,lymphocyte activation involved in immune response,2.1955,<2.2e-16,MIR-27A
GO:0002521,leukocyte differentiation,2.1857,<2.2e-16,MIR-27A
GO:0001818,negative regulation of cytokine production,2.1567,<2.2e-16,MIR-27A
GO:0002507,tolerance induction,2.1027,<2.2e-16,MIR-27A
GO:0019882,antigen processing and presentation,2.0985,<2.2e-16,MIR-27A
GO:0001525,angiogenesis,2.2737,<2.2e-16,MIR-27B
GO:0007159,leukocyte cell-cell adhesion,2.2091,<2.2e-16,MIR-27B
GO:0042110,T cell activation,2.1387,<2.2e-16,MIR-27B
GO:0002285,lymphocyte activation involved in immune response,2.1304,<2.2e-16,MIR-27B
GO:0002764,immune response-regulating signaling pathway,2.1023,<2.2e-16,MIR-27B
GO:0032635,interleukin-6 production,2.0962,<2.2e-16,MIR-27B
GO:0002250,adaptive immune response,2.5477,<2.2e-16,MIR-28
GO:0002449,lymphocyte mediated immunity,2.5029,<2.2e-16,MIR-28
GO:0007159,leukocyte cell-cell adhesion,2.4365,<2.2e-16,MIR-28
GO:0002764,immune response-regulating signaling pathway,2.3839,<2.2e-16,MIR-28
GO:0042110,T cell activation,2.3645,<2.2e-16,MIR-28
GO:0002694,regulation of leukocyte activation,2.3557,<2.2e-16,MIR-28
GO:0034341,response to interferon-gamma,2.3491,<2.2e-16,MIR-28
GO:0036230,granulocyte activation,2.349,<2.2e-16,MIR-28
GO:0032609,interferon-gamma production,2.3487,<2.2e-16,MIR-28
GO:0002446,neutrophil mediated immunity,2.3093,<2.2e-16,MIR-28
GO:0002697,regulation of immune effector process,2.2976,<2.2e-16,MIR-28
GO:0001819,positive regulation of cytokine production,2.2972,<2.2e-16,MIR-28
GO:0002285,lymphocyte activation involved in immune response,2.2859,<2.2e-16,MIR-28
GO:0045088,regulation of innate immune response,2.285,<2.2e-16,MIR-28
GO:0002250,adaptive immune response,2.6762,<2.2e-16,MIR-29A
GO:0002764,immune response-regulating signaling pathway,2.5664,<2.2e-16,MIR-29A
GO:0002449,lymphocyte mediated immunity,2.5519,<2.2e-16,MIR-29A
GO:0001819,positive regulation of cytokine production,2.5411,<2.2e-16,MIR-29A
GO:0002697,regulation of immune effector process,2.5263,<2.2e-16,MIR-29A
GO:0007159,leukocyte cell-cell adhesion,2.4236,<2.2e-16,MIR-29A
GO:0002526,acute inflammatory response,2.3608,<2.2e-16,MIR-29A
GO:0002694,regulation of leukocyte activation,2.3283,<2.2e-16,MIR-29A
GO:0001818,negative regulation of cytokine production,2.2864,<2.2e-16,MIR-29A
GO:0006959,humoral immune response,2.2707,<2.2e-16,MIR-29A
GO:0002285,lymphocyte activation involved in immune response,2.23,<2.2e-16,MIR-29A
GO:0002446,neutrophil mediated immunity,2.2267,<2.2e-16,MIR-29A
GO:0002683,negative regulation of immune system process,2.2239,<2.2e-16,MIR-29A
GO:0002269,leukocyte activation involved in inflammatory response,2.0636,<2.2e-16,MIR-29A
GO:0002521,leukocyte differentiation,2.143,<2.2e-16,MIR-29A
GO:0002446,neutrophil mediated immunity,-2.1683,<2.2e-16,MIR-296
GO:0036230,granulocyte activation,-2.1894,<2.2e-16,MIR-296
GO:0002526,acute inflammatory response,-1.7556,0.082290,MIR-296
GO:0032612,interleukin-1 production,-1.6738,0.085364,MIR-296
GO:0032620,interleukin-17 production,-1.6547,0.087215,MIR-296
GO:0050663,cytokine secretion,-1.6921,0.088554,MIR-296
GO:0002764,immune response-regulating signaling pathway,-1.6395,0.089001,MIR-296
GO:0035456,response to interferon-beta,-2.3404,<2.2e-16,MIR-299
GO:0032606,type I interferon production,-2.3426,<2.2e-16,MIR-299
GO:0034340,response to type I interferon,-2.607,<2.2e-16,MIR-299
GO:0002250,adaptive immune response,2.7037,<2.2e-16,MIR-29B-1
GO:0002449,lymphocyte mediated immunity,2.5946,<2.2e-16,MIR-29B-1
GO:0002697,regulation of immune effector process,2.5783,<2.2e-16,MIR-29B-1
GO:0002764,immune response-regulating signaling pathway,2.5329,<2.2e-16,MIR-29B-1
GO:0001819,positive regulation of cytokine production,2.5117,<2.2e-16,MIR-29B-1
GO:0007159,leukocyte cell-cell adhesion,2.4673,<2.2e-16,MIR-29B-1
GO:0002694,regulation of leukocyte activation,2.4469,<2.2e-16,MIR-29B-1
GO:0002285,lymphocyte activation involved in immune response,2.4151,<2.2e-16,MIR-29B-1
GO:0001818,negative regulation of cytokine production,2.3311,<2.2e-16,MIR-29B-1
GO:0019882,antigen processing and presentation,2.3161,<2.2e-16,MIR-29B-1
GO:0006959,humoral immune response,2.2862,<2.2e-16,MIR-29B-1
GO:0002440,production of molecular mediator of immune response,2.2606,<2.2e-16,MIR-29B-1
GO:0002446,neutrophil mediated immunity,2.257,<2.2e-16,MIR-29B-1
GO:0002526,acute inflammatory response,2.2565,<2.2e-16,MIR-29B-1
GO:0002683,negative regulation of immune system process,2.2323,<2.2e-16,MIR-29B-1
GO:0002532,production of molecular mediator involved in inflammatory response,2.1452,<2.2e-16,MIR-29B-1
GO:0002521,leukocyte differentiation,2.1984,<2.2e-16,MIR-29B-1
GO:0002250,adaptive immune response,2.628,<2.2e-16,MIR-29B-2
GO:0034340,response to type I interferon,2.6262,<2.2e-16,MIR-29B-2
GO:0034341,response to interferon-gamma,2.5737,<2.2e-16,MIR-29B-2
GO:0002449,lymphocyte mediated immunity,2.5591,<2.2e-16,MIR-29B-2
GO:0002697,regulation of immune effector process,2.3997,<2.2e-16,MIR-29B-2
GO:0002764,immune response-regulating signaling pathway,2.348,<2.2e-16,MIR-29B-2
GO:0001819,positive regulation of cytokine production,2.3307,<2.2e-16,MIR-29B-2
GO:0019882,antigen processing and presentation,2.3304,<2.2e-16,MIR-29B-2
GO:0032606,type I interferon production,2.2973,<2.2e-16,MIR-29B-2
GO:0007159,leukocyte cell-cell adhesion,2.2699,<2.2e-16,MIR-29B-2
GO:0032609,interferon-gamma production,2.2652,<2.2e-16,MIR-29B-2
GO:0002526,acute inflammatory response,2.2643,<2.2e-16,MIR-29B-2
GO:0002446,neutrophil mediated immunity,2.2132,<2.2e-16,MIR-29B-2
GO:0006959,humoral immune response,2.1853,<2.2e-16,MIR-29B-2
GO:0002694,regulation of leukocyte activation,2.1576,<2.2e-16,MIR-29B-2
GO:0032635,interleukin-6 production,2.0461,<2.2e-16,MIR-29B-2
GO:0002250,adaptive immune response,2.6125,<2.2e-16,MIR-29C
GO:0002449,lymphocyte mediated immunity,2.483,<2.2e-16,MIR-29C
GO:0002764,immune response-regulating signaling pathway,2.4818,<2.2e-16,MIR-29C
GO:0002697,regulation of immune effector process,2.4456,<2.2e-16,MIR-29C
GO:0001819,positive regulation of cytokine production,2.4346,<2.2e-16,MIR-29C
GO:0007159,leukocyte cell-cell adhesion,2.401,<2.2e-16,MIR-29C
GO:0002694,regulation of leukocyte activation,2.3895,<2.2e-16,MIR-29C
GO:0002285,lymphocyte activation involved in immune response,2.3113,<2.2e-16,MIR-29C
GO:0006959,humoral immune response,2.2863,<2.2e-16,MIR-29C
GO:0019882,antigen processing and presentation,2.2715,<2.2e-16,MIR-29C
GO:0002526,acute inflammatory response,2.2538,<2.2e-16,MIR-29C
GO:0002446,neutrophil mediated immunity,2.217,<2.2e-16,MIR-29C
GO:0001818,negative regulation of cytokine production,2.2104,<2.2e-16,MIR-29C
GO:0002521,leukocyte differentiation,2.2009,<2.2e-16,MIR-29C
GO:0002683,negative regulation of immune system process,2.1927,<2.2e-16,MIR-29C
GO:0002521,leukocyte differentiation,-2.0094,<2.2e-16,MIR-301A
GO:0002694,regulation of leukocyte activation,-2.0096,<2.2e-16,MIR-301A
GO:0032615,interleukin-12 production,-2.0136,<2.2e-16,MIR-301A
GO:0001819,positive regulation of cytokine production,-2.027,<2.2e-16,MIR-301A
GO:0034341,response to interferon-gamma,-2.0444,<2.2e-16,MIR-301A
GO:0032609,interferon-gamma production,-2.0505,<2.2e-16,MIR-301A
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0524,<2.2e-16,MIR-301A
GO:0002250,adaptive immune response,-2.0551,<2.2e-16,MIR-301A
GO:0050900,leukocyte migration,-2.062,<2.2e-16,MIR-301A
GO:0032633,interleukin-4 production,-2.1011,<2.2e-16,MIR-301A
GO:0042110,T cell activation,-2.109,<2.2e-16,MIR-301A
GO:0050663,cytokine secretion,-2.1298,<2.2e-16,MIR-301A
GO:0070661,leukocyte proliferation,-2.1323,<2.2e-16,MIR-301A
GO:0032635,interleukin-6 production,-2.1367,<2.2e-16,MIR-301A
GO:0007159,leukocyte cell-cell adhesion,-2.2426,<2.2e-16,MIR-301A
GO:0002764,immune response-regulating signaling pathway,-2.2561,<2.2e-16,MIR-301A
GO:0002285,lymphocyte activation involved in immune response,-2.0922,<2.2e-16,MIR-30A
GO:0002446,neutrophil mediated immunity,-2.1041,<2.2e-16,MIR-30A
GO:0070661,leukocyte proliferation,-2.1071,<2.2e-16,MIR-30A
GO:0036230,granulocyte activation,-2.1288,<2.2e-16,MIR-30A
GO:0032633,interleukin-4 production,-2.1588,<2.2e-16,MIR-30A
GO:0042110,T cell activation,-2.1823,<2.2e-16,MIR-30A
GO:0001773,myeloid dendritic cell activation,-2.1884,<2.2e-16,MIR-30A
GO:0002694,regulation of leukocyte activation,-2.1921,<2.2e-16,MIR-30A
GO:0002250,adaptive immune response,-2.195,<2.2e-16,MIR-30A
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.1973,<2.2e-16,MIR-30A
GO:0007159,leukocyte cell-cell adhesion,-2.2718,<2.2e-16,MIR-30A
GO:0032609,interferon-gamma production,-2.2939,<2.2e-16,MIR-30A
GO:0002521,leukocyte differentiation,-2.0296,0.00044941,MIR-30A
GO:0032613,interleukin-10 production,-2.0326,0.00047081,MIR-30A
GO:0019882,antigen processing and presentation,-2.0032,0.00065913,MIR-30A
GO:0034340,response to type I interferon,2.0195,0.0044544,MIR-30B
GO:0034341,response to interferon-gamma,1.8379,0.026727,MIR-30B
GO:0002269,leukocyte activation involved in inflammatory response,1.6833,0.10309,MIR-30B
GO:0002250,adaptive immune response,1.6432,0.10745,MIR-30B
GO:0070670,response to interleukin-4,1.691,0.10765,MIR-30B
GO:0002251,organ or tissue specific immune response,1.6289,0.11606,MIR-30B
GO:0035456,response to interferon-beta,1.6975,0.11938,MIR-30B
GO:0042116,macrophage activation,1.6059,0.12695,MIR-30B
GO:0035455,response to interferon-alpha,1.6099,0.13043,MIR-30B
GO:0002449,lymphocyte mediated immunity,1.5564,0.16316,MIR-30B
GO:0032606,type I interferon production,1.551,0.1645,MIR-30B
GO:0045088,regulation of innate immune response,1.5356,0.17146,MIR-30B
GO:0050900,leukocyte migration,-2.2904,<2.2e-16,MIR-30C-1
GO:0002446,neutrophil mediated immunity,-2.4027,<2.2e-16,MIR-30C-1
GO:0036230,granulocyte activation,-2.4042,<2.2e-16,MIR-30C-1
GO:0032612,interleukin-1 production,-2.1192,0.00019846,MIR-30C-1
GO:0032637,interleukin-8 production,-2.1292,0.00022900,MIR-30C-1
GO:0070661,leukocyte proliferation,-2.0336,0.00024808,MIR-30C-1
GO:0050663,cytokine secretion,-2.0394,0.00025886,MIR-30C-1
GO:0034341,response to interferon-gamma,-2.0432,0.00027063,MIR-30C-1
GO:0050727,regulation of inflammatory response,-2.1471,0.00027063,MIR-30C-1
GO:0032602,chemokine production,-2.0595,0.00029769,MIR-30C-1
GO:1990868,response to chemokine,-2.17,0.00029769,MIR-30C-1
GO:0002250,adaptive immune response,-2.0773,0.00033077,MIR-30C-1
GO:0006959,humoral immune response,-2.1761,0.00033077,MIR-30C-1
GO:0002526,acute inflammatory response,-2.2464,0.00049616,MIR-30C-1
GO:0036230,granulocyte activation,-2.208,<2.2e-16,MIR-30C-2
GO:0002446,neutrophil mediated immunity,-2.2196,<2.2e-16,MIR-30C-2
GO:0019882,antigen processing and presentation,-2.0545,0.0012672,MIR-30C-2
GO:0034341,response to interferon-gamma,-1.9609,0.0018432,MIR-30C-2
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9723,0.0020276,MIR-30C-2
GO:0002251,organ or tissue specific immune response,-1.9536,0.0021121,MIR-30C-2
GO:0007159,leukocyte cell-cell adhesion,-1.9497,0.0021724,MIR-30C-2
GO:0001773,myeloid dendritic cell activation,-1.9498,0.0023395,MIR-30C-2
GO:0070671,response to interleukin-12,-1.9068,0.0063362,MIR-30C-2
GO:0050900,leukocyte migration,-1.8949,0.0076034,MIR-30C-2
GO:0035456,response to interferon-beta,1.9782,0.0046367,MIR-30D
GO:0034340,response to type I interferon,1.9174,0.0076505,MIR-30D
GO:0035455,response to interferon-alpha,1.7158,0.056747,MIR-30D
GO:0034341,response to interferon-gamma,1.5405,0.14469,MIR-30D
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.0439,<2.2e-16,MIR-30E
GO:0001525,angiogenesis,-2.2203,<2.2e-16,MIR-30E
GO:0034340,response to type I interferon,1.7439,0.040080,MIR-30E
GO:0002250,adaptive immune response,2.5321,<2.2e-16,MIR-31
GO:0002285,lymphocyte activation involved in immune response,2.4047,<2.2e-16,MIR-31
GO:0070661,leukocyte proliferation,2.3742,<2.2e-16,MIR-31
GO:0007159,leukocyte cell-cell adhesion,2.3669,<2.2e-16,MIR-31
GO:0002449,lymphocyte mediated immunity,2.3665,<2.2e-16,MIR-31
GO:0042110,T cell activation,2.3581,<2.2e-16,MIR-31
GO:0034341,response to interferon-gamma,2.2712,0.00017840,MIR-31
GO:0050900,leukocyte migration,2.2937,0.00021805,MIR-31
GO:1990868,response to chemokine,2.2076,0.00026761,MIR-31
GO:0002764,immune response-regulating signaling pathway,2.2165,0.00028035,MIR-31
GO:0045088,regulation of innate immune response,2.1802,0.00029073,MIR-31
GO:0002526,acute inflammatory response,2.1825,0.00030192,MIR-31
GO:0006959,humoral immune response,2.2188,0.00030986,MIR-31
GO:0002697,regulation of immune effector process,2.1847,0.00031399,MIR-31
GO:0001819,positive regulation of cytokine production,2.219,0.00032707,MIR-31
GO:0042113,B cell activation,2.1874,0.00032707,MIR-31
GO:0002446,neutrophil mediated immunity,2.2236,0.00034631,MIR-31
GO:0032635,interleukin-6 production,-1.5443,0.15350,MIR-32
GO:0010573,vascular endothelial growth factor production,-1.5464,0.15629,MIR-32
GO:0002683,negative regulation of immune system process,-1.5131,0.15987,MIR-32
GO:0032606,type I interferon production,2.0431,0.024392,MIR-320A
GO:0034340,response to type I interferon,2.0562,0.031234,MIR-320A
GO:0035455,response to interferon-alpha,1.8408,0.094433,MIR-320A
GO:0045088,regulation of innate immune response,1.7879,0.10131,MIR-320A
GO:0002250,adaptive immune response,1.7275,0.13621,MIR-320A
GO:0034341,response to interferon-gamma,1.7302,0.13930,MIR-320A
GO:0034341,response to interferon-gamma,2.0772,0.0038104,MIR-33A
GO:0032606,type I interferon production,2.0259,0.0079468,MIR-33A
GO:0001525,angiogenesis,1.9568,0.013741,MIR-33A
GO:0007159,leukocyte cell-cell adhesion,2.2629,<2.2e-16,MIR-34A
GO:0034341,response to interferon-gamma,2.2286,<2.2e-16,MIR-34A
GO:0002250,adaptive immune response,2.2048,<2.2e-16,MIR-34A
GO:0002449,lymphocyte mediated immunity,2.1308,<2.2e-16,MIR-34A
GO:0032637,interleukin-8 production,2.1284,<2.2e-16,MIR-34A
GO:0001819,positive regulation of cytokine production,2.1265,<2.2e-16,MIR-34A
GO:0002697,regulation of immune effector process,2.1038,<2.2e-16,MIR-34A
GO:0002694,regulation of leukocyte activation,2.1001,<2.2e-16,MIR-34A
GO:0032609,interferon-gamma production,2.0996,<2.2e-16,MIR-34A
GO:0002526,acute inflammatory response,2.0828,<2.2e-16,MIR-34A
GO:0002764,immune response-regulating signaling pathway,2.0696,<2.2e-16,MIR-34A
GO:0002269,leukocyte activation involved in inflammatory response,2.0645,<2.2e-16,MIR-34A
GO:0032635,interleukin-6 production,2.0579,<2.2e-16,MIR-34A
GO:0002285,lymphocyte activation involved in immune response,2.0545,<2.2e-16,MIR-34A
GO:0001525,angiogenesis,2.006,<2.2e-16,MIR-34A
GO:0002521,leukocyte differentiation,2.029,<2.2e-16,MIR-34A
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-2.07,<2.2e-16,MIR-34B
GO:0042092,type 2 immune response,-2.0717,<2.2e-16,MIR-34B
GO:0050727,regulation of inflammatory response,-2.0753,<2.2e-16,MIR-34B
GO:0071887,leukocyte apoptotic process,-2.0824,<2.2e-16,MIR-34B
GO:0002683,negative regulation of immune system process,-2.1203,<2.2e-16,MIR-34B
GO:0032623,interleukin-2 production,-2.1266,<2.2e-16,MIR-34B
GO:0032609,interferon-gamma production,-2.127,<2.2e-16,MIR-34B
GO:0002440,production of molecular mediator of immune response,-2.1867,<2.2e-16,MIR-34B
GO:0002285,lymphocyte activation involved in immune response,-2.2211,<2.2e-16,MIR-34B
GO:0001525,angiogenesis,-2.3302,<2.2e-16,MIR-34B
GO:0002250,adaptive immune response,-2.4273,<2.2e-16,MIR-34B
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-2.1821,<2.2e-16,MIR-34C
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.0683,0.0014126,MIR-34C
GO:0050663,cytokine secretion,-2.0135,0.0050225,MIR-34C
GO:0071887,leukocyte apoptotic process,-1.9004,0.010706,MIR-34C
GO:0002285,lymphocyte activation involved in immune response,-1.8482,0.011753,MIR-34C
GO:0042092,type 2 immune response,-1.8836,0.011866,MIR-34C
GO:0032634,interleukin-5 production,1.4806,0.75360,MIR-34C
GO:0071559,response to transforming growth factor beta,-1.8547,0.034800,MIR-7-1
GO:0002200,somatic diversification of immune receptors,1.5948,0.35993,MIR-7-2
GO:0060759,regulation of response to cytokine stimulus,1.6313,0.38101,MIR-7-2
GO:0034341,response to interferon-gamma,-2.5194,<2.2e-16,MIR-7-3
GO:0034340,response to type I interferon,-2.6025,<2.2e-16,MIR-7-3
GO:0035456,response to interferon-beta,-2.1113,0.0034898,MIR-7-3
GO:0035455,response to interferon-alpha,-2.0365,0.0065434,MIR-7-3
GO:0002507,tolerance induction,-1.9174,0.0098150,MIR-7-3
GO:0032615,interleukin-12 production,-1.8813,0.013801,MIR-7-3
GO:0001773,myeloid dendritic cell activation,-1.8382,0.023757,MIR-7-3
GO:0042110,T cell activation,-1.8223,0.025475,MIR-7-3
GO:0032633,interleukin-4 production,-1.8118,0.026173,MIR-7-3
GO:0032609,interferon-gamma production,-1.7966,0.028945,MIR-7-3
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.7644,0.033240,MIR-7-3
GO:0002250,adaptive immune response,-1.7698,0.033612,MIR-7-3
GO:0006959,humoral immune response,-2.1152,<2.2e-16,MIR-9-1
GO:0002250,adaptive immune response,-2.1318,<2.2e-16,MIR-9-1
GO:0001819,positive regulation of cytokine production,-2.1575,<2.2e-16,MIR-9-1
GO:0002521,leukocyte differentiation,-2.1656,<2.2e-16,MIR-9-1
GO:0002694,regulation of leukocyte activation,-2.1677,<2.2e-16,MIR-9-1
GO:0002526,acute inflammatory response,-2.1768,<2.2e-16,MIR-9-1
GO:0032635,interleukin-6 production,-2.1784,<2.2e-16,MIR-9-1
GO:0002764,immune response-regulating signaling pathway,-2.1896,<2.2e-16,MIR-9-1
GO:0032637,interleukin-8 production,-2.2062,<2.2e-16,MIR-9-1
GO:0042116,macrophage activation,-2.2236,<2.2e-16,MIR-9-1
GO:0001525,angiogenesis,-2.2469,<2.2e-16,MIR-9-1
GO:0032609,interferon-gamma production,-2.2613,<2.2e-16,MIR-9-1
GO:0042110,T cell activation,-2.28,<2.2e-16,MIR-9-1
GO:0032615,interleukin-12 production,-2.0772,<2.2e-16,MIR-9-2
GO:0032623,interleukin-2 production,-2.0807,<2.2e-16,MIR-9-2
GO:0032633,interleukin-4 production,-2.0846,<2.2e-16,MIR-9-2
GO:0001818,negative regulation of cytokine production,-2.0993,<2.2e-16,MIR-9-2
GO:0002683,negative regulation of immune system process,-2.1087,<2.2e-16,MIR-9-2
GO:0006959,humoral immune response,-2.1149,<2.2e-16,MIR-9-2
GO:0001819,positive regulation of cytokine production,-2.1508,<2.2e-16,MIR-9-2
GO:0002250,adaptive immune response,-2.1565,<2.2e-16,MIR-9-2
GO:0002694,regulation of leukocyte activation,-2.1826,<2.2e-16,MIR-9-2
GO:0002526,acute inflammatory response,-2.1874,<2.2e-16,MIR-9-2
GO:0032635,interleukin-6 production,-2.2079,<2.2e-16,MIR-9-2
GO:0001525,angiogenesis,-2.219,<2.2e-16,MIR-9-2
GO:0002521,leukocyte differentiation,-2.2285,<2.2e-16,MIR-9-2
GO:0002764,immune response-regulating signaling pathway,-2.2732,<2.2e-16,MIR-9-2
GO:0032609,interferon-gamma production,-2.2404,<2.2e-16,MIR-92A-1
GO:0045088,regulation of innate immune response,-2.2643,<2.2e-16,MIR-92A-1
GO:0002449,lymphocyte mediated immunity,-2.2993,<2.2e-16,MIR-92A-1
GO:0019882,antigen processing and presentation,-2.319,<2.2e-16,MIR-92A-1
GO:0002764,immune response-regulating signaling pathway,-2.3299,<2.2e-16,MIR-92A-1
GO:0002697,regulation of immune effector process,-2.366,<2.2e-16,MIR-92A-1
GO:0001819,positive regulation of cytokine production,-2.3738,<2.2e-16,MIR-92A-1
GO:0042110,T cell activation,-2.3937,<2.2e-16,MIR-92A-1
GO:0034340,response to type I interferon,-2.4033,<2.2e-16,MIR-92A-1
GO:0002446,neutrophil mediated immunity,-2.5857,<2.2e-16,MIR-92A-1
GO:0034341,response to interferon-gamma,-2.6706,<2.2e-16,MIR-92A-1
GO:0002250,adaptive immune response,-2.5546,<2.2e-16,MIR-92A-1
GO:0036230,granulocyte activation,-2.6157,<2.2e-16,MIR-92A-1
GO:0002285,lymphocyte activation involved in immune response,-2.0681,<2.2e-16,MIR-92A-2
GO:0002448,mast cell mediated immunity,-2.0877,<2.2e-16,MIR-92A-2
GO:0006959,humoral immune response,-2.1003,<2.2e-16,MIR-92A-2
GO:0002521,leukocyte differentiation,-2.1093,<2.2e-16,MIR-92A-2
GO:0002449,lymphocyte mediated immunity,-2.1109,<2.2e-16,MIR-92A-2
GO:0002526,acute inflammatory response,-2.1295,<2.2e-16,MIR-92A-2
GO:0001819,positive regulation of cytokine production,-2.1656,<2.2e-16,MIR-92A-2
GO:0002697,regulation of immune effector process,-2.2169,<2.2e-16,MIR-92A-2
GO:0019882,antigen processing and presentation,-2.2301,<2.2e-16,MIR-92A-2
GO:0002764,immune response-regulating signaling pathway,-2.2788,<2.2e-16,MIR-92A-2
GO:0002250,adaptive immune response,-2.4757,<2.2e-16,MIR-92A-2
GO:0002446,neutrophil mediated immunity,-2.6232,<2.2e-16,MIR-92A-2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.9567,0.0049052,MIR-93
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-1.9679,0.0049052,MIR-93
GO:0001525,angiogenesis,-1.8418,0.015370,MIR-93
GO:0034340,response to type I interferon,-2.1081,0.0037834,MIR-95
GO:0019882,antigen processing and presentation,-1.6949,0.047621,MIR-95
GO:0034341,response to interferon-gamma,-2.0673,<2.2e-16,MIR-96
GO:0007159,leukocyte cell-cell adhesion,-2.0712,<2.2e-16,MIR-96
GO:0002694,regulation of leukocyte activation,-2.0789,<2.2e-16,MIR-96
GO:0042110,T cell activation,-2.0866,<2.2e-16,MIR-96
GO:0002250,adaptive immune response,-2.159,<2.2e-16,MIR-96
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.1669,<2.2e-16,MIR-96
GO:0032609,interferon-gamma production,-2.2175,<2.2e-16,MIR-96
GO:0070661,leukocyte proliferation,-1.9747,0.00010685,MIR-96
GO:0002449,lymphocyte mediated immunity,-1.9917,0.00011220,MIR-96
GO:0002521,leukocyte differentiation,-2.0056,0.00013200,MIR-96
GO:0002532,production of molecular mediator involved in inflammatory response,-2.0324,0.00016028,MIR-96
GO:0050727,regulation of inflammatory response,-2.0469,0.00018699,MIR-96
GO:0034340,response to type I interferon,2.5749,<2.2e-16,MIR-98
GO:0034341,response to interferon-gamma,2.4142,<2.2e-16,MIR-98
GO:0045088,regulation of innate immune response,2.2454,<2.2e-16,MIR-98
GO:0036230,granulocyte activation,2.1255,<2.2e-16,MIR-98
GO:0032606,type I interferon production,2.1236,<2.2e-16,MIR-98
GO:0035455,response to interferon-alpha,2.12,<2.2e-16,MIR-98
GO:0002446,neutrophil mediated immunity,2.1075,<2.2e-16,MIR-98
GO:0002250,adaptive immune response,2.0993,<2.2e-16,MIR-98
GO:0035456,response to interferon-beta,2.0925,<2.2e-16,MIR-98
GO:0002764,immune response-regulating signaling pathway,2.0202,0.00047842,MIR-98
GO:0002532,production of molecular mediator involved in inflammatory response,1.9904,0.00077744,MIR-98
GO:0002449,lymphocyte mediated immunity,1.9964,0.00088850,MIR-98
GO:0002526,acute inflammatory response,1.9656,0.0010366,MIR-98
GO:0002697,regulation of immune effector process,1.9808,0.0010976,MIR-98
GO:0048536,spleen development,-1.6152,0.12162,MIR-99A
GO:0150076,neuroinflammatory response,1.4895,0.33362,MIR-99A
GO:0035455,response to interferon-alpha,1.4213,0.41803,MIR-99A
GO:0032606,type I interferon production,1.3773,0.49890,MIR-99A
GO:0032613,interleukin-10 production,-1.5857,0.18986,MIR-99B
GO:0034341,response to interferon-gamma,-1.5963,0.19281,MIR-99B
GO:0045088,regulation of innate immune response,-1.5181,0.22317,MIR-99B
GO:0032635,interleukin-6 production,-1.6008,0.23577,MIR-99B
GO:0002764,immune response-regulating signaling pathway,-1.6215,0.26084,MIR-99B
GO:0032620,interleukin-17 production,-1.66,0.30409,MIR-99B
GO:0030101,natural killer cell activation,-1.3745,0.31189,MIR-99B
GO:0036230,granulocyte activation,-2.291,<2.2e-16,MIR-17
GO:0002446,neutrophil mediated immunity,-2.3026,<2.2e-16,MIR-17
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.9607,0.0016332,MIR-17
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-1.9598,0.0020324,MIR-17
GO:0001525,angiogenesis,-1.9284,0.0036293,MIR-17
GO:0006959,humoral immune response,1.1195,0.47809,MIR-570
GO:0001525,angiogenesis,1.9714,<2.2e-16,MIR-133B
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.9384,<2.2e-16,MIR-133B
GO:0035456,response to interferon-beta,1.6799,0.15221,MIR-135B
GO:0048536,spleen development,-1.5646,0.18123,MIR-135B
GO:0070670,response to interleukin-4,1.5635,0.27835,MIR-135B
GO:0032623,interleukin-2 production,1.5039,0.34747,MIR-135B
GO:0034340,response to type I interferon,2.1646,<2.2e-16,MIR-148B
GO:0001525,angiogenesis,-2.0716,<2.2e-16,MIR-148B
GO:0002200,somatic diversification of immune receptors,-1.1344,0.82228,MIR-302C
GO:0008356,asymmetric cell division,-1.1676,0.84111,MIR-302C
GO:0070671,response to interleukin-12,-1.1744,0.84841,MIR-302C
GO:0002269,leukocyte activation involved in inflammatory response,0.20624,0.99833,MIR-302C
GO:0030101,natural killer cell activation,1.3756,1.0,MIR-302C
GO:0002285,lymphocyte activation involved in immune response,1.3184,1.0,MIR-302C
GO:0070661,leukocyte proliferation,1.2838,1.0,MIR-302C
GO:1990868,response to chemokine,-1.8291,0.017863,MIR-324
GO:0070661,leukocyte proliferation,-1.844,0.018639,MIR-324
GO:0034341,response to interferon-gamma,-1.7733,0.026167,MIR-324
GO:0032620,interleukin-17 production,-1.7234,0.037861,MIR-324
GO:0032602,chemokine production,-1.6884,0.044881,MIR-324
GO:0070555,response to interleukin-1,-1.6928,0.048517,MIR-324
GO:0002251,organ or tissue specific immune response,-1.6714,0.049261,MIR-324
GO:0006959,humoral immune response,-1.658,0.053588,MIR-324
GO:0050663,cytokine secretion,-1.6263,0.065432,MIR-324
GO:0032635,interleukin-6 production,-1.6081,0.067826,MIR-324
GO:0007159,leukocyte cell-cell adhesion,2.4213,<2.2e-16,MIR-326
GO:0002250,adaptive immune response,2.3862,<2.2e-16,MIR-326
GO:0002449,lymphocyte mediated immunity,2.2981,<2.2e-16,MIR-326
GO:0002764,immune response-regulating signaling pathway,2.2733,<2.2e-16,MIR-326
GO:0002694,regulation of leukocyte activation,2.2649,<2.2e-16,MIR-326
GO:0001819,positive regulation of cytokine production,2.2512,<2.2e-16,MIR-326
GO:0002521,leukocyte differentiation,2.2118,<2.2e-16,MIR-326
GO:0001525,angiogenesis,2.2028,<2.2e-16,MIR-326
GO:0002446,neutrophil mediated immunity,2.2,<2.2e-16,MIR-326
GO:0002697,regulation of immune effector process,2.1991,<2.2e-16,MIR-326
GO:0001818,negative regulation of cytokine production,2.1529,<2.2e-16,MIR-326
GO:0002532,production of molecular mediator involved in inflammatory response,2.1128,<2.2e-16,MIR-326
GO:0002269,leukocyte activation involved in inflammatory response,2.1107,<2.2e-16,MIR-326
GO:0002526,acute inflammatory response,2.1075,<2.2e-16,MIR-326
GO:0002683,negative regulation of immune system process,2.1058,<2.2e-16,MIR-326
GO:0006959,humoral immune response,1.9958,<2.2e-16,MIR-326
GO:0070671,response to interleukin-12,-1.9497,0.012819,MIR-328
GO:0032623,interleukin-2 production,-1.6831,0.13156,MIR-328
GO:0002250,adaptive immune response,2.8055,<2.2e-16,MIR-330
GO:0007159,leukocyte cell-cell adhesion,2.6311,<2.2e-16,MIR-330
GO:0002449,lymphocyte mediated immunity,2.603,<2.2e-16,MIR-330
GO:0002697,regulation of immune effector process,2.5581,<2.2e-16,MIR-330
GO:0002764,immune response-regulating signaling pathway,2.5543,<2.2e-16,MIR-330
GO:0001819,positive regulation of cytokine production,2.5478,<2.2e-16,MIR-330
GO:0002694,regulation of leukocyte activation,2.4576,<2.2e-16,MIR-330
GO:0002285,lymphocyte activation involved in immune response,2.4376,<2.2e-16,MIR-330
GO:0002521,leukocyte differentiation,2.3879,<2.2e-16,MIR-330
GO:0002440,production of molecular mediator of immune response,2.3466,<2.2e-16,MIR-330
GO:0002683,negative regulation of immune system process,2.3137,<2.2e-16,MIR-330
GO:0019882,antigen processing and presentation,2.2547,<2.2e-16,MIR-330
GO:0001818,negative regulation of cytokine production,2.2541,<2.2e-16,MIR-330
GO:0002446,neutrophil mediated immunity,2.249,<2.2e-16,MIR-330
GO:0002507,tolerance induction,2.208,<2.2e-16,MIR-330
GO:0032633,interleukin-4 production,-1.6817,0.051422,MIR-331
GO:0045576,mast cell activation,-1.6326,0.069015,MIR-331
GO:0002448,mast cell mediated immunity,-1.5793,0.083417,MIR-331
GO:0070661,leukocyte proliferation,-1.524,0.11818,MIR-331
GO:0050900,leukocyte migration,-2.1105,<2.2e-16,MIR-335
GO:0032609,interferon-gamma production,-2.1134,<2.2e-16,MIR-335
GO:0032637,interleukin-8 production,-2.1195,<2.2e-16,MIR-335
GO:0002449,lymphocyte mediated immunity,-2.1205,<2.2e-16,MIR-335
GO:0002521,leukocyte differentiation,-2.1429,<2.2e-16,MIR-335
GO:0019882,antigen processing and presentation,-2.1755,<2.2e-16,MIR-335
GO:0001819,positive regulation of cytokine production,-2.1833,<2.2e-16,MIR-335
GO:0002448,mast cell mediated immunity,-2.1858,<2.2e-16,MIR-335
GO:0002526,acute inflammatory response,-2.1942,<2.2e-16,MIR-335
GO:0050663,cytokine secretion,-2.1962,<2.2e-16,MIR-335
GO:0050727,regulation of inflammatory response,-2.218,<2.2e-16,MIR-335
GO:0042110,T cell activation,-2.2528,<2.2e-16,MIR-335
GO:0002250,adaptive immune response,-2.2697,<2.2e-16,MIR-335
GO:0045576,mast cell activation,-2.3013,<2.2e-16,MIR-335
GO:0036230,granulocyte activation,-2.4761,<2.2e-16,MIR-335
GO:0002764,immune response-regulating signaling pathway,-2.3132,<2.2e-16,MIR-335
GO:0035456,response to interferon-beta,-2.4056,<2.2e-16,MIR-337
GO:0032606,type I interferon production,-2.446,<2.2e-16,MIR-337
GO:0034340,response to type I interferon,-2.5724,<2.2e-16,MIR-337
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7423,0.0011066,MIR-337
GO:0035456,response to interferon-beta,-2.2422,<2.2e-16,MIR-338
GO:0034341,response to interferon-gamma,-2.278,<2.2e-16,MIR-338
GO:0034340,response to type I interferon,-2.39,<2.2e-16,MIR-338
GO:0019882,antigen processing and presentation,-1.9566,0.0024832,MIR-338
GO:0032615,interleukin-12 production,-1.9144,0.0042491,MIR-338
GO:0001819,positive regulation of cytokine production,-1.8587,0.0062578,MIR-338
GO:0050663,cytokine secretion,-1.8237,0.0076850,MIR-338
GO:0007159,leukocyte cell-cell adhesion,-1.8273,0.0077256,MIR-338
GO:0060759,regulation of response to cytokine stimulus,-1.8318,0.0077711,MIR-338
GO:0034612,response to tumor necrosis factor,-1.8084,0.0099081,MIR-338
GO:0042110,T cell activation,-1.801,0.010264,MIR-338
GO:0002250,adaptive immune response,-1.7919,0.012010,MIR-338
GO:0002250,adaptive immune response,2.089,0.00060240,MIR-339
GO:0002449,lymphocyte mediated immunity,2.1193,0.0012048,MIR-339
GO:0034341,response to interferon-gamma,2.0493,0.0019879,MIR-339
GO:0036230,granulocyte activation,1.9678,0.0064382,MIR-339
GO:0070671,response to interleukin-12,1.9623,0.0064847,MIR-339
GO:0071706,tumor necrosis factor superfamily cytokine production,1.9528,0.0074296,MIR-339
GO:0007159,leukocyte cell-cell adhesion,1.9434,0.0077995,MIR-339
GO:0002446,neutrophil mediated immunity,1.933,0.0080421,MIR-339
GO:0036230,granulocyte activation,1.9053,0.018657,MIR-340
GO:0002446,neutrophil mediated immunity,1.907,0.031983,MIR-340
GO:0002250,adaptive immune response,1.7691,0.048355,MIR-340
GO:0050900,leukocyte migration,1.6765,0.058355,MIR-340
GO:0007159,leukocyte cell-cell adhesion,1.6779,0.060856,MIR-340
GO:0002250,adaptive immune response,1.9265,<2.2e-16,MIR-342
GO:0007159,leukocyte cell-cell adhesion,1.8781,<2.2e-16,MIR-342
GO:0002449,lymphocyte mediated immunity,1.8752,<2.2e-16,MIR-342
GO:0042110,T cell activation,1.8651,<2.2e-16,MIR-342
GO:0032609,interferon-gamma production,1.864,<2.2e-16,MIR-342
GO:0032615,interleukin-12 production,1.841,<2.2e-16,MIR-342
GO:0034341,response to interferon-gamma,1.8242,<2.2e-16,MIR-342
GO:0002694,regulation of leukocyte activation,1.8222,<2.2e-16,MIR-342
GO:0032623,interleukin-2 production,1.8089,<2.2e-16,MIR-342
GO:0002285,lymphocyte activation involved in immune response,1.7989,<2.2e-16,MIR-342
GO:0001773,myeloid dendritic cell activation,1.7898,<2.2e-16,MIR-342
GO:0002764,immune response-regulating signaling pathway,1.7858,<2.2e-16,MIR-342
GO:0045576,mast cell activation,1.7843,<2.2e-16,MIR-342
GO:0042116,macrophage activation,1.7841,<2.2e-16,MIR-342
GO:0002521,leukocyte differentiation,1.7832,<2.2e-16,MIR-342
GO:0019882,antigen processing and presentation,1.7732,<2.2e-16,MIR-342
GO:0035455,response to interferon-alpha,-1.2441,0.56269,MIR-345
GO:0001525,angiogenesis,2.0978,<2.2e-16,MIR-346
GO:0071706,tumor necrosis factor superfamily cytokine production,1.9478,0.0037740,MIR-346
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1.9563,0.0040436,MIR-346
GO:0034341,response to interferon-gamma,-2.2052,<2.2e-16,MIR-376C
GO:0034340,response to type I interferon,-2.389,<2.2e-16,MIR-376C
GO:0035456,response to interferon-beta,-2.4085,<2.2e-16,MIR-376C
GO:0045576,mast cell activation,-2.1663,0.00069257,MIR-376C
GO:0002250,adaptive immune response,-2.1028,0.0010074,MIR-376C
GO:0032609,interferon-gamma production,-2.0355,0.0012786,MIR-376C
GO:0032615,interleukin-12 production,-2.0027,0.0013851,MIR-376C
GO:0070661,leukocyte proliferation,-2.009,0.0013851,MIR-376C
GO:0002449,lymphocyte mediated immunity,-2.005,0.0014775,MIR-376C
GO:0002697,regulation of immune effector process,-1.9534,0.0020777,MIR-376C
GO:0035456,response to interferon-beta,-2.2635,<2.2e-16,MIR-369
GO:0034340,response to type I interferon,-2.4975,<2.2e-16,MIR-369
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7079,0.0048842,MIR-369
GO:0032606,type I interferon production,-1.922,0.0088368,MIR-369
GO:0035456,response to interferon-beta,-2.3025,<2.2e-16,MIR-370
GO:0032606,type I interferon production,-2.3354,<2.2e-16,MIR-370
GO:0034340,response to type I interferon,-2.6808,<2.2e-16,MIR-370
GO:0006959,humoral immune response,-2.0642,<2.2e-16,MIR-372
GO:0002285,lymphocyte activation involved in immune response,-2.0741,<2.2e-16,MIR-372
GO:0032633,interleukin-4 production,-2.0768,<2.2e-16,MIR-372
GO:0002764,immune response-regulating signaling pathway,-2.0958,<2.2e-16,MIR-372
GO:0002449,lymphocyte mediated immunity,-2.1181,<2.2e-16,MIR-372
GO:0032609,interferon-gamma production,-2.1194,<2.2e-16,MIR-372
GO:0001525,angiogenesis,-2.1253,<2.2e-16,MIR-372
GO:0032635,interleukin-6 production,-2.1392,<2.2e-16,MIR-372
GO:0001819,positive regulation of cytokine production,-2.1449,<2.2e-16,MIR-372
GO:0032623,interleukin-2 production,-2.1478,<2.2e-16,MIR-372
GO:0002446,neutrophil mediated immunity,-2.196,<2.2e-16,MIR-372
GO:0036230,granulocyte activation,-2.2335,<2.2e-16,MIR-372
GO:0002521,leukocyte differentiation,-2.2457,<2.2e-16,MIR-372
GO:0002694,regulation of leukocyte activation,-2.259,<2.2e-16,MIR-372
GO:0002250,adaptive immune response,-2.3678,<2.2e-16,MIR-372
GO:0007159,leukocyte cell-cell adhesion,-2.4314,<2.2e-16,MIR-372
GO:0050663,cytokine secretion,-2.0499,<2.2e-16,MIR-373
GO:0002694,regulation of leukocyte activation,-2.1231,<2.2e-16,MIR-373
GO:0042110,T cell activation,-2.1324,<2.2e-16,MIR-373
GO:0002521,leukocyte differentiation,-2.1354,<2.2e-16,MIR-373
GO:0002683,negative regulation of immune system process,-2.1539,<2.2e-16,MIR-373
GO:0050900,leukocyte migration,-2.1618,<2.2e-16,MIR-373
GO:0001525,angiogenesis,-2.3406,<2.2e-16,MIR-373
GO:0032609,interferon-gamma production,2.3008,<2.2e-16,MIR-374A
GO:0002764,immune response-regulating signaling pathway,2.2627,<2.2e-16,MIR-374A
GO:0007159,leukocyte cell-cell adhesion,2.2559,<2.2e-16,MIR-374A
GO:0002250,adaptive immune response,2.2432,<2.2e-16,MIR-374A
GO:0001819,positive regulation of cytokine production,2.2246,<2.2e-16,MIR-374A
GO:0002449,lymphocyte mediated immunity,2.2116,<2.2e-16,MIR-374A
GO:0034341,response to interferon-gamma,2.1928,<2.2e-16,MIR-374A
GO:0042116,macrophage activation,2.1846,<2.2e-16,MIR-374A
GO:0032635,interleukin-6 production,2.1712,<2.2e-16,MIR-374A
GO:0002526,acute inflammatory response,2.1394,<2.2e-16,MIR-374A
GO:0002269,leukocyte activation involved in inflammatory response,2.1317,<2.2e-16,MIR-374A
GO:0002532,production of molecular mediator involved in inflammatory response,2.1207,<2.2e-16,MIR-374A
GO:0036230,granulocyte activation,2.1203,<2.2e-16,MIR-374A
GO:0032612,interleukin-1 production,2.1121,<2.2e-16,MIR-374A
GO:0042110,T cell activation,2.0855,<2.2e-16,MIR-374A
GO:0050900,leukocyte migration,1.6706,0.17725,MIR-196B
GO:0034341,response to interferon-gamma,2.383,<2.2e-16,MIR-361
GO:0034340,response to type I interferon,2.3665,<2.2e-16,MIR-361
GO:0002250,adaptive immune response,2.3324,<2.2e-16,MIR-361
GO:0045088,regulation of innate immune response,2.2566,<2.2e-16,MIR-361
GO:0007159,leukocyte cell-cell adhesion,2.2491,<2.2e-16,MIR-361
GO:0032609,interferon-gamma production,2.2482,<2.2e-16,MIR-361
GO:0002697,regulation of immune effector process,2.2363,<2.2e-16,MIR-361
GO:0032606,type I interferon production,2.2168,<2.2e-16,MIR-361
GO:0002764,immune response-regulating signaling pathway,2.2018,<2.2e-16,MIR-361
GO:0042110,T cell activation,2.1766,<2.2e-16,MIR-361
GO:0002449,lymphocyte mediated immunity,2.17,<2.2e-16,MIR-361
GO:0001819,positive regulation of cytokine production,2.1543,<2.2e-16,MIR-361
GO:0002694,regulation of leukocyte activation,2.1243,<2.2e-16,MIR-361
GO:0070661,leukocyte proliferation,2.1142,<2.2e-16,MIR-361
GO:0035456,response to interferon-beta,2.092,<2.2e-16,MIR-361
GO:0071706,tumor necrosis factor superfamily cytokine production,2.0478,<2.2e-16,MIR-361
GO:0001525,angiogenesis,-2.2597,<2.2e-16,MIR-375
GO:0002250,adaptive immune response,-2.0166,0.00034635,MIR-375
GO:0032615,interleukin-12 production,-1.9876,0.00042331,MIR-375
GO:0071887,leukocyte apoptotic process,-1.9564,0.00043959,MIR-375
GO:0050900,leukocyte migration,-1.9567,0.00045718,MIR-375
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.998,0.00047623,MIR-375
GO:0001818,negative regulation of cytokine production,-2.0424,<2.2e-16,MIR-376A-1
GO:0035455,response to interferon-alpha,-2.0529,<2.2e-16,MIR-376A-1
GO:0032633,interleukin-4 production,-2.1332,<2.2e-16,MIR-376A-1
GO:0002764,immune response-regulating signaling pathway,-2.1368,<2.2e-16,MIR-376A-1
GO:0002449,lymphocyte mediated immunity,-2.1375,<2.2e-16,MIR-376A-1
GO:0032615,interleukin-12 production,-2.1528,<2.2e-16,MIR-376A-1
GO:0032635,interleukin-6 production,-2.2062,<2.2e-16,MIR-376A-1
GO:0070661,leukocyte proliferation,-2.2137,<2.2e-16,MIR-376A-1
GO:0060759,regulation of response to cytokine stimulus,-2.2207,<2.2e-16,MIR-376A-1
GO:0007159,leukocyte cell-cell adhesion,-2.2471,<2.2e-16,MIR-376A-1
GO:0035456,response to interferon-beta,-2.309,<2.2e-16,MIR-376A-1
GO:0032606,type I interferon production,-2.3389,<2.2e-16,MIR-376A-1
GO:0032609,interferon-gamma production,-2.5072,<2.2e-16,MIR-376A-1
GO:0034341,response to interferon-gamma,-2.6751,<2.2e-16,MIR-376A-1
GO:0034340,response to type I interferon,-2.7093,<2.2e-16,MIR-376A-1
GO:0001819,positive regulation of cytokine production,-2.0219,0.00023218,MIR-376A-1
GO:0045088,regulation of innate immune response,-2.0027,0.00064083,MIR-376A-1
GO:0035456,response to interferon-beta,-2.4653,<2.2e-16,MIR-377
GO:0032606,type I interferon production,-2.6303,<2.2e-16,MIR-377
GO:0034340,response to type I interferon,-2.7747,<2.2e-16,MIR-377
GO:0035455,response to interferon-alpha,-1.9623,0.0042833,MIR-377
GO:0035456,response to interferon-beta,-2.192,<2.2e-16,MIR-379
GO:0034340,response to type I interferon,-2.3326,<2.2e-16,MIR-379
GO:0034340,response to type I interferon,-2.2583,<2.2e-16,MIR-380
GO:0035456,response to interferon-beta,-2.3277,<2.2e-16,MIR-380
GO:0034341,response to interferon-gamma,-2.1067,0.0016523,MIR-380
GO:0035455,response to interferon-alpha,-1.9539,0.0066092,MIR-380
GO:0032635,interleukin-6 production,-1.8307,0.025335,MIR-380
GO:0032633,interleukin-4 production,-1.8365,0.026643,MIR-380
GO:0032609,interferon-gamma production,-1.8088,0.027038,MIR-380
GO:0006925,inflammatory cell apoptotic process,-1.7903,0.032633,MIR-380
GO:0045576,mast cell activation,-1.769,0.035052,MIR-380
GO:0032612,interleukin-1 production,-1.7036,0.050671,MIR-380
GO:0042092,type 2 immune response,-1.6508,0.061207,MIR-380
GO:0034340,response to type I interferon,-2.1894,0.00063314,MIR-381
GO:0035456,response to interferon-beta,-2.2055,0.00071228,MIR-381
GO:0032606,type I interferon production,-2.1698,<2.2e-16,MIR-382
GO:0035456,response to interferon-beta,-2.3612,<2.2e-16,MIR-382
GO:0034340,response to type I interferon,-2.7058,<2.2e-16,MIR-382
GO:0035455,response to interferon-alpha,-2.0593,0.0023640,MIR-382
GO:0035456,response to interferon-beta,-2.045,0.0042850,MIR-383
GO:0032620,interleukin-17 production,1.6653,0.18223,MIR-383
GO:0071559,response to transforming growth factor beta,-2.0458,0.00075338,MIR-422A
GO:0070671,response to interleukin-12,2.1677,0.074939,MIR-422A
GO:0006959,humoral immune response,1.6466,0.12914,MIR-422A
GO:0002449,lymphocyte mediated immunity,1.7556,0.13072,MIR-422A
GO:0035456,response to interferon-beta,1.6488,0.13208,MIR-422A
GO:0002250,adaptive immune response,1.6527,0.13372,MIR-422A
GO:0002250,adaptive immune response,2.2988,<2.2e-16,MIR-423
GO:0007159,leukocyte cell-cell adhesion,2.2654,<2.2e-16,MIR-423
GO:0032609,interferon-gamma production,2.2569,<2.2e-16,MIR-423
GO:0042110,T cell activation,2.1935,<2.2e-16,MIR-423
GO:0002694,regulation of leukocyte activation,2.1843,<2.2e-16,MIR-423
GO:0002449,lymphocyte mediated immunity,2.1574,<2.2e-16,MIR-423
GO:0001819,positive regulation of cytokine production,2.1428,<2.2e-16,MIR-423
GO:0002697,regulation of immune effector process,2.141,<2.2e-16,MIR-423
GO:0032635,interleukin-6 production,2.1361,<2.2e-16,MIR-423
GO:0002764,immune response-regulating signaling pathway,2.1339,<2.2e-16,MIR-423
GO:0002285,lymphocyte activation involved in immune response,2.125,<2.2e-16,MIR-423
GO:0002521,leukocyte differentiation,2.0858,<2.2e-16,MIR-423
GO:0034341,response to interferon-gamma,2.06,<2.2e-16,MIR-423
GO:0032615,interleukin-12 production,2.0594,<2.2e-16,MIR-423
GO:0042113,B cell activation,2.0539,<2.2e-16,MIR-423
GO:0071559,response to transforming growth factor beta,-1.9315,0.00089222,MIR-425
GO:0002250,adaptive immune response,2.5321,<2.2e-16,MIR-31
GO:0002285,lymphocyte activation involved in immune response,2.4047,<2.2e-16,MIR-31
GO:0070661,leukocyte proliferation,2.3742,<2.2e-16,MIR-31
GO:0007159,leukocyte cell-cell adhesion,2.3669,<2.2e-16,MIR-31
GO:0002449,lymphocyte mediated immunity,2.3665,<2.2e-16,MIR-31
GO:0042110,T cell activation,2.3581,<2.2e-16,MIR-31
GO:0034341,response to interferon-gamma,2.2712,0.00017840,MIR-31
GO:0050900,leukocyte migration,2.2937,0.00021805,MIR-31
GO:1990868,response to chemokine,2.2076,0.00026761,MIR-31
GO:0002764,immune response-regulating signaling pathway,2.2165,0.00028035,MIR-31
GO:0045088,regulation of innate immune response,2.1802,0.00029073,MIR-31
GO:0002526,acute inflammatory response,2.1825,0.00030192,MIR-31
GO:0006959,humoral immune response,2.2188,0.00030986,MIR-31
GO:0002697,regulation of immune effector process,2.1847,0.00031399,MIR-31
GO:0001819,positive regulation of cytokine production,2.219,0.00032707,MIR-31
GO:0042113,B cell activation,2.1874,0.00032707,MIR-31
GO:0002446,neutrophil mediated immunity,2.2236,0.00034631,MIR-31
GO:0001525,angiogenesis,-1.884,0.0018791,MIR-429
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.6906,0.013802,MIR-429
GO:0034340,response to type I interferon,1.847,0.040519,MIR-429
GO:0032606,type I interferon production,1.447,0.31255,MIR-429
GO:0001818,negative regulation of cytokine production,-2.0169,<2.2e-16,MIR-448
GO:0006959,humoral immune response,-2.0731,<2.2e-16,MIR-448
GO:0032623,interleukin-2 production,-2.0936,<2.2e-16,MIR-448
GO:0002526,acute inflammatory response,-1.9808,0.0012941,MIR-448
GO:0050727,regulation of inflammatory response,-1.9342,0.0026422,MIR-448
GO:0036230,granulocyte activation,-1.9402,0.0028824,MIR-448
GO:0002532,production of molecular mediator involved in inflammatory response,-1.9439,0.0031706,MIR-448
GO:0002250,adaptive immune response,-1.9,0.0035759,MIR-448
GO:0002446,neutrophil mediated immunity,-1.9001,0.0037746,MIR-448
GO:0042116,macrophage activation,-1.9003,0.0039966,MIR-448
GO:0070555,response to interleukin-1,-1.8853,0.0045295,MIR-448
GO:0001819,positive regulation of cytokine production,-1.8453,0.0054005,MIR-448
GO:0008356,asymmetric cell division,1.4063,0.40389,MIR-448
GO:0050727,regulation of inflammatory response,-2.039,<2.2e-16,MIR-449A
GO:0050900,leukocyte migration,-2.0532,<2.2e-16,MIR-449A
GO:0002521,leukocyte differentiation,-2.0557,<2.2e-16,MIR-449A
GO:0001525,angiogenesis,-2.1172,<2.2e-16,MIR-449A
GO:0002250,adaptive immune response,-1.9819,0.00027156,MIR-449A
GO:0032634,interleukin-5 production,1.5124,0.41761,MIR-449A
GO:0002507,tolerance induction,1.7686,0.045798,MIR-450A-1
GO:0071559,response to transforming growth factor beta,-2.1593,<2.2e-16,MIR-362
GO:0036230,granulocyte activation,1.9468,0.0016731,MIR-362
GO:0002446,neutrophil mediated immunity,1.9419,0.0016731,MIR-362
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.514,0.15781,MIR-363
GO:0036230,granulocyte activation,-1.8281,0.031029,MIR-20B
GO:0002446,neutrophil mediated immunity,-1.7895,0.038608,MIR-20B
GO:0036230,granulocyte activation,-2.1038,0.0090253,MIR-18B
GO:0002446,neutrophil mediated immunity,-1.9215,0.013538,MIR-18B
GO:0032635,interleukin-6 production,-1.7553,0.035393,MIR-18B
GO:0032620,interleukin-17 production,-1.7566,0.037605,MIR-18B
GO:0032606,type I interferon production,-2.5244,<2.2e-16,MIR-433
GO:0035456,response to interferon-beta,-2.5736,<2.2e-16,MIR-433
GO:0034340,response to type I interferon,-2.9612,<2.2e-16,MIR-433
GO:0034341,response to interferon-gamma,-2.0694,0.00099842,MIR-433
GO:0060759,regulation of response to cytokine stimulus,-1.7364,0.041435,MIR-433
GO:0035455,response to interferon-alpha,-1.7233,0.042206,MIR-433
GO:0032633,interleukin-4 production,-2.1638,<2.2e-16,MIR-431
GO:0019882,antigen processing and presentation,-2.2015,<2.2e-16,MIR-431
GO:0032609,interferon-gamma production,-2.2271,<2.2e-16,MIR-431
GO:0002449,lymphocyte mediated immunity,-2.2353,<2.2e-16,MIR-431
GO:0032606,type I interferon production,-2.4817,<2.2e-16,MIR-431
GO:0034341,response to interferon-gamma,-2.5086,<2.2e-16,MIR-431
GO:0035456,response to interferon-beta,-2.5486,<2.2e-16,MIR-431
GO:0034340,response to type I interferon,-2.8211,<2.2e-16,MIR-431
GO:0060759,regulation of response to cytokine stimulus,-2.0455,0.00058257,MIR-431
GO:0032615,interleukin-12 production,-2.0835,0.00079442,MIR-431
GO:0042092,type 2 immune response,-2.0233,0.0010923,MIR-431
GO:0007159,leukocyte cell-cell adhesion,-1.9792,0.0024274,MIR-431
GO:0045576,mast cell activation,-1.9752,0.0024967,MIR-431
GO:0032623,interleukin-2 production,-1.9575,0.0031777,MIR-431
GO:0002764,immune response-regulating signaling pathway,-2.2335,<2.2e-16,MIR-329-1
GO:0034341,response to interferon-gamma,-2.4602,<2.2e-16,MIR-329-1
GO:0032606,type I interferon production,-2.4765,<2.2e-16,MIR-329-1
GO:0035456,response to interferon-beta,-2.542,<2.2e-16,MIR-329-1
GO:0034340,response to type I interferon,-2.8539,<2.2e-16,MIR-329-1
GO:0060759,regulation of response to cytokine stimulus,-2.1311,0.00064101,MIR-329-1
GO:0019882,antigen processing and presentation,-2.1146,0.0010256,MIR-329-1
GO:0032633,interleukin-4 production,-2.1193,0.0010989,MIR-329-1
GO:0032609,interferon-gamma production,-2.1235,0.0011834,MIR-329-1
GO:0002697,regulation of immune effector process,-2.0723,0.0024038,MIR-329-1
GO:0035455,response to interferon-alpha,-2.0083,0.0028339,MIR-329-1
GO:0002250,adaptive immune response,-2.0415,0.0029914,MIR-329-1
GO:0032623,interleukin-2 production,-1.961,0.0035255,MIR-329-1
GO:0032606,type I interferon production,-2.1988,<2.2e-16,MIR-329-2
GO:0002764,immune response-regulating signaling pathway,-2.2038,<2.2e-16,MIR-329-2
GO:0034341,response to interferon-gamma,-2.3139,<2.2e-16,MIR-329-2
GO:0035456,response to interferon-beta,-2.4427,<2.2e-16,MIR-329-2
GO:0034340,response to type I interferon,-2.6646,<2.2e-16,MIR-329-2
GO:0032609,interferon-gamma production,-2.0318,0.00099702,MIR-329-2
GO:0002449,lymphocyte mediated immunity,-2.0395,0.0010635,MIR-329-2
GO:0019882,antigen processing and presentation,-1.9077,0.0054574,MIR-329-2
GO:0006925,inflammatory cell apoptotic process,-1.9321,0.0060994,MIR-329-2
GO:0042092,type 2 immune response,-1.893,0.0067797,MIR-329-2
GO:0002250,adaptive immune response,-1.8558,0.0076294,MIR-329-2
GO:0002250,adaptive immune response,2.5503,<2.2e-16,MIR-452
GO:0002449,lymphocyte mediated immunity,2.4507,<2.2e-16,MIR-452
GO:0007159,leukocyte cell-cell adhesion,2.4441,<2.2e-16,MIR-452
GO:0002694,regulation of leukocyte activation,2.3805,<2.2e-16,MIR-452
GO:0002764,immune response-regulating signaling pathway,2.3803,<2.2e-16,MIR-452
GO:0002446,neutrophil mediated immunity,2.3766,<2.2e-16,MIR-452
GO:0002285,lymphocyte activation involved in immune response,2.32,<2.2e-16,MIR-452
GO:0002697,regulation of immune effector process,2.3189,<2.2e-16,MIR-452
GO:0001819,positive regulation of cytokine production,2.3048,<2.2e-16,MIR-452
GO:0002526,acute inflammatory response,2.3036,<2.2e-16,MIR-452
GO:0002521,leukocyte differentiation,2.3026,<2.2e-16,MIR-452
GO:0006959,humoral immune response,2.2598,<2.2e-16,MIR-452
GO:0002532,production of molecular mediator involved in inflammatory response,2.1944,<2.2e-16,MIR-452
GO:0002683,negative regulation of immune system process,2.1772,<2.2e-16,MIR-452
GO:0002440,production of molecular mediator of immune response,2.1332,<2.2e-16,MIR-452
GO:0001818,negative regulation of cytokine production,2.1195,<2.2e-16,MIR-452
GO:0002448,mast cell mediated immunity,2.0572,<2.2e-16,MIR-452
GO:0001773,myeloid dendritic cell activation,2.0437,<2.2e-16,MIR-452
GO:0002269,leukocyte activation involved in inflammatory response,1.9456,<2.2e-16,MIR-452
GO:0035456,response to interferon-beta,-2.2342,<2.2e-16,MIR-409
GO:0032606,type I interferon production,-2.4744,<2.2e-16,MIR-409
GO:0034340,response to type I interferon,-2.8875,<2.2e-16,MIR-409
GO:0035455,response to interferon-alpha,-2.0465,0.0013124,MIR-409
GO:0035456,response to interferon-beta,-2.4419,<2.2e-16,MIR-412
GO:0034340,response to type I interferon,-2.501,<2.2e-16,MIR-412
GO:0035455,response to interferon-alpha,-2.1786,0.0043632,MIR-412
GO:0032606,type I interferon production,-1.9606,0.013713,MIR-412
GO:0034341,response to interferon-gamma,-1.8952,0.022907,MIR-412
GO:0032609,interferon-gamma production,-1.8441,0.027925,MIR-412
GO:0032633,interleukin-4 production,-1.7035,0.059215,MIR-412
GO:0060759,regulation of response to cytokine stimulus,-1.5237,0.15969,MIR-412
GO:0006925,inflammatory cell apoptotic process,-1.4847,0.17707,MIR-412
GO:0032623,interleukin-2 production,-1.4782,0.17767,MIR-412
GO:0035456,response to interferon-beta,-2.5957,<2.2e-16,MIR-410
GO:0034340,response to type I interferon,-2.9206,<2.2e-16,MIR-410
GO:0034341,response to interferon-gamma,-2.1979,0.0010582,MIR-410
GO:0032606,type I interferon production,-2.2839,0.0014109,MIR-410
GO:0060759,regulation of response to cytokine stimulus,-2.0155,0.0019536,MIR-410
GO:0035455,response to interferon-alpha,-2.021,0.0021164,MIR-410
GO:0032609,interferon-gamma production,-1.9634,0.0036281,MIR-410
GO:0032633,interleukin-4 production,-1.9192,0.0048375,MIR-410
GO:0006959,humoral immune response,-1.2045,0.4639,MIR-376B
GO:0032616,interleukin-13 production,-1.1857,0.46642,MIR-376B
GO:0002251,organ or tissue specific immune response,-1.1736,0.46836,MIR-376B
GO:0035456,response to interferon-beta,-2.4736,<2.2e-16,MIR-485
GO:0032606,type I interferon production,-2.5565,<2.2e-16,MIR-485
GO:0034340,response to type I interferon,-2.7348,<2.2e-16,MIR-485
GO:0002440,production of molecular mediator of immune response,-2.0419,<2.2e-16,MIR-488
GO:0002526,acute inflammatory response,-2.132,<2.2e-16,MIR-488
GO:0002507,tolerance induction,-2.1552,<2.2e-16,MIR-488
GO:0001773,myeloid dendritic cell activation,-2.1675,<2.2e-16,MIR-488
GO:0001818,negative regulation of cytokine production,-2.2234,<2.2e-16,MIR-488
GO:0002285,lymphocyte activation involved in immune response,-2.2243,<2.2e-16,MIR-488
GO:0006959,humoral immune response,-2.2307,<2.2e-16,MIR-488
GO:0002532,production of molecular mediator involved in inflammatory response,-2.2973,<2.2e-16,MIR-488
GO:0002697,regulation of immune effector process,-2.3536,<2.2e-16,MIR-488
GO:0002683,negative regulation of immune system process,-2.3635,<2.2e-16,MIR-488
GO:0002521,leukocyte differentiation,-2.3638,<2.2e-16,MIR-488
GO:0002449,lymphocyte mediated immunity,-2.4053,<2.2e-16,MIR-488
GO:0002694,regulation of leukocyte activation,-2.4307,<2.2e-16,MIR-488
GO:0001819,positive regulation of cytokine production,-2.4335,<2.2e-16,MIR-488
GO:0002764,immune response-regulating signaling pathway,-2.5261,<2.2e-16,MIR-488
GO:0002250,adaptive immune response,-2.6306,<2.2e-16,MIR-488
GO:0002446,neutrophil mediated immunity,-2.6398,<2.2e-16,MIR-488
GO:0071559,response to transforming growth factor beta,-1.7119,0.061329,MIR-489
GO:0002200,somatic diversification of immune receptors,1.6259,0.48510,MIR-489
GO:0032633,interleukin-4 production,1.5478,0.52284,MIR-489
GO:0002285,lymphocyte activation involved in immune response,1.4315,0.55007,MIR-489
GO:0032615,interleukin-12 production,-2.0335,<2.2e-16,MIR-490
GO:0070671,response to interleukin-12,-1.9211,0.0052837,MIR-490
GO:0032609,interferon-gamma production,-1.7262,0.047700,MIR-490
GO:0002250,adaptive immune response,-1.6776,0.066633,MIR-490
GO:0002449,lymphocyte mediated immunity,-1.6399,0.073751,MIR-490
GO:0007159,leukocyte cell-cell adhesion,-1.5867,0.10797,MIR-490
GO:0034341,response to interferon-gamma,1.9051,0.0077594,MIR-491
GO:0060759,regulation of response to cytokine stimulus,1.866,0.013579,MIR-491
GO:0001525,angiogenesis,1.7932,0.014101,MIR-491
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1.8288,0.014428,MIR-491
GO:0050900,leukocyte migration,1.8037,0.015060,MIR-491
GO:0002250,adaptive immune response,2.084,<2.2e-16,MIR-511
GO:0007159,leukocyte cell-cell adhesion,2.0763,<2.2e-16,MIR-511
GO:0002449,lymphocyte mediated immunity,2.0651,<2.2e-16,MIR-511
GO:0002694,regulation of leukocyte activation,2.0191,<2.2e-16,MIR-511
GO:0002285,lymphocyte activation involved in immune response,2.0004,<2.2e-16,MIR-511
GO:0002697,regulation of immune effector process,1.9961,<2.2e-16,MIR-511
GO:0001819,positive regulation of cytokine production,1.9645,<2.2e-16,MIR-511
GO:0001773,myeloid dendritic cell activation,1.9602,<2.2e-16,MIR-511
GO:0002507,tolerance induction,1.9534,<2.2e-16,MIR-511
GO:0002440,production of molecular mediator of immune response,1.9495,<2.2e-16,MIR-511
GO:0002764,immune response-regulating signaling pathway,1.9469,<2.2e-16,MIR-511
GO:0019882,antigen processing and presentation,1.9449,<2.2e-16,MIR-511
GO:0002521,leukocyte differentiation,1.9389,<2.2e-16,MIR-511
GO:0006959,humoral immune response,1.9377,<2.2e-16,MIR-511
GO:0002446,neutrophil mediated immunity,1.9216,<2.2e-16,MIR-511
GO:0001818,negative regulation of cytokine production,1.9208,<2.2e-16,MIR-511
GO:0002683,negative regulation of immune system process,1.9203,<2.2e-16,MIR-511
GO:0002250,adaptive immune response,2.2673,<2.2e-16,MIR-146B
GO:0034340,response to type I interferon,2.2645,<2.2e-16,MIR-146B
GO:0034341,response to interferon-gamma,2.2488,<2.2e-16,MIR-146B
GO:0002449,lymphocyte mediated immunity,2.1214,<2.2e-16,MIR-146B
GO:0002764,immune response-regulating signaling pathway,2.1168,<2.2e-16,MIR-146B
GO:0002697,regulation of immune effector process,2.1109,<2.2e-16,MIR-146B
GO:0032623,interleukin-2 production,2.0993,<2.2e-16,MIR-146B
GO:0007159,leukocyte cell-cell adhesion,2.0787,<2.2e-16,MIR-146B
GO:0032609,interferon-gamma production,2.0544,<2.2e-16,MIR-146B
GO:0001819,positive regulation of cytokine production,2.0454,<2.2e-16,MIR-146B
GO:0002694,regulation of leukocyte activation,2.0402,<2.2e-16,MIR-146B
GO:0002285,lymphocyte activation involved in immune response,2.0298,<2.2e-16,MIR-146B
GO:0002440,production of molecular mediator of immune response,2.0244,<2.2e-16,MIR-146B
GO:0019882,antigen processing and presentation,1.9863,<2.2e-16,MIR-146B
GO:0032615,interleukin-12 production,1.9795,<2.2e-16,MIR-146B
GO:0032606,type I interferon production,1.971,<2.2e-16,MIR-146B
GO:0001773,myeloid dendritic cell activation,1.9587,<2.2e-16,MIR-146B
GO:0001818,negative regulation of cytokine production,1.9235,<2.2e-16,MIR-146B
GO:0043276,anoikis,-1.5425,0.24885,MIR-146B
GO:1990868,response to chemokine,-2.1084,<2.2e-16,MIR-202
GO:0019882,antigen processing and presentation,-2.1287,<2.2e-16,MIR-202
GO:0002285,lymphocyte activation involved in immune response,-2.1331,<2.2e-16,MIR-202
GO:0002250,adaptive immune response,-2.1583,<2.2e-16,MIR-202
GO:0050900,leukocyte migration,-2.1607,<2.2e-16,MIR-202
GO:0007159,leukocyte cell-cell adhesion,-2.2282,<2.2e-16,MIR-202
GO:0042110,T cell activation,-2.2385,<2.2e-16,MIR-202
GO:0071887,leukocyte apoptotic process,-1.9963,0.00020296,MIR-202
GO:0042092,type 2 immune response,-1.956,0.00026474,MIR-202
GO:0002521,leukocyte differentiation,-1.957,0.00027677,MIR-202
GO:0042113,B cell activation,-1.9609,0.00028995,MIR-202
GO:0002694,regulation of leukocyte activation,-1.9831,0.00032047,MIR-202
GO:0036230,granulocyte activation,-1.9891,0.00035817,MIR-202
GO:0035455,response to interferon-alpha,1.7637,0.17957,MIR-202
GO:0034341,response to interferon-gamma,2.5173,<2.2e-16,MIR-492
GO:0034340,response to type I interferon,2.3364,<2.2e-16,MIR-492
GO:0002764,immune response-regulating signaling pathway,2.0664,0.00035690,MIR-492
GO:0032606,type I interferon production,2.0549,0.00093687,MIR-492
GO:0042092,type 2 immune response,2.0121,0.0014573,MIR-492
GO:0036230,granulocyte activation,2.0041,0.0015374,MIR-492
GO:0045088,regulation of innate immune response,2.0353,0.0016655,MIR-492
GO:0045576,mast cell activation,1.9782,0.0016655,MIR-492
GO:0002446,neutrophil mediated immunity,1.9886,0.0017176,MIR-492
GO:0002250,adaptive immune response,2.0228,0.0017488,MIR-492
GO:0019882,antigen processing and presentation,1.9844,0.0017635,MIR-492
GO:0035456,response to interferon-beta,1.9557,0.0021038,MIR-492
GO:0002449,lymphocyte mediated immunity,1.9166,0.0026173,MIR-492
GO:0035455,response to interferon-alpha,-2.0625,<2.2e-16,MIR-493
GO:0032606,type I interferon production,-2.0743,<2.2e-16,MIR-493
GO:0035456,response to interferon-beta,-2.389,<2.2e-16,MIR-493
GO:0034340,response to type I interferon,-2.7683,<2.2e-16,MIR-493
GO:0032606,type I interferon production,-2.4302,<2.2e-16,MIR-432
GO:0035456,response to interferon-beta,-2.5353,<2.2e-16,MIR-432
GO:0034340,response to type I interferon,-2.9892,<2.2e-16,MIR-432
GO:0035455,response to interferon-alpha,-2.0355,0.0036612,MIR-432
GO:0034341,response to interferon-gamma,-2.4263,<2.2e-16,MIR-494
GO:0032606,type I interferon production,-2.4349,<2.2e-16,MIR-494
GO:0035456,response to interferon-beta,-2.5645,<2.2e-16,MIR-494
GO:0034340,response to type I interferon,-2.8909,<2.2e-16,MIR-494
GO:0032609,interferon-gamma production,-2.1497,0.00060783,MIR-494
GO:0019882,antigen processing and presentation,-2.0747,0.0013436,MIR-494
GO:0035455,response to interferon-alpha,-2.0821,0.0014183,MIR-494
GO:0042092,type 2 immune response,-2.0828,0.0015017,MIR-494
GO:0002449,lymphocyte mediated immunity,-2.093,0.0015955,MIR-494
GO:0002250,adaptive immune response,-2.0272,0.0021274,MIR-494
GO:0019882,antigen processing and presentation,-2.0925,<2.2e-16,MIR-495
GO:0070671,response to interleukin-12,-2.1671,<2.2e-16,MIR-495
GO:0032606,type I interferon production,-2.2018,<2.2e-16,MIR-495
GO:0034341,response to interferon-gamma,-2.3583,<2.2e-16,MIR-495
GO:0035456,response to interferon-beta,-2.5653,<2.2e-16,MIR-495
GO:0034340,response to type I interferon,-2.9597,<2.2e-16,MIR-495
GO:0032606,type I interferon production,-2.3941,<2.2e-16,MIR-496
GO:0035456,response to interferon-beta,-2.4737,<2.2e-16,MIR-496
GO:0034340,response to type I interferon,-2.8658,<2.2e-16,MIR-496
GO:0035455,response to interferon-alpha,-2.2057,0.0018445,MIR-496
GO:0034341,response to interferon-gamma,-1.9039,0.010329,MIR-496
GO:0060759,regulation of response to cytokine stimulus,-1.6489,0.070092,MIR-496
GO:0045576,mast cell activation,-1.5574,0.11837,MIR-496
GO:0042092,type 2 immune response,-1.5385,0.12366,MIR-496
GO:0007159,leukocyte cell-cell adhesion,2.3581,<2.2e-16,MIR-193B
GO:0002446,neutrophil mediated immunity,2.2456,<2.2e-16,MIR-193B
GO:0002526,acute inflammatory response,2.191,<2.2e-16,MIR-193B
GO:0002764,immune response-regulating signaling pathway,2.18,<2.2e-16,MIR-193B
GO:0002250,adaptive immune response,2.1191,<2.2e-16,MIR-193B
GO:0032609,interferon-gamma production,2.1065,<2.2e-16,MIR-193B
GO:0002694,regulation of leukocyte activation,2.0961,<2.2e-16,MIR-193B
GO:0002449,lymphocyte mediated immunity,2.0698,<2.2e-16,MIR-193B
GO:0001819,positive regulation of cytokine production,2.0573,<2.2e-16,MIR-193B
GO:0006959,humoral immune response,2.0427,<2.2e-16,MIR-193B
GO:0019882,antigen processing and presentation,2.0387,<2.2e-16,MIR-193B
GO:0002697,regulation of immune effector process,2.0126,<2.2e-16,MIR-193B
GO:0035456,response to interferon-beta,1.6045,0.15978,MIR-497
GO:0045576,mast cell activation,-2.0937,<2.2e-16,MIR-181D
GO:0019882,antigen processing and presentation,-2.1051,<2.2e-16,MIR-181D
GO:0032612,interleukin-1 production,-2.1366,<2.2e-16,MIR-181D
GO:0050900,leukocyte migration,-2.1725,<2.2e-16,MIR-181D
GO:0002532,production of molecular mediator involved in inflammatory response,-2.2355,<2.2e-16,MIR-181D
GO:0007159,leukocyte cell-cell adhesion,-2.2767,<2.2e-16,MIR-181D
GO:0002446,neutrophil mediated immunity,-2.454,<2.2e-16,MIR-181D
GO:0036230,granulocyte activation,-2.4969,<2.2e-16,MIR-181D
GO:0034341,response to interferon-gamma,-2.0401,0.00038265,MIR-181D
GO:0042110,T cell activation,-2.0636,0.00044643,MIR-181D
GO:0050663,cytokine secretion,-2.0834,0.00053571,MIR-181D
GO:0050727,regulation of inflammatory response,-2.0053,0.00059524,MIR-181D
GO:0002200,somatic diversification of immune receptors,5.5476,0.23699,MIR-512-1
GO:0002764,immune response-regulating signaling pathway,1.0931,0.66127,MIR-512-2
GO:0002507,tolerance induction,1.1599,0.66321,MIR-512-2
GO:0150076,neuroinflammatory response,1.1119,0.66329,MIR-512-2
GO:0030099,myeloid cell differentiation,1.5454,0.46802,MIR-498
GO:0001819,positive regulation of cytokine production,1.5573,0.46969,MIR-498
GO:0002532,production of molecular mediator involved in inflammatory response,1.5474,0.47124,MIR-498
GO:0036230,granulocyte activation,1.5331,0.47224,MIR-498
GO:0001773,myeloid dendritic cell activation,1.7215,0.47913,MIR-498
GO:0001525,angiogenesis,-2.1366,0.055672,MIR-520E
GO:0042116,macrophage activation,1.8673,0.096743,MIR-520E
GO:0032620,interleukin-17 production,2.4293,0.71478,MIR-515-1
GO:0010573,vascular endothelial growth factor production,2.6,0.79391,MIR-515-1
GO:0042092,type 2 immune response,-0.69278,0.92289,MIR-515-1
GO:0098760,response to interleukin-7,-0.7288,0.93864,MIR-515-1
GO:0035456,response to interferon-beta,-0.69525,0.9388,MIR-515-1
GO:0032634,interleukin-5 production,-0.81061,0.93992,MIR-515-1
GO:0002526,acute inflammatory response,-0.97857,0.8564,MIR-519E
GO:0032615,interleukin-12 production,-1.0476,0.86322,MIR-519E
GO:1990868,response to chemokine,-0.97897,0.86404,MIR-519E
GO:0002437,inflammatory response to antigenic stimulus,-1.0513,0.86702,MIR-519E
GO:0150076,neuroinflammatory response,-1.0691,0.86808,MIR-519E
GO:0032613,interleukin-10 production,-0.96623,0.86827,MIR-519E
GO:0002440,production of molecular mediator of immune response,0.15846,0.91798,MIR-519E
GO:0002244,hematopoietic progenitor cell differentiation,0.24207,0.91807,MIR-519E
GO:0001525,angiogenesis,-3.2225,<2.2e-16,MIR-520F
GO:0032613,interleukin-10 production,0.88595,0.69511,MIR-520F
GO:0032602,chemokine production,0.87465,0.69611,MIR-520F
GO:0071706,tumor necrosis factor superfamily cytokine production,1.6712,0.18063,MIR-515-2
GO:0070671,response to interleukin-12,1.6496,0.18198,MIR-515-2
GO:0032612,interleukin-1 production,1.5499,0.18278,MIR-515-2
GO:0001773,myeloid dendritic cell activation,1.6851,0.18320,MIR-515-2
GO:0001819,positive regulation of cytokine production,1.6294,0.18401,MIR-515-2
GO:0032613,interleukin-10 production,1.6958,0.18442,MIR-515-2
GO:0010573,vascular endothelial growth factor production,3.0149,0.6077,MIR-519C
GO:0002200,somatic diversification of immune receptors,2.7515,0.70948,MIR-519C
GO:0071559,response to transforming growth factor beta,-0.22667,0.92304,MIR-519C
GO:0002526,acute inflammatory response,-0.22987,0.92504,MIR-519C
GO:0070661,leukocyte proliferation,-0.23453,0.9256,MIR-519C
GO:0002683,negative regulation of immune system process,-0.23715,0.92837,MIR-519C
GO:0032620,interleukin-17 production,1.3812,0.32344,MIR-520A
GO:0070661,leukocyte proliferation,1.6177,0.37561,MIR-526B
GO:0006959,humoral immune response,1.6198,0.37852,MIR-526B
GO:0032612,interleukin-1 production,1.6211,0.38152,MIR-526B
GO:0050900,leukocyte migration,1.5325,0.38452,MIR-526B
GO:0042113,B cell activation,1.6327,0.38514,MIR-526B
GO:0019882,antigen processing and presentation,1.7794,0.38572,MIR-526B
GO:0042110,T cell activation,1.648,0.387,MIR-526B
GO:0071887,leukocyte apoptotic process,1.525,0.38713,MIR-526B
GO:0001819,positive regulation of cytokine production,1.6353,0.38752,MIR-526B
GO:0034340,response to type I interferon,-2.9094,0.00046542,MIR-519B
GO:0002251,organ or tissue specific immune response,0.72511,0.86748,MIR-519B
GO:0071559,response to transforming growth factor beta,-1.2795,0.41466,MIR-525
GO:0050663,cytokine secretion,0.84001,0.67116,MIR-525
GO:0042092,type 2 immune response,0.84262,0.67355,MIR-525
GO:0002697,regulation of immune effector process,0.87665,0.6758,MIR-525
GO:0030101,natural killer cell activation,0.82874,0.67672,MIR-525
GO:0001525,angiogenesis,-2.7309,0.00056005,MIR-523
GO:0048536,spleen development,1.0051,0.60482,MIR-523
GO:0033028,myeloid cell apoptotic process,1.0506,0.60947,MIR-523
GO:0032606,type I interferon production,-1.4641,0.32735,MIR-518F
GO:0032616,interleukin-13 production,0.71801,0.89464,MIR-518F
GO:0150076,neuroinflammatory response,0.69039,0.89726,MIR-518F
GO:0070670,response to interleukin-4,0.53769,0.89804,MIR-518F
GO:0032602,chemokine production,0.72304,0.89827,MIR-518F
GO:0006925,inflammatory cell apoptotic process,0.84948,0.89868,MIR-518F
GO:0033028,myeloid cell apoptotic process,0.7183,0.89874,MIR-518F
GO:0043276,anoikis,-1.6558,0.36448,MIR-520B
GO:0042092,type 2 immune response,1.1583,0.91293,MIR-520B
GO:0036230,granulocyte activation,2.5332,<2.2e-16,MIR-518B
GO:0002446,neutrophil mediated immunity,2.4927,<2.2e-16,MIR-518B
GO:0019882,antigen processing and presentation,2.1959,0.00014806,MIR-518B
GO:0002449,lymphocyte mediated immunity,2.2471,0.00017582,MIR-518B
GO:0002250,adaptive immune response,2.2494,0.00018754,MIR-518B
GO:0032609,interferon-gamma production,2.2573,0.00021640,MIR-518B
GO:0048536,spleen development,-4.9082,0.29727,MIR-526A-1
GO:0002446,neutrophil mediated immunity,-1.4176,0.72603,MIR-526A-1
GO:0060759,regulation of response to cytokine stimulus,-2.433,0.73208,MIR-526A-1
GO:0002269,leukocyte activation involved in inflammatory response,2.404,0.93387,MIR-526A-1
GO:0001818,negative regulation of cytokine production,0.10128,0.97329,MIR-526A-1
GO:0030101,natural killer cell activation,0.96419,0.71243,MIR-520C
GO:0006925,inflammatory cell apoptotic process,0.93011,0.71488,MIR-520C
GO:0032606,type I interferon production,0.90378,0.71729,MIR-520C
GO:0002437,inflammatory response to antigenic stimulus,0.99439,0.72058,MIR-520C
GO:0032616,interleukin-13 production,0.98033,0.72308,MIR-520C
GO:0034340,response to type I interferon,0.99453,0.72604,MIR-520C
GO:0070555,response to interleukin-1,0.73999,0.75088,MIR-518C
GO:0002526,acute inflammatory response,0.95467,0.75256,MIR-518C
GO:0034341,response to interferon-gamma,0.72809,0.75362,MIR-518C
GO:0070670,response to interleukin-4,0.74666,0.75426,MIR-518C
GO:0042113,B cell activation,-2.9588,<2.2e-16,MIR-524
GO:0042110,T cell activation,-2.5522,0.0033143,MIR-524
GO:0034612,response to tumor necrosis factor,-2.5083,0.0050279,MIR-524
GO:0002694,regulation of leukocyte activation,-2.4724,0.0058611,MIR-524
GO:0019882,antigen processing and presentation,1.1006,0.64626,MIR-517A
GO:0050663,cytokine secretion,1.0875,0.65439,MIR-517A
GO:0098760,response to interleukin-7,1.1285,0.66340,MIR-517A
GO:0048536,spleen development,1.0511,0.66350,MIR-517A
GO:0070670,response to interleukin-4,1.1348,0.66755,MIR-517A
GO:0071706,tumor necrosis factor superfamily cytokine production,0.97989,0.79222,MIR-519D
GO:0010573,vascular endothelial growth factor production,0.97111,0.79489,MIR-519D
GO:0002446,neutrophil mediated immunity,0.45547,0.79702,MIR-519D
GO:0032623,interleukin-2 production,0.95206,0.79756,MIR-519D
GO:0034612,response to tumor necrosis factor,0.4659,0.79810,MIR-519D
GO:0002764,immune response-regulating signaling pathway,0.46218,0.79811,MIR-519D
GO:0001819,positive regulation of cytokine production,0.45969,0.79892,MIR-519D
GO:0034341,response to interferon-gamma,1.3597,0.77793,MIR-521-2
GO:0045576,mast cell activation,-1.2925,0.78375,MIR-521-2
GO:0045088,regulation of innate immune response,1.3276,0.95173,MIR-521-2
GO:0006925,inflammatory cell apoptotic process,1.2654,0.9557,MIR-521-2
GO:0002244,hematopoietic progenitor cell differentiation,1.2326,0.95634,MIR-521-2
GO:0001818,negative regulation of cytokine production,0.68285,0.78022,MIR-520D
GO:0002764,immune response-regulating signaling pathway,0.69332,0.78594,MIR-520D
GO:0034341,response to interferon-gamma,0.97198,0.62874,MIR-517B
GO:0006959,humoral immune response,0.98612,0.63383,MIR-517B
GO:0048536,spleen development,1.0715,0.63547,MIR-517B
GO:0002507,tolerance induction,3.4149,0.64737,MIR-520G
GO:0010573,vascular endothelial growth factor production,3.2582,0.71535,MIR-520G
GO:0032609,interferon-gamma production,2.1999,0.77395,MIR-520G
GO:0002697,regulation of immune effector process,0.74026,0.83619,MIR-516B-2
GO:0032634,interleukin-5 production,3.6642,0.40611,MIR-526A-2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-5.1854,0.41046,MIR-526A-2
GO:0032616,interleukin-13 production,3.7772,0.54678,MIR-526A-2
GO:0070741,response to interleukin-6,-5.3602,0.55804,MIR-526A-2
GO:0001525,angiogenesis,-1.0748,0.57476,MIR-526A-2
GO:0034340,response to type I interferon,1.9194,0.0060662,MIR-518E
GO:0035455,response to interferon-alpha,1.6737,0.055779,MIR-518E
GO:0150076,neuroinflammatory response,-1.3289,0.44213,MIR-518E
GO:0002448,mast cell mediated immunity,-1.4966,0.44774,MIR-518E
GO:0043276,anoikis,-1.3847,0.45451,MIR-518E
GO:0001525,angiogenesis,-1.3122,0.47049,MIR-518E
GO:0002507,tolerance induction,3.9267,0.4327,MIR-518A-1
GO:0070555,response to interleukin-1,-1.2453,0.49603,MIR-518A-1
GO:0007159,leukocyte cell-cell adhesion,-1.2974,0.50214,MIR-518A-1
GO:0043276,anoikis,-1.2843,0.50242,MIR-518A-1
GO:0032623,interleukin-2 production,-1.3002,0.50464,MIR-518A-1
GO:0010573,vascular endothelial growth factor production,3.4827,0.74328,MIR-518A-1
GO:0002200,somatic diversification of immune receptors,3.2727,0.7891,MIR-518A-1
GO:0070671,response to interleukin-12,0.59352,0.87505,MIR-518A-1
GO:0001773,myeloid dendritic cell activation,-1.8408,0.36755,MIR-518D
GO:0034612,response to tumor necrosis factor,-1.363,0.47455,MIR-518D
GO:0070741,response to interleukin-6,-1.7335,0.13267,MIR-516B-1
GO:0050663,cytokine secretion,1.0856,0.65036,MIR-516B-1
GO:0034612,response to tumor necrosis factor,0.86959,0.66046,MIR-516B-1
GO:0048536,spleen development,0.85874,0.66079,MIR-516B-1
GO:0042110,T cell activation,-1.9915,0.099811,MIR-518A-2
GO:0002532,production of molecular mediator involved in inflammatory response,4.8195,0.62418,MIR-518A-2
GO:1990868,response to chemokine,1.1926,0.73253,MIR-518A-2
GO:0032616,interleukin-13 production,1.1594,0.73554,MIR-518A-2
GO:0098760,response to interleukin-7,-0.76622,0.81288,MIR-517C
GO:0071887,leukocyte apoptotic process,0.55501,0.86196,MIR-517C
GO:0032606,type I interferon production,0.40099,0.86219,MIR-517C
GO:0001818,negative regulation of cytokine production,0.27208,0.86251,MIR-517C
GO:0034341,response to interferon-gamma,0.40197,0.86378,MIR-517C
GO:0002251,organ or tissue specific immune response,0.55546,0.8646,MIR-517C
GO:0070670,response to interleukin-4,0.56388,0.86483,MIR-517C
GO:0070741,response to interleukin-6,0.55763,0.86514,MIR-517C
GO:0034612,response to tumor necrosis factor,-2.3411,0.012766,MIR-520H
GO:0002532,production of molecular mediator involved in inflammatory response,0.32388,0.91084,MIR-520H
GO:0034340,response to type I interferon,1.5894,0.42901,MIR-521-1
GO:0043276,anoikis,-1.2942,0.76455,MIR-521-1
GO:0030101,natural killer cell activation,-1.303,0.78962,MIR-521-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.3046,0.82207,MIR-521-1
GO:0002764,immune response-regulating signaling pathway,-1.0828,0.83174,MIR-521-1
GO:0002683,negative regulation of immune system process,-1.3178,0.84188,MIR-521-1
GO:0035455,response to interferon-alpha,1.5476,0.19674,MIR-522
GO:0035456,response to interferon-beta,1.5529,0.20587,MIR-522
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.1189,0.83088,MIR-522
GO:0030101,natural killer cell activation,-1.1257,0.84374,MIR-522
GO:0034340,response to type I interferon,1.8408,0.042998,MIR-519A-1
GO:0035455,response to interferon-alpha,1.7478,0.13526,MIR-519A-1
GO:0045576,mast cell activation,-1.5809,0.27839,MIR-519A-1
GO:0043276,anoikis,-1.629,0.29364,MIR-519A-1
GO:0006959,humoral immune response,-1.5077,0.31916,MIR-519A-1
GO:0002448,mast cell mediated immunity,-1.4687,0.32353,MIR-519A-1
GO:0002526,acute inflammatory response,-1.4889,0.34032,MIR-519A-1
GO:0001773,myeloid dendritic cell activation,-1.5091,0.34271,MIR-519A-1
GO:0030101,natural killer cell activation,-1.7905,0.84179,MIR-527
GO:0002448,mast cell mediated immunity,-1.9325,0.8771,MIR-527
GO:0042092,type 2 immune response,-0.51636,0.8994,MIR-527
GO:0036230,granulocyte activation,0.89588,0.95992,MIR-527
GO:0050900,leukocyte migration,0.85311,0.96011,MIR-527
GO:0034340,response to type I interferon,2.1145,<2.2e-16,MIR-516A-1
GO:0035455,response to interferon-alpha,1.8182,0.034669,MIR-516A-1
GO:0035456,response to interferon-beta,1.7688,0.035731,MIR-516A-1
GO:0002448,mast cell mediated immunity,-1.6336,0.38164,MIR-516A-1
GO:0045576,mast cell activation,-1.5199,0.48765,MIR-516A-1
GO:0043276,anoikis,-1.532,0.49932,MIR-516A-1
GO:0034340,response to type I interferon,1.8237,0.32315,MIR-516A-2
GO:0035455,response to interferon-alpha,1.8948,0.37327,MIR-516A-2
GO:0035456,response to interferon-beta,1.7184,0.46278,MIR-516A-2
GO:0034340,response to type I interferon,1.8703,0.030130,MIR-519A-2
GO:0035455,response to interferon-alpha,1.7672,0.043851,MIR-519A-2
GO:0035456,response to interferon-beta,1.6974,0.082231,MIR-519A-2
GO:0002448,mast cell mediated immunity,-1.5155,0.58396,MIR-519A-2
GO:0045576,mast cell activation,-1.3744,0.63287,MIR-519A-2
GO:0043276,anoikis,-1.3559,0.66974,MIR-519A-2
GO:0002446,neutrophil mediated immunity,2.0356,<2.2e-16,MIR-501
GO:0036230,granulocyte activation,2.0177,0.00079367,MIR-501
GO:0034341,response to interferon-gamma,2.307,<2.2e-16,MIR-502
GO:0036230,granulocyte activation,2.1865,<2.2e-16,MIR-502
GO:0002446,neutrophil mediated immunity,2.1634,<2.2e-16,MIR-502
GO:0002250,adaptive immune response,2.1282,<2.2e-16,MIR-502
GO:0007159,leukocyte cell-cell adhesion,2.0826,0.0014138,MIR-502
GO:0002526,acute inflammatory response,2.0548,0.0017672,MIR-502
GO:0002532,production of molecular mediator involved in inflammatory response,2.0217,0.0021459,MIR-502
GO:0032609,interferon-gamma production,2.0229,0.0021750,MIR-502
GO:0045576,mast cell activation,2.0302,0.0024098,MIR-502
GO:0050900,leukocyte migration,1.9948,0.0028717,MIR-502
GO:0032637,interleukin-8 production,2.0025,0.0029453,MIR-502
GO:0050663,cytokine secretion,1.9796,0.0032819,MIR-502
GO:0070661,leukocyte proliferation,1.9811,0.0034460,MIR-502
GO:0045088,regulation of innate immune response,1.983,0.0035344,MIR-502
GO:0002449,lymphocyte mediated immunity,1.955,0.0036758,MIR-502
GO:0007159,leukocyte cell-cell adhesion,-1.7002,0.065738,MIR-450A-2
GO:0032633,interleukin-4 production,-1.4783,0.15110,MIR-503
GO:0045576,mast cell activation,-1.2257,0.38702,MIR-503
GO:0002448,mast cell mediated immunity,-1.2297,0.39397,MIR-503
GO:0032613,interleukin-10 production,-2.2058,<2.2e-16,MIR-504
GO:0032615,interleukin-12 production,-2.2175,<2.2e-16,MIR-504
GO:0001819,positive regulation of cytokine production,-2.236,<2.2e-16,MIR-504
GO:0032623,interleukin-2 production,-2.238,<2.2e-16,MIR-504
GO:0042110,T cell activation,-2.2434,<2.2e-16,MIR-504
GO:0042113,B cell activation,-2.2459,<2.2e-16,MIR-504
GO:0070661,leukocyte proliferation,-2.2509,<2.2e-16,MIR-504
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.2575,<2.2e-16,MIR-504
GO:0050900,leukocyte migration,-2.3129,<2.2e-16,MIR-504
GO:0002694,regulation of leukocyte activation,-2.3306,<2.2e-16,MIR-504
GO:0050663,cytokine secretion,-2.3359,<2.2e-16,MIR-504
GO:0002250,adaptive immune response,-2.4192,<2.2e-16,MIR-504
GO:0008356,asymmetric cell division,2.2474,0.039793,MIR-504
GO:0002250,adaptive immune response,2.3436,0.0049417,MIR-505
GO:0036230,granulocyte activation,2.3308,0.0049417,MIR-505
GO:0002446,neutrophil mediated immunity,2.2992,0.0057654,MIR-505
GO:0019882,antigen processing and presentation,2.2788,0.0061772,MIR-505
GO:0002449,lymphocyte mediated immunity,2.2514,0.0070596,MIR-505
GO:0034341,response to interferon-gamma,2.0951,0.027750,MIR-505
GO:0002694,regulation of leukocyte activation,2.0746,0.028878,MIR-505
GO:0030101,natural killer cell activation,2.0629,0.028924,MIR-505
GO:0042110,T cell activation,2.046,0.029390,MIR-505
GO:0002764,immune response-regulating signaling pathway,2.1218,0.029403,MIR-505
GO:0045088,regulation of innate immune response,2.0985,0.029444,MIR-505
GO:0032609,interferon-gamma production,2.0178,0.029538,MIR-505
GO:0070661,leukocyte proliferation,2.0073,0.029959,MIR-505
GO:0007159,leukocyte cell-cell adhesion,2.0475,0.030611,MIR-505
GO:0050900,leukocyte migration,1.9798,0.032026,MIR-505
GO:0050663,cytokine secretion,-2.0057,<2.2e-16,MIR-513A-1
GO:0034612,response to tumor necrosis factor,-2.0065,<2.2e-16,MIR-513A-1
GO:0032609,interferon-gamma production,-2.0466,<2.2e-16,MIR-513A-1
GO:0002694,regulation of leukocyte activation,-2.0503,<2.2e-16,MIR-513A-1
GO:0002449,lymphocyte mediated immunity,-2.0531,<2.2e-16,MIR-513A-1
GO:0002521,leukocyte differentiation,-2.071,<2.2e-16,MIR-513A-1
GO:0002764,immune response-regulating signaling pathway,-2.0717,<2.2e-16,MIR-513A-1
GO:0002446,neutrophil mediated immunity,-2.0811,<2.2e-16,MIR-513A-1
GO:0032615,interleukin-12 production,-2.082,<2.2e-16,MIR-513A-1
GO:0007159,leukocyte cell-cell adhesion,-2.1384,<2.2e-16,MIR-513A-1
GO:0036230,granulocyte activation,-2.1459,<2.2e-16,MIR-513A-1
GO:0019882,antigen processing and presentation,-2.2103,<2.2e-16,MIR-513A-1
GO:0002446,neutrophil mediated immunity,-2.0788,<2.2e-16,MIR-513A-2
GO:0036230,granulocyte activation,-2.1089,<2.2e-16,MIR-513A-2
GO:0032615,interleukin-12 production,-2.1188,<2.2e-16,MIR-513A-2
GO:0050900,leukocyte migration,-2.1296,<2.2e-16,MIR-513A-2
GO:0042110,T cell activation,-2.1559,<2.2e-16,MIR-513A-2
GO:0007159,leukocyte cell-cell adhesion,-2.1645,<2.2e-16,MIR-513A-2
GO:0042113,B cell activation,-2.1899,<2.2e-16,MIR-513A-2
GO:0019882,antigen processing and presentation,-2.2476,<2.2e-16,MIR-513A-2
GO:1990868,response to chemokine,-2.2643,<2.2e-16,MIR-513A-2
GO:0002285,lymphocyte activation involved in immune response,-2.3345,<2.2e-16,MIR-513A-2
GO:0002250,adaptive immune response,-2.3872,<2.2e-16,MIR-513A-2
GO:0002521,leukocyte differentiation,-2.0766,0.00030088,MIR-513A-2
GO:0002694,regulation of leukocyte activation,-1.9828,0.00032093,MIR-513A-2
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9873,0.00033200,MIR-513A-2
GO:0034612,response to tumor necrosis factor,-1.9939,0.00034386,MIR-513A-2
GO:0002440,production of molecular mediator of immune response,-1.9812,<2.2e-16,MIR-506
GO:0001525,angiogenesis,-2.0236,<2.2e-16,MIR-506
GO:0032615,interleukin-12 production,-2.0279,<2.2e-16,MIR-506
GO:0002764,immune response-regulating signaling pathway,-2.0421,<2.2e-16,MIR-506
GO:0002694,regulation of leukocyte activation,-2.0542,<2.2e-16,MIR-506
GO:0001819,positive regulation of cytokine production,-2.0619,<2.2e-16,MIR-506
GO:0002521,leukocyte differentiation,-2.0678,<2.2e-16,MIR-506
GO:0002446,neutrophil mediated immunity,-2.0768,<2.2e-16,MIR-506
GO:0002449,lymphocyte mediated immunity,-2.0773,<2.2e-16,MIR-506
GO:0036230,granulocyte activation,-2.1064,<2.2e-16,MIR-506
GO:0019882,antigen processing and presentation,-2.1327,<2.2e-16,MIR-506
GO:0042113,B cell activation,-2.1387,<2.2e-16,MIR-506
GO:0002250,adaptive immune response,-2.2916,<2.2e-16,MIR-506
GO:0032615,interleukin-12 production,-2.0198,<2.2e-16,MIR-507
GO:0002449,lymphocyte mediated immunity,-2.0444,<2.2e-16,MIR-507
GO:0002446,neutrophil mediated immunity,-2.0609,<2.2e-16,MIR-507
GO:0032609,interferon-gamma production,-2.061,<2.2e-16,MIR-507
GO:0002521,leukocyte differentiation,-2.0637,<2.2e-16,MIR-507
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0683,<2.2e-16,MIR-507
GO:0002764,immune response-regulating signaling pathway,-2.0713,<2.2e-16,MIR-507
GO:0034612,response to tumor necrosis factor,-2.0783,<2.2e-16,MIR-507
GO:0002694,regulation of leukocyte activation,-2.0966,<2.2e-16,MIR-507
GO:0036230,granulocyte activation,-2.0981,<2.2e-16,MIR-507
GO:0042113,B cell activation,-2.106,<2.2e-16,MIR-507
GO:0007159,leukocyte cell-cell adhesion,-2.1769,<2.2e-16,MIR-507
GO:1990868,response to chemokine,-2.1777,<2.2e-16,MIR-507
GO:0042110,T cell activation,-2.1828,<2.2e-16,MIR-507
GO:0002250,adaptive immune response,-2.3258,<2.2e-16,MIR-507
GO:0050900,leukocyte migration,-2.2126,<2.2e-16,MIR-507
GO:0002694,regulation of leukocyte activation,-2.0034,<2.2e-16,MIR-508
GO:0019882,antigen processing and presentation,-2.0084,<2.2e-16,MIR-508
GO:0001819,positive regulation of cytokine production,-2.009,<2.2e-16,MIR-508
GO:0002446,neutrophil mediated immunity,-2.0261,<2.2e-16,MIR-508
GO:0042113,B cell activation,-2.0348,<2.2e-16,MIR-508
GO:0050663,cytokine secretion,-2.0418,<2.2e-16,MIR-508
GO:1990868,response to chemokine,-2.0423,<2.2e-16,MIR-508
GO:0036230,granulocyte activation,-2.0467,<2.2e-16,MIR-508
GO:0001525,angiogenesis,-2.0474,<2.2e-16,MIR-508
GO:0002521,leukocyte differentiation,-2.0754,<2.2e-16,MIR-508
GO:0002285,lymphocyte activation involved in immune response,-2.1155,<2.2e-16,MIR-508
GO:0002250,adaptive immune response,-2.2143,<2.2e-16,MIR-508
GO:0032615,interleukin-12 production,-1.983,<2.2e-16,MIR-509-1
GO:0042092,type 2 immune response,-1.9836,<2.2e-16,MIR-509-1
GO:0002449,lymphocyte mediated immunity,-2.0154,<2.2e-16,MIR-509-1
GO:0002694,regulation of leukocyte activation,-2.0341,<2.2e-16,MIR-509-1
GO:0001525,angiogenesis,-2.0512,<2.2e-16,MIR-509-1
GO:0042113,B cell activation,-2.0526,<2.2e-16,MIR-509-1
GO:0050663,cytokine secretion,-2.0538,<2.2e-16,MIR-509-1
GO:0002521,leukocyte differentiation,-2.0646,<2.2e-16,MIR-509-1
GO:0002446,neutrophil mediated immunity,-2.0767,<2.2e-16,MIR-509-1
GO:0001819,positive regulation of cytokine production,-2.0872,<2.2e-16,MIR-509-1
GO:0036230,granulocyte activation,-2.1045,<2.2e-16,MIR-509-1
GO:0019882,antigen processing and presentation,-2.1087,<2.2e-16,MIR-509-1
GO:0002250,adaptive immune response,-2.256,<2.2e-16,MIR-509-1
GO:0035455,response to interferon-alpha,1.4782,0.28695,MIR-509-1
GO:0032609,interferon-gamma production,-2.0198,<2.2e-16,MIR-510
GO:0002449,lymphocyte mediated immunity,-2.0298,<2.2e-16,MIR-510
GO:0002521,leukocyte differentiation,-2.0314,<2.2e-16,MIR-510
GO:0002446,neutrophil mediated immunity,-2.0688,<2.2e-16,MIR-510
GO:0071887,leukocyte apoptotic process,-2.0701,<2.2e-16,MIR-510
GO:0036230,granulocyte activation,-2.0785,<2.2e-16,MIR-510
GO:0002440,production of molecular mediator of immune response,-2.0824,<2.2e-16,MIR-510
GO:0032615,interleukin-12 production,-2.0989,<2.2e-16,MIR-510
GO:0007159,leukocyte cell-cell adhesion,-2.099,<2.2e-16,MIR-510
GO:0050900,leukocyte migration,-2.1153,<2.2e-16,MIR-510
GO:0042113,B cell activation,-2.166,<2.2e-16,MIR-510
GO:0042110,T cell activation,-2.1852,<2.2e-16,MIR-510
GO:1990868,response to chemokine,-2.2627,<2.2e-16,MIR-510
GO:0019882,antigen processing and presentation,-2.2756,<2.2e-16,MIR-510
GO:0002250,adaptive immune response,-2.3161,<2.2e-16,MIR-510
GO:0002764,immune response-regulating signaling pathway,-1.9874,0.00045137,MIR-510
GO:0002694,regulation of leukocyte activation,-1.9787,0.00064762,MIR-510
GO:0032606,type I interferon production,-2.2796,<2.2e-16,MIR-483
GO:0035456,response to interferon-beta,-2.4299,<2.2e-16,MIR-483
GO:0034340,response to type I interferon,-2.5451,<2.2e-16,MIR-483
GO:0034341,response to interferon-gamma,-2.6672,<2.2e-16,MIR-483
GO:0032620,interleukin-17 production,-2.0415,0.00094183,MIR-483
GO:0045088,regulation of innate immune response,-1.9426,0.0037987,MIR-483
GO:0019882,antigen processing and presentation,-1.8031,0.015281,MIR-483
GO:0002250,adaptive immune response,-1.7379,0.024605,MIR-483
GO:0071559,response to transforming growth factor beta,1.6325,0.053286,MIR-483
GO:0002200,somatic diversification of immune receptors,1.9495,0.0020708,MIR-484
GO:0032606,type I interferon production,-2.5744,<2.2e-16,MIR-487A
GO:0035456,response to interferon-beta,-2.5867,<2.2e-16,MIR-487A
GO:0034340,response to type I interferon,-2.8509,<2.2e-16,MIR-487A
GO:0035455,response to interferon-alpha,-1.9148,0.010620,MIR-487A
GO:0034341,response to interferon-gamma,-1.7304,0.033033,MIR-487A
GO:0035455,response to interferon-alpha,-2.0621,<2.2e-16,MIR-455
GO:0032606,type I interferon production,-2.1488,<2.2e-16,MIR-455
GO:0035456,response to interferon-beta,-2.2094,<2.2e-16,MIR-455
GO:0034340,response to type I interferon,-2.7527,<2.2e-16,MIR-455
GO:0002446,neutrophil mediated immunity,1.9499,0.0046714,MIR-205
GO:0036230,granulocyte activation,1.932,0.0046714,MIR-205
GO:0032602,chemokine production,1.8239,0.022356,MIR-205
GO:0042092,type 2 immune response,1.8059,0.027153,MIR-205
GO:0002250,adaptive immune response,1.7395,0.045713,MIR-205
GO:0007159,leukocyte cell-cell adhesion,1.7454,0.045996,MIR-205
GO:0006959,humoral immune response,1.7047,0.047715,MIR-205
GO:0034612,response to tumor necrosis factor,1.6926,0.053297,MIR-205
GO:0008356,asymmetric cell division,-1.1488,0.79104,MIR-205
GO:0032606,type I interferon production,-2.2197,<2.2e-16,MIR-539
GO:0035456,response to interferon-beta,-2.3787,<2.2e-16,MIR-539
GO:0034340,response to type I interferon,-2.5491,<2.2e-16,MIR-539
GO:0035455,response to interferon-alpha,-2.081,0.00093659,MIR-539
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7135,0.0040411,MIR-539
GO:0070670,response to interleukin-4,1.6135,0.14319,MIR-545
GO:0060759,regulation of response to cytokine stimulus,1.6258,0.14323,MIR-545
GO:0045576,mast cell activation,1.6423,0.14577,MIR-545
GO:0002521,leukocyte differentiation,1.6456,0.14706,MIR-545
GO:0050727,regulation of inflammatory response,1.5986,0.15017,MIR-545
GO:0002694,regulation of leukocyte activation,-2.1175,<2.2e-16,MIR-376A-2
GO:0045576,mast cell activation,-2.136,<2.2e-16,MIR-376A-2
GO:0002269,leukocyte activation involved in inflammatory response,-2.138,<2.2e-16,MIR-376A-2
GO:0019882,antigen processing and presentation,-2.1441,<2.2e-16,MIR-376A-2
GO:0042110,T cell activation,-2.1777,<2.2e-16,MIR-376A-2
GO:0007159,leukocyte cell-cell adhesion,-2.2013,<2.2e-16,MIR-376A-2
GO:0032623,interleukin-2 production,-2.2013,<2.2e-16,MIR-376A-2
GO:0070661,leukocyte proliferation,-2.2238,<2.2e-16,MIR-376A-2
GO:0042116,macrophage activation,-2.2259,<2.2e-16,MIR-376A-2
GO:0002449,lymphocyte mediated immunity,-2.2648,<2.2e-16,MIR-376A-2
GO:0002250,adaptive immune response,-2.2877,<2.2e-16,MIR-376A-2
GO:0032633,interleukin-4 production,-2.3031,<2.2e-16,MIR-376A-2
GO:0032609,interferon-gamma production,-2.5085,<2.2e-16,MIR-376A-2
GO:0034340,response to type I interferon,-2.5123,<2.2e-16,MIR-376A-2
GO:0034341,response to interferon-gamma,-2.6422,<2.2e-16,MIR-376A-2
GO:0032606,type I interferon production,-2.1651,<2.2e-16,MIR-487B
GO:0035456,response to interferon-beta,-2.4933,<2.2e-16,MIR-487B
GO:0034340,response to type I interferon,-3.0455,<2.2e-16,MIR-487B
GO:0034341,response to interferon-gamma,-2.0577,0.00071025,MIR-487B
GO:0042092,type 2 immune response,-1.8735,0.011905,MIR-542
GO:0034341,response to interferon-gamma,-1.7937,0.015380,MIR-542
GO:0019882,antigen processing and presentation,-1.8004,0.016318,MIR-542
GO:0032609,interferon-gamma production,-1.8069,0.017163,MIR-542
GO:0002250,adaptive immune response,2.5806,<2.2e-16,MIR-33B
GO:0034341,response to interferon-gamma,2.4897,<2.2e-16,MIR-33B
GO:0002449,lymphocyte mediated immunity,2.4315,<2.2e-16,MIR-33B
GO:0042110,T cell activation,2.4298,<2.2e-16,MIR-33B
GO:0007159,leukocyte cell-cell adhesion,2.4284,<2.2e-16,MIR-33B
GO:0019882,antigen processing and presentation,2.3067,<2.2e-16,MIR-33B
GO:0002521,leukocyte differentiation,2.2633,<2.2e-16,MIR-33B
GO:0002285,lymphocyte activation involved in immune response,2.2565,<2.2e-16,MIR-33B
GO:0050900,leukocyte migration,2.2532,<2.2e-16,MIR-33B
GO:0034340,response to type I interferon,2.2512,<2.2e-16,MIR-33B
GO:0002694,regulation of leukocyte activation,2.2457,<2.2e-16,MIR-33B
GO:0036230,granulocyte activation,2.2209,<2.2e-16,MIR-33B
GO:0001819,positive regulation of cytokine production,2.2076,<2.2e-16,MIR-33B
GO:0042092,type 2 immune response,2.1942,<2.2e-16,MIR-33B
GO:0045088,regulation of innate immune response,2.1896,<2.2e-16,MIR-33B
GO:0002446,neutrophil mediated immunity,2.1941,<2.2e-16,MIR-33B
GO:0002764,immune response-regulating signaling pathway,2.1644,<2.2e-16,MIR-33B
GO:0035456,response to interferon-beta,-2.4086,<2.2e-16,MIR-411
GO:0034340,response to type I interferon,-2.7161,<2.2e-16,MIR-411
GO:0032606,type I interferon production,-1.8626,0.013141,MIR-411
GO:0050727,regulation of inflammatory response,-2.0869,<2.2e-16,MIR-449B
GO:0001773,myeloid dendritic cell activation,-2.0879,<2.2e-16,MIR-449B
GO:0002521,leukocyte differentiation,-2.094,<2.2e-16,MIR-449B
GO:0050900,leukocyte migration,-2.1317,<2.2e-16,MIR-449B
GO:0002250,adaptive immune response,-2.1386,<2.2e-16,MIR-449B
GO:0002764,immune response-regulating signaling pathway,-2.1732,<2.2e-16,MIR-449B
GO:0002449,lymphocyte mediated immunity,-1.9328,0.00014310,MIR-449B
GO:0036230,granulocyte activation,1.7936,0.30518,MIR-532
GO:0002446,neutrophil mediated immunity,1.8043,0.33078,MIR-532
GO:0007159,leukocyte cell-cell adhesion,1.523,0.34638,MIR-532
GO:0002507,tolerance induction,1.531,0.34865,MIR-532
GO:0008356,asymmetric cell division,3.0546,0.23087,MIR-548A-3
GO:0002507,tolerance induction,-1.0938,0.78943,MIR-548A-3
GO:0002532,production of molecular mediator involved in inflammatory response,-1.0861,0.7934,MIR-548A-3
GO:0032602,chemokine production,-0.93575,0.79844,MIR-548A-3
GO:0150076,neuroinflammatory response,-0.98573,0.80425,MIR-548A-3
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-0.95064,0.80485,MIR-548A-3
GO:0010573,vascular endothelial growth factor production,-1.1065,0.8064,MIR-548A-3
GO:0002437,inflammatory response to antigenic stimulus,1.8415,0.83416,MIR-548A-3
GO:0002200,somatic diversification of immune receptors,1.8504,0.83766,MIR-548A-3
GO:0048536,spleen development,2.4258,0.85493,MIR-548A-3
GO:0035455,response to interferon-alpha,-1.7165,0.146,MIR-548B
GO:0001525,angiogenesis,-1.5633,0.25785,MIR-548B
GO:0002251,organ or tissue specific immune response,-1.4125,0.37567,MIR-548B
GO:0032620,interleukin-17 production,-1.4228,0.38421,MIR-548B
GO:0060759,regulation of response to cytokine stimulus,7.7135,0.24710,MIR-548D-1
GO:0032620,interleukin-17 production,1.4812,0.31513,MIR-548D-1
GO:0032633,interleukin-4 production,1.4868,0.31579,MIR-548D-1
GO:0032606,type I interferon production,1.3963,0.37054,MIR-548D-2
GO:0035455,response to interferon-alpha,1.4036,0.37151,MIR-548D-2
GO:0032612,interleukin-1 production,1.4046,0.37372,MIR-548D-2
GO:0150076,neuroinflammatory response,1.3775,0.37463,MIR-548D-2
GO:0050663,cytokine secretion,1.3781,0.37704,MIR-548D-2
GO:0070555,response to interleukin-1,1.5646,0.37957,MIR-548D-2
GO:0006925,inflammatory cell apoptotic process,1.4323,0.38066,MIR-548D-2
GO:0001819,positive regulation of cytokine production,-2.0491,<2.2e-16,MIR-551B
GO:0006925,inflammatory cell apoptotic process,-2.0519,<2.2e-16,MIR-551B
GO:0001818,negative regulation of cytokine production,-2.0564,<2.2e-16,MIR-551B
GO:0002697,regulation of immune effector process,-2.0617,<2.2e-16,MIR-551B
GO:0032637,interleukin-8 production,-2.0664,<2.2e-16,MIR-551B
GO:0032615,interleukin-12 production,-2.074,<2.2e-16,MIR-551B
GO:0032633,interleukin-4 production,-2.0953,<2.2e-16,MIR-551B
GO:0002250,adaptive immune response,-2.1,<2.2e-16,MIR-551B
GO:0032612,interleukin-1 production,-2.1288,<2.2e-16,MIR-551B
GO:0032613,interleukin-10 production,-2.1553,<2.2e-16,MIR-551B
GO:0032609,interferon-gamma production,-2.1875,<2.2e-16,MIR-551B
GO:0032635,interleukin-6 production,-2.2196,<2.2e-16,MIR-551B
GO:0006959,humoral immune response,-2.2623,<2.2e-16,MIR-551B
GO:0032620,interleukin-17 production,-2.3216,<2.2e-16,MIR-551B
GO:0032606,type I interferon production,-2.3234,<2.2e-16,MIR-551B
GO:0034340,response to type I interferon,-2.5252,<2.2e-16,MIR-551B
GO:0002251,organ or tissue specific immune response,-1.8544,0.015856,MIR-552
GO:0034340,response to type I interferon,-1.7833,0.019587,MIR-552
GO:0042113,B cell activation,1.5305,0.24778,MIR-552
GO:0030101,natural killer cell activation,3.2547,0.62777,MIR-555
GO:0034340,response to type I interferon,3.2633,0.6585,MIR-555
GO:0001818,negative regulation of cytokine production,0.30944,0.91847,MIR-556
GO:0002697,regulation of immune effector process,0.30447,0.91883,MIR-556
GO:0002440,production of molecular mediator of immune response,0.30676,0.91885,MIR-556
GO:0002764,immune response-regulating signaling pathway,0.19588,0.91922,MIR-556
GO:0060759,regulation of response to cytokine stimulus,1.9782,0.18922,MIR-561
GO:0048536,spleen development,-1.1961,0.73447,MIR-564
GO:1903706,regulation of hemopoiesis,0.47158,0.93082,MIR-564
GO:0006959,humoral immune response,1.1195,0.47809,MIR-570
GO:0001525,angiogenesis,-2.0726,<2.2e-16,MIR-572
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.0109,0.00032837,MIR-572
GO:0050900,leukocyte migration,-1.9438,0.0010431,MIR-572
GO:0042092,type 2 immune response,-1.8734,0.033557,MIR-573
GO:0042116,macrophage activation,-1.8537,0.034216,MIR-573
GO:0001818,negative regulation of cytokine production,-1.8759,0.034396,MIR-573
GO:0035455,response to interferon-alpha,-1.8852,0.034605,MIR-573
GO:0001819,positive regulation of cytokine production,-1.8541,0.035161,MIR-573
GO:0150076,neuroinflammatory response,-1.8858,0.035809,MIR-573
GO:0002683,negative regulation of immune system process,-1.9219,0.036131,MIR-573
GO:1990868,response to chemokine,-1.9055,0.036266,MIR-573
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9305,0.036453,MIR-573
GO:0032635,interleukin-6 production,-1.8886,0.036783,MIR-573
GO:0002764,immune response-regulating signaling pathway,-1.9335,0.037542,MIR-573
GO:0006959,humoral immune response,-1.7679,0.038305,MIR-573
GO:0002526,acute inflammatory response,-1.7455,0.038955,MIR-573
GO:0001525,angiogenesis,2.0169,<2.2e-16,MIR-574
GO:0032635,interleukin-6 production,1.8855,<2.2e-16,MIR-574
GO:0045088,regulation of innate immune response,-8.3075,0.28604,MIR-575
GO:0002683,negative regulation of immune system process,-7.0677,0.43149,MIR-575
GO:0001819,positive regulation of cytokine production,-5.0399,0.48165,MIR-575
GO:0002764,immune response-regulating signaling pathway,-4.2204,0.52954,MIR-575
GO:0001773,myeloid dendritic cell activation,3.6923,0.69452,MIR-575
GO:0043276,anoikis,3.9337,0.74455,MIR-575
GO:0002250,adaptive immune response,2.6924,<2.2e-16,MIR-576
GO:0002449,lymphocyte mediated immunity,2.5622,<2.2e-16,MIR-576
GO:0001819,positive regulation of cytokine production,2.527,<2.2e-16,MIR-576
GO:0002697,regulation of immune effector process,2.5128,<2.2e-16,MIR-576
GO:0002764,immune response-regulating signaling pathway,2.4986,<2.2e-16,MIR-576
GO:0007159,leukocyte cell-cell adhesion,2.4974,<2.2e-16,MIR-576
GO:0002694,regulation of leukocyte activation,2.4627,<2.2e-16,MIR-576
GO:0002526,acute inflammatory response,2.403,<2.2e-16,MIR-576
GO:0002446,neutrophil mediated immunity,2.3496,<2.2e-16,MIR-576
GO:0002285,lymphocyte activation involved in immune response,2.3405,<2.2e-16,MIR-576
GO:0002683,negative regulation of immune system process,2.2668,<2.2e-16,MIR-576
GO:0002521,leukocyte differentiation,2.2095,<2.2e-16,MIR-576
GO:0001818,negative regulation of cytokine production,2.1966,<2.2e-16,MIR-576
GO:0002440,production of molecular mediator of immune response,2.1924,<2.2e-16,MIR-576
GO:0002507,tolerance induction,2.1586,<2.2e-16,MIR-576
GO:0002269,leukocyte activation involved in inflammatory response,2.0443,<2.2e-16,MIR-576
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.9408,<2.2e-16,MIR-577
GO:0034340,response to type I interferon,2.0635,<2.2e-16,MIR-577
GO:0001525,angiogenesis,-2.0949,0.0010400,MIR-578
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.014,0.0041600,MIR-578
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-1.9355,0.0079419,MIR-578
GO:0050727,regulation of inflammatory response,-1.8701,0.010022,MIR-578
GO:0050663,cytokine secretion,-1.903,0.010880,MIR-578
GO:0002250,adaptive immune response,2.4549,<2.2e-16,MIR-579
GO:0034341,response to interferon-gamma,2.3459,<2.2e-16,MIR-579
GO:0002449,lymphocyte mediated immunity,2.3327,<2.2e-16,MIR-579
GO:0002697,regulation of immune effector process,2.2134,<2.2e-16,MIR-579
GO:0034340,response to type I interferon,2.1934,<2.2e-16,MIR-579
GO:0007159,leukocyte cell-cell adhesion,2.1823,<2.2e-16,MIR-579
GO:0019882,antigen processing and presentation,2.1417,<2.2e-16,MIR-579
GO:0002446,neutrophil mediated immunity,2.0752,0.00023860,MIR-579
GO:0036230,granulocyte activation,2.1364,0.00025053,MIR-579
GO:0060759,regulation of response to cytokine stimulus,2.0778,0.00025053,MIR-579
GO:0050663,cytokine secretion,2.0945,0.00031316,MIR-579
GO:0032609,interferon-gamma production,2.1042,0.00035790,MIR-579
GO:0001819,positive regulation of cytokine production,2.1136,0.00038543,MIR-579
GO:0002694,regulation of leukocyte activation,2.006,0.00038543,MIR-579
GO:0150076,neuroinflammatory response,2.9432,0.90306,MIR-580
GO:0032623,interleukin-2 production,2.2187,0.0065964,MIR-582
GO:0032634,interleukin-5 production,2.0246,0.098214,MIR-582
GO:0070555,response to interleukin-1,1.5845,0.034317,MIR-584
GO:0001773,myeloid dendritic cell activation,-1.9077,0.021542,MIR-585
GO:0034341,response to interferon-gamma,-1.7521,0.080901,MIR-585
GO:1990868,response to chemokine,1.6577,0.093812,MIR-585
GO:0032633,interleukin-4 production,-1.5794,0.15724,MIR-585
GO:0002446,neutrophil mediated immunity,-1.5543,0.17695,MIR-585
GO:0034612,response to tumor necrosis factor,-1.4794,0.17999,MIR-585
GO:0002250,adaptive immune response,-1.5161,0.18077,MIR-585
GO:0002251,organ or tissue specific immune response,-1.4629,0.18447,MIR-585
GO:0002250,adaptive immune response,2.0431,0.0011043,MIR-588
GO:0071887,leukocyte apoptotic process,1.9699,0.0027899,MIR-588
GO:0007159,leukocyte cell-cell adhesion,1.9471,0.0033130,MIR-588
GO:0036230,granulocyte activation,2.6962,<2.2e-16,MIR-589
GO:0002446,neutrophil mediated immunity,2.6851,<2.2e-16,MIR-589
GO:0007159,leukocyte cell-cell adhesion,2.4866,<2.2e-16,MIR-589
GO:0002250,adaptive immune response,2.3848,<2.2e-16,MIR-589
GO:0019882,antigen processing and presentation,2.298,<2.2e-16,MIR-589
GO:0034341,response to interferon-gamma,2.2639,<2.2e-16,MIR-589
GO:0002526,acute inflammatory response,2.2226,<2.2e-16,MIR-589
GO:0002449,lymphocyte mediated immunity,2.1934,<2.2e-16,MIR-589
GO:0002694,regulation of leukocyte activation,2.188,<2.2e-16,MIR-589
GO:0006959,humoral immune response,2.178,<2.2e-16,MIR-589
GO:0002764,immune response-regulating signaling pathway,2.1689,<2.2e-16,MIR-589
GO:0002521,leukocyte differentiation,2.168,<2.2e-16,MIR-589
GO:0002285,lymphocyte activation involved in immune response,2.1522,<2.2e-16,MIR-589
GO:0001819,positive regulation of cytokine production,2.1169,<2.2e-16,MIR-589
GO:0032616,interleukin-13 production,-1.023,0.77352,MIR-591
GO:0048536,spleen development,-1.6152,0.12162,MIR-592
GO:0150076,neuroinflammatory response,1.4895,0.33362,MIR-592
GO:0035455,response to interferon-alpha,1.4213,0.41803,MIR-592
GO:0032606,type I interferon production,1.3773,0.49890,MIR-592
GO:0050900,leukocyte migration,-2.2495,<2.2e-16,MIR-593
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.1768,0.00072619,MIR-593
GO:0002526,acute inflammatory response,-2.1781,0.00090774,MIR-593
GO:0032613,interleukin-10 production,-2.1415,0.0010374,MIR-593
GO:0007159,leukocyte cell-cell adhesion,-2.1129,0.0012103,MIR-593
GO:0050663,cytokine secretion,-2.1782,0.0012103,MIR-593
GO:0032637,interleukin-8 production,-2.1178,0.0013616,MIR-593
GO:0001773,myeloid dendritic cell activation,-2.0073,0.0014120,MIR-593
GO:0050727,regulation of inflammatory response,-2.0091,0.0014951,MIR-593
GO:0032615,interleukin-12 production,-2.0702,0.0015129,MIR-593
GO:0006959,humoral immune response,-2.0155,0.0015886,MIR-593
GO:0042110,T cell activation,-1.996,0.0017199,MIR-593
GO:0032609,interferon-gamma production,-1.9612,0.0017366,MIR-593
GO:0070661,leukocyte proliferation,-1.9721,0.0018155,MIR-593
GO:0032602,chemokine production,-2.1885,0.0018155,MIR-593
GO:0036230,granulocyte activation,-1.9431,0.0020333,MIR-593
GO:0035455,response to interferon-alpha,1.7301,0.018350,MIR-593
GO:0002446,neutrophil mediated immunity,-2.1266,0.036855,MIR-596
GO:0036230,granulocyte activation,-2.1303,0.040258,MIR-596
GO:0036230,granulocyte activation,2.0251,0.0065418,MIR-597
GO:0002446,neutrophil mediated immunity,2.0591,0.0098127,MIR-597
GO:0002244,hematopoietic progenitor cell differentiation,-1.6075,0.053315,MIR-597
GO:0019882,antigen processing and presentation,-2.1802,<2.2e-16,MIR-598
GO:0002446,neutrophil mediated immunity,-2.299,<2.2e-16,MIR-598
GO:0036230,granulocyte activation,-2.3068,<2.2e-16,MIR-598
GO:0070671,response to interleukin-12,-2.1194,0.00062733,MIR-598
GO:0034341,response to interferon-gamma,-1.927,0.0030763,MIR-598
GO:0071559,response to transforming growth factor beta,1.5774,0.099242,MIR-598
GO:0034340,response to type I interferon,-1.4918,0.29821,MIR-599
GO:0002521,leukocyte differentiation,1.4435,0.40783,MIR-599
GO:0034340,response to type I interferon,1.9698,0.00024716,MIR-600
GO:0007159,leukocyte cell-cell adhesion,2.5422,<2.2e-16,MIR-602
GO:0002764,immune response-regulating signaling pathway,2.4118,<2.2e-16,MIR-602
GO:0002250,adaptive immune response,2.3528,<2.2e-16,MIR-602
GO:0001819,positive regulation of cytokine production,2.3513,<2.2e-16,MIR-602
GO:0002694,regulation of leukocyte activation,2.342,<2.2e-16,MIR-602
GO:0001525,angiogenesis,2.3158,<2.2e-16,MIR-602
GO:0002521,leukocyte differentiation,2.2291,<2.2e-16,MIR-602
GO:0002446,neutrophil mediated immunity,2.2282,<2.2e-16,MIR-602
GO:0002683,negative regulation of immune system process,2.2107,<2.2e-16,MIR-602
GO:0002526,acute inflammatory response,2.2051,<2.2e-16,MIR-602
GO:0002449,lymphocyte mediated immunity,2.0891,<2.2e-16,MIR-602
GO:0042113,B cell activation,-4.9297,0.19185,MIR-604
GO:1903706,regulation of hemopoiesis,-4.7101,0.19688,MIR-604
GO:0007159,leukocyte cell-cell adhesion,2.6082,<2.2e-16,MIR-605
GO:0002250,adaptive immune response,2.4341,<2.2e-16,MIR-605
GO:0002764,immune response-regulating signaling pathway,2.3514,<2.2e-16,MIR-605
GO:0002446,neutrophil mediated immunity,2.3141,<2.2e-16,MIR-605
GO:0001819,positive regulation of cytokine production,2.2646,<2.2e-16,MIR-605
GO:0002694,regulation of leukocyte activation,2.2397,<2.2e-16,MIR-605
GO:0002449,lymphocyte mediated immunity,2.2335,<2.2e-16,MIR-605
GO:0002532,production of molecular mediator involved in inflammatory response,2.1454,<2.2e-16,MIR-605
GO:0002285,lymphocyte activation involved in immune response,2.1396,<2.2e-16,MIR-605
GO:0006959,humoral immune response,2.1331,<2.2e-16,MIR-605
GO:0002697,regulation of immune effector process,2.115,<2.2e-16,MIR-605
GO:0002521,leukocyte differentiation,2.1049,<2.2e-16,MIR-605
GO:0002683,negative regulation of immune system process,2.0944,<2.2e-16,MIR-605
GO:0002251,organ or tissue specific immune response,3.377,0.25714,MIR-606
GO:0007159,leukocyte cell-cell adhesion,2.744,<2.2e-16,MIR-607
GO:0002250,adaptive immune response,2.7089,<2.2e-16,MIR-607
GO:0002446,neutrophil mediated immunity,2.5715,<2.2e-16,MIR-607
GO:0002764,immune response-regulating signaling pathway,2.569,<2.2e-16,MIR-607
GO:0002449,lymphocyte mediated immunity,2.5532,<2.2e-16,MIR-607
GO:0002694,regulation of leukocyte activation,2.5291,<2.2e-16,MIR-607
GO:0001819,positive regulation of cytokine production,2.5002,<2.2e-16,MIR-607
GO:0002285,lymphocyte activation involved in immune response,2.4631,<2.2e-16,MIR-607
GO:0002697,regulation of immune effector process,2.4532,<2.2e-16,MIR-607
GO:0002532,production of molecular mediator involved in inflammatory response,2.3479,<2.2e-16,MIR-607
GO:0002683,negative regulation of immune system process,2.3245,<2.2e-16,MIR-607
GO:0001818,negative regulation of cytokine production,2.323,<2.2e-16,MIR-607
GO:0006959,humoral immune response,2.315,<2.2e-16,MIR-607
GO:0002521,leukocyte differentiation,2.3129,<2.2e-16,MIR-607
GO:0002526,acute inflammatory response,2.2656,<2.2e-16,MIR-607
GO:0002448,mast cell mediated immunity,2.034,<2.2e-16,MIR-607
GO:0002269,leukocyte activation involved in inflammatory response,2.0276,<2.2e-16,MIR-607
GO:0032612,interleukin-1 production,-1.1573,0.69776,MIR-609
GO:0070671,response to interleukin-12,-0.95118,0.72111,MIR-609
GO:0008356,asymmetric cell division,0.83776,0.73193,MIR-609
GO:0048536,spleen development,0.84974,0.73801,MIR-609
GO:0032620,interleukin-17 production,4.2248,0.52230,MIR-610
GO:0070670,response to interleukin-4,4.0984,0.63619,MIR-610
GO:0043276,anoikis,3.8706,0.75603,MIR-610
GO:0002269,leukocyte activation involved in inflammatory response,4.015,0.76461,MIR-610
GO:0002448,mast cell mediated immunity,3.9004,0.77183,MIR-610
GO:0001525,angiogenesis,0.19187,0.92244,MIR-611
GO:0034341,response to interferon-gamma,2.7429,<2.2e-16,MIR-612
GO:0002250,adaptive immune response,2.5602,<2.2e-16,MIR-612
GO:0032609,interferon-gamma production,2.5239,<2.2e-16,MIR-612
GO:0002449,lymphocyte mediated immunity,2.4874,<2.2e-16,MIR-612
GO:0032637,interleukin-8 production,2.4137,<2.2e-16,MIR-612
GO:0007159,leukocyte cell-cell adhesion,2.4022,<2.2e-16,MIR-612
GO:0002526,acute inflammatory response,2.373,<2.2e-16,MIR-612
GO:0034612,response to tumor necrosis factor,2.3132,<2.2e-16,MIR-612
GO:0034340,response to type I interferon,2.3089,<2.2e-16,MIR-612
GO:0036230,granulocyte activation,2.2983,<2.2e-16,MIR-612
GO:0001819,positive regulation of cytokine production,2.2912,<2.2e-16,MIR-612
GO:0002446,neutrophil mediated immunity,2.2893,<2.2e-16,MIR-612
GO:0032612,interleukin-1 production,2.2746,<2.2e-16,MIR-612
GO:0032615,interleukin-12 production,2.2708,<2.2e-16,MIR-612
GO:0002697,regulation of immune effector process,2.2705,<2.2e-16,MIR-612
GO:0002694,regulation of leukocyte activation,2.2328,<2.2e-16,MIR-612
GO:0042110,T cell activation,2.2207,<2.2e-16,MIR-612
GO:0098760,response to interleukin-7,-0.44479,0.96333,MIR-614
GO:0032633,interleukin-4 production,-0.62424,0.96584,MIR-614
GO:0071559,response to transforming growth factor beta,0.10771,0.99818,MIR-614
GO:0006959,humoral immune response,1.117,1.0,MIR-614
GO:0034340,response to type I interferon,-1.6423,0.1377,MIR-615
GO:0035456,response to interferon-beta,-1.6675,0.15044,MIR-615
GO:0033028,myeloid cell apoptotic process,-1.2087,0.92928,MIR-615
GO:0008356,asymmetric cell division,-1.21,1.0,MIR-615
GO:0002250,adaptive immune response,2.547,<2.2e-16,MIR-616
GO:0036230,granulocyte activation,2.4313,<2.2e-16,MIR-616
GO:0002446,neutrophil mediated immunity,2.3972,<2.2e-16,MIR-616
GO:0002449,lymphocyte mediated immunity,2.3399,<2.2e-16,MIR-616
GO:0019882,antigen processing and presentation,2.2783,<2.2e-16,MIR-616
GO:0002285,lymphocyte activation involved in immune response,2.2166,<2.2e-16,MIR-616
GO:0001819,positive regulation of cytokine production,2.201,<2.2e-16,MIR-616
GO:0002697,regulation of immune effector process,2.1888,<2.2e-16,MIR-616
GO:0007159,leukocyte cell-cell adhesion,2.1776,<2.2e-16,MIR-616
GO:0002694,regulation of leukocyte activation,2.1453,<2.2e-16,MIR-616
GO:0032609,interferon-gamma production,2.1342,<2.2e-16,MIR-616
GO:0002764,immune response-regulating signaling pathway,2.1322,<2.2e-16,MIR-616
GO:0045088,regulation of innate immune response,2.1218,<2.2e-16,MIR-616
GO:0030101,natural killer cell activation,2.1002,<2.2e-16,MIR-616
GO:0042110,T cell activation,2.0983,<2.2e-16,MIR-616
GO:0034341,response to interferon-gamma,2.0964,<2.2e-16,MIR-616
GO:1990868,response to chemokine,1.9111,<2.2e-16,MIR-618
GO:0001525,angiogenesis,1.9069,<2.2e-16,MIR-618
GO:0050900,leukocyte migration,1.8838,<2.2e-16,MIR-618
GO:0032634,interleukin-5 production,4.4855,0.29788,MIR-621
GO:0032616,interleukin-13 production,4.3032,0.4994,MIR-621
GO:0002532,production of molecular mediator involved in inflammatory response,3.9932,0.70266,MIR-621
GO:0002437,inflammatory response to antigenic stimulus,4.0354,0.70745,MIR-621
GO:0032637,interleukin-8 production,4.1079,0.71609,MIR-621
GO:0032623,interleukin-2 production,3.8347,0.87997,MIR-621
GO:0033028,myeloid cell apoptotic process,-2.0651,0.037175,MIR-622
GO:0008356,asymmetric cell division,-1.5934,0.44523,MIR-622
GO:0070741,response to interleukin-6,-1.5235,0.5973,MIR-622
GO:0032634,interleukin-5 production,2.1448,0.70179,MIR-623
GO:0042116,macrophage activation,-0.72945,0.83927,MIR-623
GO:0002269,leukocyte activation involved in inflammatory response,-0.73742,0.84362,MIR-623
GO:0002507,tolerance induction,-0.68424,0.84744,MIR-623
GO:1990868,response to chemokine,-0.73961,0.85016,MIR-623
GO:0045576,mast cell activation,5.8902,0.18546,MIR-624
GO:0002448,mast cell mediated immunity,5.6303,0.20554,MIR-624
GO:0002532,production of molecular mediator involved in inflammatory response,5.7431,0.2213,MIR-624
GO:0033028,myeloid cell apoptotic process,5.2674,0.35752,MIR-624
GO:0098760,response to interleukin-7,-4.1053,0.46892,MIR-624
GO:0002250,adaptive immune response,2.068,0.015434,MIR-625
GO:0032609,interferon-gamma production,1.8312,0.020065,MIR-625
GO:0070671,response to interleukin-12,1.872,0.020108,MIR-625
GO:0002449,lymphocyte mediated immunity,1.9365,0.022474,MIR-625
GO:0002250,adaptive immune response,2.9394,<2.2e-16,MIR-627
GO:0002449,lymphocyte mediated immunity,2.8843,<2.2e-16,MIR-627
GO:0034341,response to interferon-gamma,2.6,<2.2e-16,MIR-627
GO:0032609,interferon-gamma production,2.5989,<2.2e-16,MIR-627
GO:0032615,interleukin-12 production,2.4762,<2.2e-16,MIR-627
GO:0007159,leukocyte cell-cell adhesion,2.4406,<2.2e-16,MIR-627
GO:0002285,lymphocyte activation involved in immune response,2.4387,<2.2e-16,MIR-627
GO:0042110,T cell activation,2.3754,<2.2e-16,MIR-627
GO:0002697,regulation of immune effector process,2.3578,<2.2e-16,MIR-627
GO:0002694,regulation of leukocyte activation,2.3484,<2.2e-16,MIR-627
GO:0070661,leukocyte proliferation,2.3386,<2.2e-16,MIR-627
GO:0032612,interleukin-1 production,2.3131,<2.2e-16,MIR-627
GO:0070671,response to interleukin-12,2.3008,<2.2e-16,MIR-627
GO:0034340,response to type I interferon,2.2884,<2.2e-16,MIR-627
GO:0045088,regulation of innate immune response,2.2779,<2.2e-16,MIR-627
GO:0001819,positive regulation of cytokine production,2.2211,<2.2e-16,MIR-627
GO:0002250,adaptive immune response,1.6877,0.23807,MIR-628
GO:0002449,lymphocyte mediated immunity,1.4859,0.35665,MIR-628
GO:0002250,adaptive immune response,2.5575,<2.2e-16,MIR-629
GO:0002449,lymphocyte mediated immunity,2.4777,<2.2e-16,MIR-629
GO:0002694,regulation of leukocyte activation,2.3958,<2.2e-16,MIR-629
GO:0002764,immune response-regulating signaling pathway,2.3613,<2.2e-16,MIR-629
GO:0002521,leukocyte differentiation,2.3589,<2.2e-16,MIR-629
GO:0002285,lymphocyte activation involved in immune response,2.3425,<2.2e-16,MIR-629
GO:0002697,regulation of immune effector process,2.3422,<2.2e-16,MIR-629
GO:0001819,positive regulation of cytokine production,2.316,<2.2e-16,MIR-629
GO:0002446,neutrophil mediated immunity,2.289,<2.2e-16,MIR-629
GO:0002440,production of molecular mediator of immune response,2.2538,<2.2e-16,MIR-629
GO:0002683,negative regulation of immune system process,2.2341,<2.2e-16,MIR-629
GO:0001818,negative regulation of cytokine production,2.1612,<2.2e-16,MIR-629
GO:0002526,acute inflammatory response,2.151,<2.2e-16,MIR-629
GO:0006959,humoral immune response,2.0991,<2.2e-16,MIR-629
GO:0002507,tolerance induction,2.0766,<2.2e-16,MIR-629
GO:0001773,myeloid dendritic cell activation,2.0321,<2.2e-16,MIR-629
GO:0002448,mast cell mediated immunity,1.9916,<2.2e-16,MIR-629
GO:0035455,response to interferon-alpha,1.2082,0.58205,MIR-630
GO:0002532,production of molecular mediator involved in inflammatory response,-0.51284,0.82674,MIR-630
GO:0002200,somatic diversification of immune receptors,-0.52212,0.83268,MIR-630
GO:0002251,organ or tissue specific immune response,-1.1033,0.84552,MIR-631
GO:0032634,interleukin-5 production,-0.87925,0.88251,MIR-631
GO:0006959,humoral immune response,0.13565,0.97614,MIR-631
GO:0002200,somatic diversification of immune receptors,1.9325,0.0023371,MIR-632
GO:0034340,response to type I interferon,1.836,0.0051416,MIR-632
GO:0032635,interleukin-6 production,-1.9611,0.0070086,MIR-636
GO:0050663,cytokine secretion,-1.9081,0.0093448,MIR-636
GO:0150076,neuroinflammatory response,-2.0261,0.0093448,MIR-636
GO:0032637,interleukin-8 production,-1.8477,0.026699,MIR-636
GO:0002269,leukocyte activation involved in inflammatory response,-1.8293,0.035043,MIR-636
GO:0032634,interleukin-5 production,-1.4885,0.57826,MIR-637
GO:0032602,chemokine production,-1.4724,0.61497,MIR-637
GO:0050663,cytokine secretion,-1.5076,0.66179,MIR-637
GO:0032616,interleukin-13 production,-1.4974,0.66659,MIR-637
GO:0032623,interleukin-2 production,-1.4313,0.69423,MIR-637
GO:0008356,asymmetric cell division,-1.3006,0.70902,MIR-637
GO:0001525,angiogenesis,-2.1772,<2.2e-16,MIR-639
GO:0050900,leukocyte migration,-2.0495,0.00033831,MIR-639
GO:0006959,humoral immune response,-2.0158,0.00041638,MIR-639
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.9961,0.00054129,MIR-639
GO:0050727,regulation of inflammatory response,-0.17041,0.97448,MIR-640
GO:0032635,interleukin-6 production,-0.18717,0.97523,MIR-640
GO:0019882,antigen processing and presentation,-0.21763,0.9846,MIR-640
GO:0034340,response to type I interferon,-2.2529,<2.2e-16,MIR-641
GO:0034341,response to interferon-gamma,-2.3138,<2.2e-16,MIR-641
GO:0032635,interleukin-6 production,-2.0993,0.0010985,MIR-641
GO:0032602,chemokine production,-2.1542,0.0018309,MIR-641
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0165,0.0034329,MIR-641
GO:0042116,macrophage activation,-1.9961,0.0038448,MIR-641
GO:0032637,interleukin-8 production,-2.0194,0.0039233,MIR-641
GO:0002764,immune response-regulating signaling pathway,-1.972,0.0041194,MIR-641
GO:0060759,regulation of response to cytokine stimulus,-1.9336,0.0051264,MIR-641
GO:0032606,type I interferon production,-1.9259,0.0051493,MIR-641
GO:0070555,response to interleukin-1,-1.9149,0.0067132,MIR-641
GO:0035455,response to interferon-alpha,-1.9026,0.0069380,MIR-641
GO:0045088,regulation of innate immune response,-1.8936,0.0076896,MIR-641
GO:0034612,response to tumor necrosis factor,-1.8746,0.0094159,MIR-641
GO:0001525,angiogenesis,-1.8355,0.013503,MIR-641
GO:0032609,interferon-gamma production,-2.0923,<2.2e-16,MIR-647
GO:0001818,negative regulation of cytokine production,-2.1014,<2.2e-16,MIR-647
GO:0030101,natural killer cell activation,-2.1093,<2.2e-16,MIR-647
GO:0002683,negative regulation of immune system process,-2.1561,<2.2e-16,MIR-647
GO:0034341,response to interferon-gamma,-2.1575,<2.2e-16,MIR-647
GO:0002694,regulation of leukocyte activation,-2.1745,<2.2e-16,MIR-647
GO:0002449,lymphocyte mediated immunity,-2.1792,<2.2e-16,MIR-647
GO:0032612,interleukin-1 production,-2.1962,<2.2e-16,MIR-647
GO:0002250,adaptive immune response,-2.2544,<2.2e-16,MIR-647
GO:0002521,leukocyte differentiation,-2.3208,<2.2e-16,MIR-647
GO:0002764,immune response-regulating signaling pathway,-2.3882,<2.2e-16,MIR-647
GO:0036230,granulocyte activation,-2.617,<2.2e-16,MIR-647
GO:0042110,T cell activation,-2.4184,<2.2e-16,MIR-647
GO:0006925,inflammatory cell apoptotic process,2.0206,0.77579,MIR-648
GO:0002697,regulation of immune effector process,-2.0625,<2.2e-16,MIR-92B
GO:0001773,myeloid dendritic cell activation,-2.0963,<2.2e-16,MIR-92B
GO:0001525,angiogenesis,-2.131,<2.2e-16,MIR-92B
GO:0002526,acute inflammatory response,-2.1621,<2.2e-16,MIR-92B
GO:0006959,humoral immune response,-2.1849,<2.2e-16,MIR-92B
GO:0002532,production of molecular mediator involved in inflammatory response,-2.2052,<2.2e-16,MIR-92B
GO:0002285,lymphocyte activation involved in immune response,-2.2183,<2.2e-16,MIR-92B
GO:0002449,lymphocyte mediated immunity,-2.2466,<2.2e-16,MIR-92B
GO:0002683,negative regulation of immune system process,-2.279,<2.2e-16,MIR-92B
GO:0002694,regulation of leukocyte activation,-2.292,<2.2e-16,MIR-92B
GO:0001819,positive regulation of cytokine production,-2.2969,<2.2e-16,MIR-92B
GO:0002521,leukocyte differentiation,-2.3079,<2.2e-16,MIR-92B
GO:0007159,leukocyte cell-cell adhesion,-2.48,<2.2e-16,MIR-92B
GO:0002764,immune response-regulating signaling pathway,-2.5523,<2.2e-16,MIR-92B
GO:0002446,neutrophil mediated immunity,-2.5792,<2.2e-16,MIR-92B
GO:0032635,interleukin-6 production,1.178,0.8311,MIR-650
GO:0002269,leukocyte activation involved in inflammatory response,1.1789,0.83903,MIR-650
GO:0071887,leukocyte apoptotic process,1.1802,0.83989,MIR-650
GO:0006925,inflammatory cell apoptotic process,1.1802,0.85036,MIR-650
GO:0001818,negative regulation of cytokine production,1.1673,0.8576,MIR-650
GO:0007159,leukocyte cell-cell adhesion,1.175,0.85928,MIR-650
GO:0071706,tumor necrosis factor superfamily cytokine production,1.1803,0.85944,MIR-650
GO:0002683,negative regulation of immune system process,1.1724,0.8617,MIR-650
GO:0002697,regulation of immune effector process,1.1754,0.86355,MIR-650
GO:0002764,immune response-regulating signaling pathway,1.158,0.86512,MIR-650
GO:0150076,neuroinflammatory response,1.1584,0.86733,MIR-650
GO:0001525,angiogenesis,-2.0052,<2.2e-16,MIR-651
GO:0050900,leukocyte migration,-1.8358,0.0031453,MIR-651
GO:0002250,adaptive immune response,2.6049,<2.2e-16,MIR-652
GO:0002446,neutrophil mediated immunity,2.5524,<2.2e-16,MIR-652
GO:0007159,leukocyte cell-cell adhesion,2.4786,<2.2e-16,MIR-652
GO:0002449,lymphocyte mediated immunity,2.4626,<2.2e-16,MIR-652
GO:0002697,regulation of immune effector process,2.4435,<2.2e-16,MIR-652
GO:0034340,response to type I interferon,2.3878,<2.2e-16,MIR-652
GO:0034341,response to interferon-gamma,2.3868,<2.2e-16,MIR-652
GO:0032609,interferon-gamma production,2.2948,<2.2e-16,MIR-652
GO:0019882,antigen processing and presentation,2.2682,<2.2e-16,MIR-652
GO:0001819,positive regulation of cytokine production,2.263,<2.2e-16,MIR-652
GO:0002285,lymphocyte activation involved in immune response,2.2308,<2.2e-16,MIR-652
GO:0002764,immune response-regulating signaling pathway,2.2184,<2.2e-16,MIR-652
GO:0032606,type I interferon production,2.2062,<2.2e-16,MIR-652
GO:0002694,regulation of leukocyte activation,2.1829,<2.2e-16,MIR-652
GO:0002526,acute inflammatory response,2.1826,<2.2e-16,MIR-652
GO:0002694,regulation of leukocyte activation,-2.0822,<2.2e-16,MIR-653
GO:0042110,T cell activation,-2.1107,<2.2e-16,MIR-653
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.1528,<2.2e-16,MIR-653
GO:0007159,leukocyte cell-cell adhesion,-2.2137,<2.2e-16,MIR-653
GO:0070555,response to interleukin-1,-2.0605,0.00027344,MIR-653
GO:1990868,response to chemokine,-2.0298,0.00031251,MIR-653
GO:0050663,cytokine secretion,-2.0328,0.00036459,MIR-653
GO:0032635,interleukin-6 production,-2.0419,0.00039774,MIR-653
GO:0002526,acute inflammatory response,-2.0453,0.00043751,MIR-653
GO:0050727,regulation of inflammatory response,-1.9939,0.00051472,MIR-653
GO:0070661,leukocyte proliferation,-2.0055,0.00054689,MIR-653
GO:0034341,response to interferon-gamma,-1.9608,0.00069604,MIR-653
GO:0002521,leukocyte differentiation,-1.9404,0.0010096,MIR-653
GO:0032606,type I interferon production,-2.3303,<2.2e-16,MIR-654
GO:0035456,response to interferon-beta,-2.4831,<2.2e-16,MIR-654
GO:0034340,response to type I interferon,-2.8448,<2.2e-16,MIR-654
GO:0034340,response to type I interferon,-2.2443,<2.2e-16,MIR-655
GO:0035456,response to interferon-beta,-2.3322,<2.2e-16,MIR-655
GO:0035455,response to interferon-alpha,-1.9228,0.0038706,MIR-655
GO:0034341,response to interferon-gamma,-1.8395,0.010532,MIR-655
GO:0032606,type I interferon production,-2.0708,<2.2e-16,MIR-656
GO:0032613,interleukin-10 production,-2.0945,<2.2e-16,MIR-656
GO:0002285,lymphocyte activation involved in immune response,-2.1011,<2.2e-16,MIR-656
GO:0001818,negative regulation of cytokine production,-2.1025,<2.2e-16,MIR-656
GO:0002526,acute inflammatory response,-2.2072,<2.2e-16,MIR-656
GO:0019882,antigen processing and presentation,-2.2275,<2.2e-16,MIR-656
GO:0032615,interleukin-12 production,-2.2651,<2.2e-16,MIR-656
GO:0032609,interferon-gamma production,-2.2708,<2.2e-16,MIR-656
GO:0001819,positive regulation of cytokine production,-2.2899,<2.2e-16,MIR-656
GO:0002764,immune response-regulating signaling pathway,-2.2943,<2.2e-16,MIR-656
GO:0002694,regulation of leukocyte activation,-2.326,<2.2e-16,MIR-656
GO:0002697,regulation of immune effector process,-2.3298,<2.2e-16,MIR-656
GO:0002449,lymphocyte mediated immunity,-2.3597,<2.2e-16,MIR-656
GO:0007159,leukocyte cell-cell adhesion,-2.404,<2.2e-16,MIR-656
GO:0002446,neutrophil mediated immunity,-2.4806,<2.2e-16,MIR-656
GO:0002250,adaptive immune response,-2.5094,<2.2e-16,MIR-656
GO:0002694,regulation of leukocyte activation,-2.145,<2.2e-16,MIR-657
GO:0034340,response to type I interferon,-2.1561,<2.2e-16,MIR-657
GO:0007159,leukocyte cell-cell adhesion,-2.1782,<2.2e-16,MIR-657
GO:0002449,lymphocyte mediated immunity,-2.2538,<2.2e-16,MIR-657
GO:0002250,adaptive immune response,-2.3344,<2.2e-16,MIR-657
GO:0034341,response to interferon-gamma,-2.3591,<2.2e-16,MIR-657
GO:0035456,response to interferon-beta,-2.0376,0.0010973,MIR-657
GO:0002437,inflammatory response to antigenic stimulus,-2.0462,0.0011888,MIR-657
GO:0042092,type 2 immune response,-2.0853,0.0012227,MIR-657
GO:0002764,immune response-regulating signaling pathway,-2.0529,0.0012968,MIR-657
GO:0042110,T cell activation,-2.0554,0.0014265,MIR-657
GO:0032633,interleukin-4 production,-2.0684,0.0014265,MIR-657
GO:0002697,regulation of immune effector process,-1.9754,0.0015562,MIR-657
GO:0045088,regulation of innate immune response,-1.9941,0.0015850,MIR-657
GO:0032609,interferon-gamma production,-2.0644,0.0015850,MIR-657
GO:0050663,cytokine secretion,-1.9626,0.0016126,MIR-657
GO:0019882,antigen processing and presentation,-1.9768,0.0016303,MIR-657
GO:0050727,regulation of inflammatory response,-1.9541,0.0017118,MIR-657
GO:0002449,lymphocyte mediated immunity,2.1783,<2.2e-16,MIR-658
GO:0002250,adaptive immune response,2.1571,<2.2e-16,MIR-658
GO:0002285,lymphocyte activation involved in immune response,2.1007,<2.2e-16,MIR-658
GO:0032606,type I interferon production,2.0111,0.00010448,MIR-658
GO:0002446,neutrophil mediated immunity,2.0122,0.00010997,MIR-658
GO:0002200,somatic diversification of immune receptors,2.015,0.00011608,MIR-658
GO:0036230,granulocyte activation,2.0409,0.00013930,MIR-658
GO:0002697,regulation of immune effector process,2.052,0.00016073,MIR-658
GO:0071559,response to transforming growth factor beta,-1.6806,0.052902,MIR-658
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.7541,0.055855,MIR-658
GO:0035455,response to interferon-alpha,2.1064,0.0013896,MIR-659
GO:0034340,response to type I interferon,2.06,0.0026054,MIR-659
GO:0035456,response to interferon-beta,1.8924,0.0096400,MIR-659
GO:0032606,type I interferon production,1.8315,0.016211,MIR-659
GO:0034341,response to interferon-gamma,1.7013,0.038300,MIR-659
GO:0070671,response to interleukin-12,1.6787,0.045487,MIR-659
GO:0002449,lymphocyte mediated immunity,1.5955,0.070534,MIR-659
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.902,0.0047858,MIR-660
GO:0032623,interleukin-2 production,1.6161,0.11200,MIR-660
GO:0032606,type I interferon production,1.7154,0.11505,MIR-660
GO:0002764,immune response-regulating signaling pathway,1.6491,0.12216,MIR-660
GO:0002446,neutrophil mediated immunity,1.7357,0.12297,MIR-660
GO:0002507,tolerance induction,1.6764,0.12639,MIR-660
GO:0036230,granulocyte activation,1.7417,0.13207,MIR-660
GO:0002250,adaptive immune response,1.7515,0.13704,MIR-660
GO:0032613,interleukin-10 production,1.5791,0.13785,MIR-660
GO:0001525,angiogenesis,-2.2179,<2.2e-16,MIR-661
GO:0034340,response to type I interferon,1.8361,0.034008,MIR-662
GO:0002446,neutrophil mediated immunity,1.6575,0.078073,MIR-662
GO:0036230,granulocyte activation,1.6799,0.087265,MIR-662
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-2.07,<2.2e-16,MIR-34B
GO:0042092,type 2 immune response,-2.0717,<2.2e-16,MIR-34B
GO:0050727,regulation of inflammatory response,-2.0753,<2.2e-16,MIR-34B
GO:0071887,leukocyte apoptotic process,-2.0824,<2.2e-16,MIR-34B
GO:0002683,negative regulation of immune system process,-2.1203,<2.2e-16,MIR-34B
GO:0032623,interleukin-2 production,-2.1266,<2.2e-16,MIR-34B
GO:0032609,interferon-gamma production,-2.127,<2.2e-16,MIR-34B
GO:0002440,production of molecular mediator of immune response,-2.1867,<2.2e-16,MIR-34B
GO:0002285,lymphocyte activation involved in immune response,-2.2211,<2.2e-16,MIR-34B
GO:0001525,angiogenesis,-2.3302,<2.2e-16,MIR-34B
GO:0002250,adaptive immune response,-2.4273,<2.2e-16,MIR-34B
GO:0032606,type I interferon production,-2.29,<2.2e-16,MIR-758
GO:0035456,response to interferon-beta,-2.4708,<2.2e-16,MIR-758
GO:0034340,response to type I interferon,-2.6912,<2.2e-16,MIR-758
GO:0035455,response to interferon-alpha,-2.0242,0.0020619,MIR-758
GO:0034340,response to type I interferon,2.135,<2.2e-16,MIR-671
GO:0034341,response to interferon-gamma,1.9439,0.0069460,MIR-671
GO:0019882,antigen processing and presentation,1.9021,0.012363,MIR-671
GO:0036230,granulocyte activation,1.7746,0.036167,MIR-671
GO:0002446,neutrophil mediated immunity,1.7713,0.036313,MIR-671
GO:0002449,lymphocyte mediated immunity,-2.1642,<2.2e-16,MIR-668
GO:0060759,regulation of response to cytokine stimulus,-2.1698,<2.2e-16,MIR-668
GO:0032615,interleukin-12 production,-2.2331,<2.2e-16,MIR-668
GO:0032609,interferon-gamma production,-2.3697,<2.2e-16,MIR-668
GO:0035456,response to interferon-beta,-2.4072,<2.2e-16,MIR-668
GO:0032606,type I interferon production,-2.4883,<2.2e-16,MIR-668
GO:0034341,response to interferon-gamma,-2.5086,<2.2e-16,MIR-668
GO:0034340,response to type I interferon,-2.9062,<2.2e-16,MIR-668
GO:0002250,adaptive immune response,-2.0513,0.00045140,MIR-668
GO:0001819,positive regulation of cytokine production,-2.0575,0.00048364,MIR-668
GO:0007159,leukocyte cell-cell adhesion,-2.0642,0.00052085,MIR-668
GO:0002269,leukocyte activation involved in inflammatory response,-1.9825,0.00064486,MIR-668
GO:0032633,interleukin-4 production,-1.9896,0.00067710,MIR-668
GO:0034341,response to interferon-gamma,-2.3337,<2.2e-16,MIR-767
GO:0032635,interleukin-6 production,-2.1166,0.0028491,MIR-767
GO:0032637,interleukin-8 production,-2.1329,0.0042736,MIR-767
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0069,0.0048841,MIR-767
GO:0035455,response to interferon-alpha,-2.0041,0.0053420,MIR-767
GO:0042116,macrophage activation,-1.9852,0.0054391,MIR-767
GO:0007159,leukocyte cell-cell adhesion,-1.96,0.0054946,MIR-767
GO:0032615,interleukin-12 production,-1.9959,0.0059831,MIR-767
GO:0002532,production of molecular mediator involved in inflammatory response,-1.9367,0.0074076,MIR-767
GO:0050900,leukocyte migration,-1.8916,0.014720,MIR-767
GO:0048010,vascular endothelial growth factor receptor signaling pathway,-1.8455,0.020941,MIR-767
GO:0002764,immune response-regulating signaling pathway,-1.7925,0.022354,MIR-767
GO:0034340,response to type I interferon,-1.8156,0.022922,MIR-767
GO:0050727,regulation of inflammatory response,-1.7803,0.023109,MIR-767
GO:0002764,immune response-regulating signaling pathway,-2.0955,<2.2e-16,MIR-454
GO:0036230,granulocyte activation,-2.2814,<2.2e-16,MIR-454
GO:0002446,neutrophil mediated immunity,-2.2842,<2.2e-16,MIR-454
GO:0032612,interleukin-1 production,-2.0347,0.0012703,MIR-454
GO:0050663,cytokine secretion,-1.9991,0.0013550,MIR-454
GO:0050900,leukocyte migration,-1.9436,0.0026743,MIR-454
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9406,0.0027947,MIR-454
GO:0032635,interleukin-6 production,-1.9173,0.0028720,MIR-454
GO:0032635,interleukin-6 production,-1.9051,0.074480,MIR-769
GO:0002764,immune response-regulating signaling pathway,-1.5561,0.19173,MIR-769
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.5857,0.19764,MIR-769
GO:0002526,acute inflammatory response,-1.557,0.19833,MIR-769
GO:0002269,leukocyte activation involved in inflammatory response,-1.5665,0.20124,MIR-769
GO:0050663,cytokine secretion,-1.6018,0.20216,MIR-769
GO:0032633,interleukin-4 production,-1.6521,0.20535,MIR-769
GO:0007159,leukocyte cell-cell adhesion,2.1857,<2.2e-16,MIR-766
GO:0002250,adaptive immune response,2.1531,<2.2e-16,MIR-766
GO:0032609,interferon-gamma production,2.15,<2.2e-16,MIR-766
GO:0042110,T cell activation,2.122,<2.2e-16,MIR-766
GO:0050900,leukocyte migration,2.1015,<2.2e-16,MIR-766
GO:0002285,lymphocyte activation involved in immune response,2.0602,<2.2e-16,MIR-766
GO:0036230,granulocyte activation,2.0554,<2.2e-16,MIR-766
GO:0002521,leukocyte differentiation,2.0533,<2.2e-16,MIR-766
GO:0002694,regulation of leukocyte activation,2.0403,<2.2e-16,MIR-766
GO:0002446,neutrophil mediated immunity,2.0306,<2.2e-16,MIR-766
GO:1990868,response to chemokine,2.0203,<2.2e-16,MIR-766
GO:0050663,cytokine secretion,2.0152,<2.2e-16,MIR-766
GO:0002449,lymphocyte mediated immunity,2.0031,<2.2e-16,MIR-766
GO:0042113,B cell activation,1.9866,<2.2e-16,MIR-766
GO:0002683,negative regulation of immune system process,1.9759,<2.2e-16,MIR-766
GO:0001525,angiogenesis,1.6898,0.018768,MIR-765
GO:0070661,leukocyte proliferation,-2.1427,<2.2e-16,MIR-770
GO:0032606,type I interferon production,-2.2312,<2.2e-16,MIR-770
GO:0032633,interleukin-4 production,-2.2333,<2.2e-16,MIR-770
GO:0045576,mast cell activation,-2.2657,<2.2e-16,MIR-770
GO:0002449,lymphocyte mediated immunity,-2.2948,<2.2e-16,MIR-770
GO:0002250,adaptive immune response,-2.3284,<2.2e-16,MIR-770
GO:0019882,antigen processing and presentation,-2.3321,<2.2e-16,MIR-770
GO:0032609,interferon-gamma production,-2.4259,<2.2e-16,MIR-770
GO:0035456,response to interferon-beta,-2.4577,<2.2e-16,MIR-770
GO:0034340,response to type I interferon,-2.6197,<2.2e-16,MIR-770
GO:0034341,response to interferon-gamma,-2.646,<2.2e-16,MIR-770
GO:0045088,regulation of innate immune response,-2.0436,0.00056375,MIR-770
GO:0032623,interleukin-2 production,-2.047,0.00058826,MIR-770
GO:0006959,humoral immune response,-2.033,<2.2e-16,MIR-298
GO:0002269,leukocyte activation involved in inflammatory response,-2.0404,<2.2e-16,MIR-298
GO:0030101,natural killer cell activation,-2.0499,<2.2e-16,MIR-298
GO:0002683,negative regulation of immune system process,-2.075,<2.2e-16,MIR-298
GO:0002440,production of molecular mediator of immune response,-2.1218,<2.2e-16,MIR-298
GO:0002526,acute inflammatory response,-2.128,<2.2e-16,MIR-298
GO:0002446,neutrophil mediated immunity,-2.1653,<2.2e-16,MIR-298
GO:0001773,myeloid dendritic cell activation,-2.1782,<2.2e-16,MIR-298
GO:0001525,angiogenesis,-2.1953,<2.2e-16,MIR-298
GO:0002285,lymphocyte activation involved in immune response,-2.2313,<2.2e-16,MIR-298
GO:0001819,positive regulation of cytokine production,-2.2345,<2.2e-16,MIR-298
GO:0002449,lymphocyte mediated immunity,-2.2462,<2.2e-16,MIR-298
GO:0002697,regulation of immune effector process,-2.2517,<2.2e-16,MIR-298
GO:0002521,leukocyte differentiation,-2.2566,<2.2e-16,MIR-298
GO:0002764,immune response-regulating signaling pathway,-2.3244,<2.2e-16,MIR-298
GO:0002764,immune response-regulating signaling pathway,-1.9748,<2.2e-16,MIR-509-2
GO:0002440,production of molecular mediator of immune response,-1.9777,<2.2e-16,MIR-509-2
GO:0002449,lymphocyte mediated immunity,-2.027,<2.2e-16,MIR-509-2
GO:0001525,angiogenesis,-2.0409,<2.2e-16,MIR-509-2
GO:0002446,neutrophil mediated immunity,-2.047,<2.2e-16,MIR-509-2
GO:0002694,regulation of leukocyte activation,-2.0479,<2.2e-16,MIR-509-2
GO:0001819,positive regulation of cytokine production,-2.0625,<2.2e-16,MIR-509-2
GO:0032615,interleukin-12 production,-2.0634,<2.2e-16,MIR-509-2
GO:0002521,leukocyte differentiation,-2.0724,<2.2e-16,MIR-509-2
GO:0036230,granulocyte activation,-2.0748,<2.2e-16,MIR-509-2
GO:0042113,B cell activation,-2.1047,<2.2e-16,MIR-509-2
GO:0019882,antigen processing and presentation,-2.1094,<2.2e-16,MIR-509-2
GO:0002250,adaptive immune response,-2.241,<2.2e-16,MIR-509-2
GO:0034341,response to interferon-gamma,-2.4094,<2.2e-16,MIR-450B
GO:0019882,antigen processing and presentation,-2.1021,0.0012424,MIR-450B
GO:0007159,leukocyte cell-cell adhesion,-2.0057,0.0021298,MIR-450B
GO:0070671,response to interleukin-12,-2.0165,0.0021741,MIR-450B
GO:0034340,response to type I interferon,-2.0475,0.0022362,MIR-450B
GO:0002250,adaptive immune response,-2.0045,0.0024847,MIR-450B
GO:0002764,immune response-regulating signaling pathway,-1.9483,0.0032612,MIR-450B
GO:0032615,interleukin-12 production,-1.9296,0.0039463,MIR-450B
GO:0032613,interleukin-10 production,-1.8966,0.0045117,MIR-450B
GO:0045088,regulation of innate immune response,-1.8649,0.0055096,MIR-450B
GO:0002694,regulation of leukocyte activation,-1.8561,0.0055161,MIR-450B
GO:0002251,organ or tissue specific immune response,-1.9821,0.83747,MIR-891B
GO:0060759,regulation of response to cytokine stimulus,-1.573,0.92842,MIR-891B
GO:0070555,response to interleukin-1,-0.67781,0.94918,MIR-891B
GO:0002507,tolerance induction,-0.26222,0.94938,MIR-891B
GO:0034340,response to type I interferon,-1.315,0.64217,MIR-888
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.1601,0.67062,MIR-888
GO:0035455,response to interferon-alpha,-1.1691,0.67328,MIR-888
GO:0002507,tolerance induction,0.15264,0.99909,MIR-888
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.4767,0.54407,MIR-892B
GO:0006925,inflammatory cell apoptotic process,-1.178,0.60272,MIR-892B
GO:0034341,response to interferon-gamma,-1.1523,0.617,MIR-892B
GO:0098760,response to interleukin-7,-1.1613,0.61882,MIR-892B
GO:0001773,myeloid dendritic cell activation,0.23038,0.99979,MIR-892B
GO:0045088,regulation of innate immune response,-2.1755,<2.2e-16,MIR-541
GO:0032609,interferon-gamma production,-2.3,<2.2e-16,MIR-541
GO:0002250,adaptive immune response,-2.3321,<2.2e-16,MIR-541
GO:0035456,response to interferon-beta,-2.3961,<2.2e-16,MIR-541
GO:0002449,lymphocyte mediated immunity,-2.4155,<2.2e-16,MIR-541
GO:0032606,type I interferon production,-2.4586,<2.2e-16,MIR-541
GO:0034341,response to interferon-gamma,-2.6029,<2.2e-16,MIR-541
GO:0034340,response to type I interferon,-2.8691,<2.2e-16,MIR-541
GO:0032633,interleukin-4 production,-2.1101,0.00046295,MIR-541
GO:0002697,regulation of immune effector process,-2.0659,0.0011438,MIR-541
GO:0060759,regulation of response to cytokine stimulus,-2.0794,0.0012152,MIR-541
GO:0002764,immune response-regulating signaling pathway,-2.0387,0.0017056,MIR-541
GO:0035455,response to interferon-alpha,-2.0424,0.0018004,MIR-541
GO:0032623,interleukin-2 production,-1.9881,0.0021604,MIR-541
GO:0071887,leukocyte apoptotic process,0.2082,0.91087,MIR-876
GO:0002694,regulation of leukocyte activation,0.19728,0.91197,MIR-876
GO:0034341,response to interferon-gamma,2.22,<2.2e-16,MIR-147B
GO:0002250,adaptive immune response,2.1675,0.0011191,MIR-147B
GO:0034340,response to type I interferon,2.1736,0.0016787,MIR-147B
GO:0045088,regulation of innate immune response,2.0906,0.0039169,MIR-147B
GO:0032609,interferon-gamma production,2.0666,0.0041967,MIR-147B
GO:0002697,regulation of immune effector process,2.0208,0.0096142,MIR-147B
GO:0002449,lymphocyte mediated immunity,2.0254,0.0098855,MIR-147B
GO:0006959,humoral immune response,2.0219,0.010408,MIR-147B
GO:0002764,immune response-regulating signaling pathway,2.0136,0.010911,MIR-147B
GO:0002446,neutrophil mediated immunity,1.9304,0.015050,MIR-147B
GO:0050663,cytokine secretion,1.9266,0.015164,MIR-147B
GO:0032612,interleukin-1 production,1.9341,0.015295,MIR-147B
GO:0032623,interleukin-2 production,1.9213,0.015866,MIR-147B
GO:0036230,granulocyte activation,1.9509,0.016451,MIR-147B
GO:0001525,angiogenesis,2.137,<2.2e-16,MIR-744
GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.109,<2.2e-16,MIR-744
GO:0032620,interleukin-17 production,-1.6093,0.14068,MIR-877
GO:0002251,organ or tissue specific immune response,-1.537,0.16231,MIR-877
GO:0002269,leukocyte activation involved in inflammatory response,-1.4587,0.22932,MIR-877
GO:0150076,neuroinflammatory response,-1.4091,0.29698,MIR-877
GO:0034340,response to type I interferon,-2.7423,<2.2e-16,MIR-665
GO:0035456,response to interferon-beta,-2.063,0.0026923,MIR-665
GO:0032606,type I interferon production,-1.9544,0.0048461,MIR-665
GO:0034340,response to type I interferon,-2.267,<2.2e-16,MIR-873
GO:0035456,response to interferon-beta,-2.13,0.0029877,MIR-873
GO:0034341,response to interferon-gamma,-2.1167,0.0039837,MIR-873
GO:0070671,response to interleukin-12,-1.9445,0.0053115,MIR-873
GO:0036230,granulocyte activation,-1.822,0.017223,MIR-873
GO:0002446,neutrophil mediated immunity,-1.8784,0.019719,MIR-873
GO:0002250,adaptive immune response,2.2754,<2.2e-16,MIR-374B
GO:0045088,regulation of innate immune response,2.26,<2.2e-16,MIR-374B
GO:0034340,response to type I interferon,2.174,<2.2e-16,MIR-374B
GO:0002764,immune response-regulating signaling pathway,2.1667,<2.2e-16,MIR-374B
GO:0034341,response to interferon-gamma,2.1389,<2.2e-16,MIR-374B
GO:0032606,type I interferon production,2.0813,<2.2e-16,MIR-374B
GO:0032609,interferon-gamma production,2.0581,<2.2e-16,MIR-374B
GO:0007159,leukocyte cell-cell adhesion,2.0311,<2.2e-16,MIR-374B
GO:1990868,response to chemokine,2.0282,<2.2e-16,MIR-374B
GO:0032623,interleukin-2 production,1.9882,0.00044495,MIR-374B
GO:0001819,positive regulation of cytokine production,1.9921,0.00050428,MIR-374B
GO:0002697,regulation of immune effector process,1.9988,0.00054030,MIR-374B
GO:0002449,lymphocyte mediated immunity,1.9458,0.00065776,MIR-374B
GO:0042110,T cell activation,1.9401,0.00070599,MIR-374B
GO:0032633,interleukin-4 production,-2.1834,<2.2e-16,MIR-301B
GO:0002697,regulation of immune effector process,-2.1947,<2.2e-16,MIR-301B
GO:0032606,type I interferon production,-2.2009,<2.2e-16,MIR-301B
GO:0002250,adaptive immune response,-2.2103,<2.2e-16,MIR-301B
GO:0032612,interleukin-1 production,-2.2271,<2.2e-16,MIR-301B
GO:0042110,T cell activation,-2.2649,<2.2e-16,MIR-301B
GO:0042116,macrophage activation,-2.3062,<2.2e-16,MIR-301B
GO:0007159,leukocyte cell-cell adhesion,-2.3217,<2.2e-16,MIR-301B
GO:0045088,regulation of innate immune response,-2.3263,<2.2e-16,MIR-301B
GO:0032609,interferon-gamma production,-2.3512,<2.2e-16,MIR-301B
GO:0032635,interleukin-6 production,-2.3847,<2.2e-16,MIR-301B
GO:0001819,positive regulation of cytokine production,-2.4045,<2.2e-16,MIR-301B
GO:0034340,response to type I interferon,-2.457,<2.2e-16,MIR-301B
GO:0002764,immune response-regulating signaling pathway,-2.5237,<2.2e-16,MIR-301B
GO:0035455,response to interferon-alpha,-2.1507,<2.2e-16,MIR-216B
GO:0034341,response to interferon-gamma,-2.2589,<2.2e-16,MIR-216B
GO:0034340,response to type I interferon,-2.2886,<2.2e-16,MIR-216B
GO:0035456,response to interferon-beta,-2.3912,<2.2e-16,MIR-216B
GO:0070555,response to interleukin-1,-1.997,0.0033848,MIR-216B
GO:0032615,interleukin-12 production,-2.0121,0.0037233,MIR-216B
GO:0042116,macrophage activation,-1.9706,0.0040915,MIR-216B
GO:0060759,regulation of response to cytokine stimulus,-2.0166,0.0041370,MIR-216B
GO:0032606,type I interferon production,-1.9468,0.0043217,MIR-216B
GO:0032635,interleukin-6 production,-1.9291,0.0053190,MIR-216B
GO:0032623,interleukin-2 production,-1.8679,0.0090423,MIR-216B
GO:0007159,leukocyte cell-cell adhesion,-1.858,0.010131,MIR-216B
GO:0150076,neuroinflammatory response,-1.8304,0.011252,MIR-216B
GO:0030099,myeloid cell differentiation,-1.8354,0.011524,MIR-216B
GO:0098760,response to interleukin-7,-1.5109,0.68101,MIR-922
GO:0048536,spleen development,-1.3661,0.75815,MIR-922
GO:0070555,response to interleukin-1,-1.3586,0.75909,MIR-922
GO:0035456,response to interferon-beta,0.31951,0.99951,MIR-922
GO:0042110,T cell activation,1.8233,0.034640,MIR-934
GO:0050727,regulation of inflammatory response,1.8258,0.035205,MIR-934
GO:0032620,interleukin-17 production,1.7877,0.035288,MIR-934
GO:0002446,neutrophil mediated immunity,1.8137,0.035584,MIR-934
GO:0002526,acute inflammatory response,1.8083,0.035725,MIR-934
GO:0032637,interleukin-8 production,1.8414,0.035975,MIR-934
GO:0036230,granulocyte activation,1.833,0.036039,MIR-934
GO:0045088,regulation of innate immune response,1.8265,0.036183,MIR-934
GO:0050663,cytokine secretion,1.7984,0.036395,MIR-934
GO:1990868,response to chemokine,1.8502,0.036523,MIR-934
GO:0070661,leukocyte proliferation,1.8435,0.036670,MIR-934
GO:0030101,natural killer cell activation,1.7728,0.036920,MIR-934
GO:0001819,positive regulation of cytokine production,1.8536,0.037191,MIR-934
GO:0032602,chemokine production,1.7639,0.037947,MIR-934
GO:0002449,lymphocyte mediated immunity,1.8553,0.038189,MIR-934
GO:0032609,interferon-gamma production,-2.0641,<2.2e-16,MIR-935
GO:0070671,response to interleukin-12,-2.1368,<2.2e-16,MIR-935
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0196,0.0022990,MIR-935
GO:0007159,leukocyte cell-cell adhesion,-1.9789,0.0035762,MIR-935
GO:0032613,interleukin-10 production,-1.9927,0.0040233,MIR-935
GO:0032637,interleukin-8 production,-1.9462,0.0088512,MIR-935
GO:0032623,interleukin-2 production,-1.9161,0.012436,MIR-935
GO:0050663,cytokine secretion,-1.8654,0.015590,MIR-935
GO:0032620,interleukin-17 production,-1.7843,0.026257,MIR-935
GO:0002285,lymphocyte activation involved in immune response,-1.7319,0.033649,MIR-935
GO:0060759,regulation of response to cytokine stimulus,2.4688,0.6166,MIR-938
GO:0006959,humoral immune response,1.5476,0.7428,MIR-938
GO:0030101,natural killer cell activation,1.6533,0.7453,MIR-938
GO:0002200,somatic diversification of immune receptors,1.5777,0.74536,MIR-938
GO:0032620,interleukin-17 production,-1.4313,0.50468,MIR-940
GO:0032613,interleukin-10 production,-1.3942,0.55314,MIR-940
GO:0032635,interleukin-6 production,-1.3325,0.69429,MIR-940
GO:0002526,acute inflammatory response,-1.2873,0.77907,MIR-940
GO:0030101,natural killer cell activation,-1.2906,0.80753,MIR-940
GO:0032634,interleukin-5 production,-1.2371,0.84329,MIR-940
GO:0002449,lymphocyte mediated immunity,2.1335,0.012707,MIR-941-1
GO:0007159,leukocyte cell-cell adhesion,2.1532,0.013033,MIR-941-1
GO:0032602,chemokine production,2.1859,0.013684,MIR-941-1
GO:0001819,positive regulation of cytokine production,1.9881,0.022900,MIR-941-1
GO:0010573,vascular endothelial growth factor production,1.9955,0.023785,MIR-941-1
GO:0002526,acute inflammatory response,1.9544,0.026587,MIR-941-1
GO:0032612,interleukin-1 production,1.945,0.026880,MIR-941-1
GO:0002250,adaptive immune response,1.9405,0.026909,MIR-941-1
GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.0448,0.029715,MIR-941-1
GO:0050900,leukocyte migration,1.826,0.032843,MIR-941-1
GO:0034341,response to interferon-gamma,1.8566,0.033234,MIR-941-1
GO:0033028,myeloid cell apoptotic process,1.8816,0.033319,MIR-941-1
GO:0002250,adaptive immune response,2.6796,<2.2e-16,MIR-942
GO:0002449,lymphocyte mediated immunity,2.4693,<2.2e-16,MIR-942
GO:0007159,leukocyte cell-cell adhesion,2.405,<2.2e-16,MIR-942
GO:0034341,response to interferon-gamma,2.4037,<2.2e-16,MIR-942
GO:0002764,immune response-regulating signaling pathway,2.3886,<2.2e-16,MIR-942
GO:0019882,antigen processing and presentation,2.3325,<2.2e-16,MIR-942
GO:0001819,positive regulation of cytokine production,2.3191,<2.2e-16,MIR-942
GO:0002694,regulation of leukocyte activation,2.3143,<2.2e-16,MIR-942
GO:0032609,interferon-gamma production,2.2513,<2.2e-16,MIR-942
GO:0002697,regulation of immune effector process,2.2382,<2.2e-16,MIR-942
GO:0002285,lymphocyte activation involved in immune response,2.2349,<2.2e-16,MIR-942
GO:0032606,type I interferon production,2.2269,<2.2e-16,MIR-942
GO:0002446,neutrophil mediated immunity,2.224,<2.2e-16,MIR-942
GO:0032615,interleukin-12 production,2.2223,<2.2e-16,MIR-942
GO:0034340,response to type I interferon,2.1898,<2.2e-16,MIR-942
GO:0032613,interleukin-10 production,2.131,<2.2e-16,MIR-942
GO:0032637,interleukin-8 production,-2.1285,<2.2e-16,MIR-943
GO:0034340,response to type I interferon,-2.1538,<2.2e-16,MIR-943
GO:0034341,response to interferon-gamma,-2.1574,<2.2e-16,MIR-943
GO:0007159,leukocyte cell-cell adhesion,-2.0432,0.0021891,MIR-943
GO:0035455,response to interferon-alpha,-2.0238,0.0032431,MIR-943
GO:0002251,organ or tissue specific immune response,-1.9458,0.011145,MIR-943
GO:0002269,leukocyte activation involved in inflammatory response,-1.8833,0.020207,MIR-943
GO:0032609,interferon-gamma production,-1.7928,0.034442,MIR-943
GO:0050727,regulation of inflammatory response,-1.8065,0.038674,MIR-943
GO:0032635,interleukin-6 production,-1.7517,0.041107,MIR-943
GO:0001819,positive regulation of cytokine production,-1.7547,0.042640,MIR-943
GO:0035456,response to interferon-beta,-1.7075,0.043517,MIR-943
GO:0032615,interleukin-12 production,1.8304,0.0046533,MIR-708
GO:0002250,adaptive immune response,1.7824,0.0083759,MIR-708
GO:0002697,regulation of immune effector process,1.7549,0.010610,MIR-708
GO:0050663,cytokine secretion,1.7638,0.010703,MIR-708
GO:0032623,interleukin-2 production,1.7501,0.010999,MIR-708
GO:1990868,response to chemokine,1.7301,0.015976,MIR-708
GO:0032609,interferon-gamma production,1.8396,0.016752,MIR-708
GO:0002440,production of molecular mediator of immune response,1.7203,0.018470,MIR-708
GO:0045088,regulation of innate immune response,1.6865,0.020209,MIR-708
GO:0032635,interleukin-6 production,1.7015,0.020707,MIR-708
GO:0034341,response to interferon-gamma,1.711,0.020740,MIR-708
GO:0001818,negative regulation of cytokine production,1.7064,0.021095,MIR-708
GO:0007159,leukocyte cell-cell adhesion,1.6791,0.021122,MIR-708
GO:0002449,lymphocyte mediated immunity,1.6868,0.021126,MIR-708
GO:0042110,T cell activation,1.6736,0.021638,MIR-708
GO:0001819,positive regulation of cytokine production,1.6872,0.022042,MIR-708
GO:0070741,response to interleukin-6,1.4961,0.18173,MIR-885
GO:0007159,leukocyte cell-cell adhesion,1.4083,0.18568,MIR-885
GO:1990823,response to leukemia inhibitory factor,1.4721,0.18594,MIR-885
GO:0002250,adaptive immune response,1.4094,0.18689,MIR-885
GO:0001819,positive regulation of cytokine production,1.4175,0.18973,MIR-885
GO:0032633,interleukin-4 production,-2.1789,<2.2e-16,MIR-543
GO:0032606,type I interferon production,-2.1907,<2.2e-16,MIR-543
GO:0035456,response to interferon-beta,-2.5181,<2.2e-16,MIR-543
GO:0034340,response to type I interferon,-2.7879,<2.2e-16,MIR-543
GO:0019882,antigen processing and presentation,-1.965,0.0024340,MIR-543
GO:0034341,response to interferon-gamma,-1.9673,0.0026553,MIR-543
GO:0045576,mast cell activation,-1.8965,0.0097362,MIR-543
GO:0042092,type 2 immune response,-1.877,0.010345,MIR-543
GO:0060759,regulation of response to cytokine stimulus,-1.8358,0.010663,MIR-543
GO:0002449,lymphocyte mediated immunity,-1.8778,0.011034,MIR-543
GO:0042092,type 2 immune response,-1.941,<2.2e-16,MIR-509-3
GO:0002764,immune response-regulating signaling pathway,-1.9789,<2.2e-16,MIR-509-3
GO:0032615,interleukin-12 production,-1.9988,<2.2e-16,MIR-509-3
GO:0002449,lymphocyte mediated immunity,-2.0022,<2.2e-16,MIR-509-3
GO:0002446,neutrophil mediated immunity,-2.0156,<2.2e-16,MIR-509-3
GO:0002694,regulation of leukocyte activation,-2.0169,<2.2e-16,MIR-509-3
GO:0001525,angiogenesis,-2.0265,<2.2e-16,MIR-509-3
GO:0001819,positive regulation of cytokine production,-2.0339,<2.2e-16,MIR-509-3
GO:0036230,granulocyte activation,-2.0424,<2.2e-16,MIR-509-3
GO:0042113,B cell activation,-2.0592,<2.2e-16,MIR-509-3
GO:0002521,leukocyte differentiation,-2.0811,<2.2e-16,MIR-509-3
GO:0019882,antigen processing and presentation,-2.1283,<2.2e-16,MIR-509-3
GO:0042110,T cell activation,-2.1757,<2.2e-16,MIR-509-3
GO:0002250,adaptive immune response,-2.2248,<2.2e-16,MIR-509-3
GO:0035455,response to interferon-alpha,1.53,0.27067,MIR-509-3
GO:0034340,response to type I interferon,2.4877,<2.2e-16,MIR-937
GO:0032606,type I interferon production,2.002,0.00025047,MIR-937
GO:0035456,response to interferon-beta,2.0214,0.00028626,MIR-937
GO:0035455,response to interferon-alpha,2.0411,0.00033397,MIR-937
GO:0060759,regulation of response to cytokine stimulus,1.912,0.0036433,MIR-937
GO:0034341,response to interferon-gamma,1.9006,0.0060114,MIR-937
GO:0001818,negative regulation of cytokine production,1.8103,0.020863,MIR-937
GO:0045088,regulation of innate immune response,1.7536,0.042271,MIR-937
GO:0010573,vascular endothelial growth factor production,-1.6203,0.11837,MIR-937
GO:0002200,somatic diversification of immune receptors,1.8398,0.015188,MIR-944
GO:0035456,response to interferon-beta,-1.3169,0.52525,MIR-944
GO:0070671,response to interleukin-12,-1.686,0.11583,MIR-891A
GO:0035456,response to interferon-beta,-1.5362,0.25964,MIR-892A
GO:0035455,response to interferon-alpha,-1.5022,0.28388,MIR-892A
GO:0032635,interleukin-6 production,-2.1654,<2.2e-16,MIR-874
GO:0002251,organ or tissue specific immune response,-2.1951,<2.2e-16,MIR-874
GO:0045576,mast cell activation,-2.123,0.0013700,MIR-874
GO:0032637,interleukin-8 production,-2.1007,0.0019179,MIR-874
GO:0034341,response to interferon-gamma,-2.1045,0.0021310,MIR-874
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9824,0.0068498,MIR-874
GO:0032620,interleukin-17 production,-1.9437,0.0077916,MIR-874
GO:0006959,humoral immune response,-1.9327,0.0078974,MIR-874
GO:0002532,production of molecular mediator involved in inflammatory response,-1.8628,0.013627,MIR-874
GO:0002269,leukocyte activation involved in inflammatory response,-1.8542,0.014864,MIR-874
GO:0034341,response to interferon-gamma,-2.094,<2.2e-16,MIR-889
GO:0002449,lymphocyte mediated immunity,-2.1244,<2.2e-16,MIR-889
GO:0034340,response to type I interferon,-2.4489,<2.2e-16,MIR-889
GO:0035456,response to interferon-beta,-2.5189,<2.2e-16,MIR-889
GO:0002250,adaptive immune response,-2.0433,0.00091351,MIR-889
GO:0045576,mast cell activation,-2.0128,0.0010049,MIR-889
GO:0032609,interferon-gamma production,-2.0437,0.0010049,MIR-889
GO:0032633,interleukin-4 production,-2.0168,0.0010766,MIR-889
GO:0032615,interleukin-12 production,-2.0546,0.0011165,MIR-889
GO:0019882,antigen processing and presentation,-2.0207,0.0011595,MIR-889
GO:0032606,type I interferon production,-2.0581,0.0012561,MIR-889
GO:0060759,regulation of response to cytokine stimulus,-1.9267,0.0044660,MIR-889
GO:0002764,immune response-regulating signaling pathway,-1.8975,0.0068753,MIR-889
GO:0035455,response to interferon-alpha,-1.885,0.0072852,MIR-889
GO:0032623,interleukin-2 production,-1.882,0.0076561,MIR-889
GO:0036230,granulocyte activation,-2.0451,<2.2e-16,MIR-190B
GO:0002440,production of molecular mediator of immune response,-2.0498,<2.2e-16,MIR-190B
GO:0002250,adaptive immune response,-2.0565,<2.2e-16,MIR-190B
GO:0002694,regulation of leukocyte activation,-2.0588,<2.2e-16,MIR-190B
GO:0042110,T cell activation,-2.08,<2.2e-16,MIR-190B
GO:0050663,cytokine secretion,-2.084,<2.2e-16,MIR-190B
GO:0019882,antigen processing and presentation,-2.1201,<2.2e-16,MIR-190B
GO:0032609,interferon-gamma production,-2.1204,<2.2e-16,MIR-190B
GO:0050900,leukocyte migration,-2.1354,<2.2e-16,MIR-190B
GO:0007159,leukocyte cell-cell adhesion,-2.1721,<2.2e-16,MIR-190B
GO:0002764,immune response-regulating signaling pathway,-2.0119,0.00044024,MIR-190B
GO:0032634,interleukin-5 production,1.5673,0.11393,MIR-190B
GO:0070671,response to interleukin-12,-1.7324,0.038133,MIR-887
GO:0032633,interleukin-4 production,-2.109,<2.2e-16,MIR-760
GO:0032620,interleukin-17 production,-2.122,<2.2e-16,MIR-760
GO:0002683,negative regulation of immune system process,-2.1359,<2.2e-16,MIR-760
GO:0002521,leukocyte differentiation,-2.1415,<2.2e-16,MIR-760
GO:0002526,acute inflammatory response,-2.1502,<2.2e-16,MIR-760
GO:0001819,positive regulation of cytokine production,-2.1625,<2.2e-16,MIR-760
GO:0001773,myeloid dendritic cell activation,-2.1714,<2.2e-16,MIR-760
GO:0032635,interleukin-6 production,-2.1883,<2.2e-16,MIR-760
GO:0002269,leukocyte activation involved in inflammatory response,-2.2158,<2.2e-16,MIR-760
GO:0002694,regulation of leukocyte activation,-2.3382,<2.2e-16,MIR-760
GO:0032609,interferon-gamma production,-2.3484,<2.2e-16,MIR-760
GO:0002449,lymphocyte mediated immunity,-2.3569,<2.2e-16,MIR-760
GO:0007159,leukocyte cell-cell adhesion,-2.5191,<2.2e-16,MIR-760
GO:0034341,response to interferon-gamma,-2.1629,<2.2e-16,MIR-933
GO:0042110,T cell activation,-2.1989,<2.2e-16,MIR-933
GO:0002694,regulation of leukocyte activation,-2.2088,<2.2e-16,MIR-933
GO:0032637,interleukin-8 production,-2.215,<2.2e-16,MIR-933
GO:0032602,chemokine production,-2.2473,<2.2e-16,MIR-933
GO:0032635,interleukin-6 production,-2.2629,<2.2e-16,MIR-933
GO:0002764,immune response-regulating signaling pathway,-2.2923,<2.2e-16,MIR-933
GO:0050727,regulation of inflammatory response,-2.3097,<2.2e-16,MIR-933
GO:0032612,interleukin-1 production,-2.3113,<2.2e-16,MIR-933
GO:0007159,leukocyte cell-cell adhesion,-2.3378,<2.2e-16,MIR-933
GO:0036230,granulocyte activation,-2.5556,<2.2e-16,MIR-933
GO:1903706,regulation of hemopoiesis,1.4868,0.39843,MIR-939
GO:0002250,adaptive immune response,1.4989,0.41066,MIR-939
GO:0002446,neutrophil mediated immunity,1.4928,0.41289,MIR-939
GO:0007159,leukocyte cell-cell adhesion,2.3581,<2.2e-16,MIR-193B
GO:0002446,neutrophil mediated immunity,2.2456,<2.2e-16,MIR-193B
GO:0002526,acute inflammatory response,2.191,<2.2e-16,MIR-193B
GO:0002764,immune response-regulating signaling pathway,2.18,<2.2e-16,MIR-193B
GO:0002250,adaptive immune response,2.1191,<2.2e-16,MIR-193B
GO:0032609,interferon-gamma production,2.1065,<2.2e-16,MIR-193B
GO:0002694,regulation of leukocyte activation,2.0961,<2.2e-16,MIR-193B
GO:0002449,lymphocyte mediated immunity,2.0698,<2.2e-16,MIR-193B
GO:0001819,positive regulation of cytokine production,2.0573,<2.2e-16,MIR-193B
GO:0006959,humoral immune response,2.0427,<2.2e-16,MIR-193B
GO:0019882,antigen processing and presentation,2.0387,<2.2e-16,MIR-193B
GO:0002697,regulation of immune effector process,2.0126,<2.2e-16,MIR-193B
GO:0002446,neutrophil mediated immunity,-1.459,0.43272,MIR-124-2
GO:0098760,response to interleukin-7,0.40562,0.99874,MIR-124-2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.9484,<2.2e-16,MIR-181A-1
GO:0034340,response to type I interferon,-1.6667,0.043957,MIR-181A-1
GO:0042092,type 2 immune response,-2.1399,<2.2e-16,MIR-1224
GO:0032613,interleukin-10 production,-2.1416,<2.2e-16,MIR-1224
GO:0036230,granulocyte activation,-2.1433,<2.2e-16,MIR-1224
GO:0042113,B cell activation,-2.1621,<2.2e-16,MIR-1224
GO:0001818,negative regulation of cytokine production,-2.1652,<2.2e-16,MIR-1224
GO:0032633,interleukin-4 production,-2.2159,<2.2e-16,MIR-1224
GO:0032606,type I interferon production,-2.2166,<2.2e-16,MIR-1224
GO:0002697,regulation of immune effector process,-2.2344,<2.2e-16,MIR-1224
GO:0032612,interleukin-1 production,-2.3149,<2.2e-16,MIR-1224
GO:0032635,interleukin-6 production,-2.3178,<2.2e-16,MIR-1224
GO:0032623,interleukin-2 production,-2.3261,<2.2e-16,MIR-1224
GO:0002694,regulation of leukocyte activation,-2.3303,<2.2e-16,MIR-1224
GO:0007159,leukocyte cell-cell adhesion,-2.3697,<2.2e-16,MIR-1224
GO:0032615,interleukin-12 production,-2.3888,<2.2e-16,MIR-1224
GO:0002285,lymphocyte activation involved in immune response,-2.4208,<2.2e-16,MIR-1224
GO:0034340,response to type I interferon,-2.5322,<2.2e-16,MIR-1224
GO:0002449,lymphocyte mediated immunity,-2.5671,<2.2e-16,MIR-1224
GO:0002250,adaptive immune response,-2.6122,<2.2e-16,MIR-1224
GO:0002764,immune response-regulating signaling pathway,-2.75,<2.2e-16,MIR-1224
GO:0050900,leukocyte migration,-2.0908,0.00062164,MIR-1225
GO:0007159,leukocyte cell-cell adhesion,-2.1152,0.0015541,MIR-1225
GO:0002446,neutrophil mediated immunity,-1.8784,0.0057724,MIR-1225
GO:0036230,granulocyte activation,-1.8603,0.0060921,MIR-1225
GO:0002764,immune response-regulating signaling pathway,-2.1027,<2.2e-16,MIR-1284
GO:0032637,interleukin-8 production,-2.118,<2.2e-16,MIR-1284
GO:0007159,leukocyte cell-cell adhesion,-2.119,<2.2e-16,MIR-1284
GO:0034341,response to interferon-gamma,-2.134,<2.2e-16,MIR-1284
GO:0070661,leukocyte proliferation,-2.2271,<2.2e-16,MIR-1284
GO:0002694,regulation of leukocyte activation,-2.0775,0.00098427,MIR-1284
GO:0050727,regulation of inflammatory response,-2.0785,0.0011483,MIR-1284
GO:0032635,interleukin-6 production,-2.0122,0.0017863,MIR-1284
GO:0032609,interferon-gamma production,-1.9883,0.0019139,MIR-1284
GO:0032612,interleukin-1 production,-1.9916,0.0020878,MIR-1284
GO:0042116,macrophage activation,-1.9375,0.0022966,MIR-1284
GO:0001773,myeloid dendritic cell activation,-1.9673,0.0026499,MIR-1284
GO:0042110,T cell activation,-1.9261,0.0029346,MIR-1284
GO:1990868,response to chemokine,-1.9164,0.0031427,MIR-1284
GO:0002697,regulation of immune effector process,-1.9579,<2.2e-16,MIR-513C
GO:0032609,interferon-gamma production,-1.9615,<2.2e-16,MIR-513C
GO:0042092,type 2 immune response,-1.9677,<2.2e-16,MIR-513C
GO:0032615,interleukin-12 production,-1.992,<2.2e-16,MIR-513C
GO:0001525,angiogenesis,-2.0018,<2.2e-16,MIR-513C
GO:0002440,production of molecular mediator of immune response,-2.0031,<2.2e-16,MIR-513C
GO:0002764,immune response-regulating signaling pathway,-2.0205,<2.2e-16,MIR-513C
GO:0001819,positive regulation of cytokine production,-2.0415,<2.2e-16,MIR-513C
GO:0002449,lymphocyte mediated immunity,-2.0426,<2.2e-16,MIR-513C
GO:0002446,neutrophil mediated immunity,-2.0485,<2.2e-16,MIR-513C
GO:0002694,regulation of leukocyte activation,-2.0624,<2.2e-16,MIR-513C
GO:0019882,antigen processing and presentation,-2.0675,<2.2e-16,MIR-513C
GO:0036230,granulocyte activation,-2.0826,<2.2e-16,MIR-513C
GO:0007159,leukocyte cell-cell adhesion,-2.2211,<2.2e-16,MIR-513C
GO:0002521,leukocyte differentiation,-2.0925,<2.2e-16,MIR-513C
GO:0002250,adaptive immune response,-2.2999,<2.2e-16,MIR-513C
GO:0002526,acute inflammatory response,1.666,0.22605,MIR-1468
GO:0006959,humoral immune response,1.4707,0.34359,MIR-1468
GO:0002532,production of molecular mediator involved in inflammatory response,1.4383,0.37395,MIR-1468
GO:0034341,response to interferon-gamma,-2.0676,<2.2e-16,MIR-1265
GO:0002250,adaptive immune response,-2.1728,<2.2e-16,MIR-1265
GO:0034340,response to type I interferon,-2.2181,<2.2e-16,MIR-1265
GO:0002449,lymphocyte mediated immunity,-2.0029,0.00075204,MIR-1265
GO:0002764,immune response-regulating signaling pathway,-1.9637,0.0012033,MIR-1265
GO:0070661,leukocyte proliferation,-1.9158,0.0030081,MIR-1265
GO:0032609,interferon-gamma production,-1.9297,0.0030081,MIR-1265
GO:0007159,leukocyte cell-cell adhesion,-1.8824,0.0040109,MIR-1265
GO:0045088,regulation of innate immune response,-1.864,0.0054147,MIR-1265
GO:0035456,response to interferon-beta,-1.8488,0.0054147,MIR-1265
GO:0002694,regulation of leukocyte activation,-1.8501,0.0058014,MIR-1265
GO:0042110,T cell activation,-1.8524,0.0060163,MIR-1265
GO:0050663,cytokine secretion,-1.8506,0.0062477,MIR-1265
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.821,0.0093783,MIR-1265
GO:0032635,interleukin-6 production,-1.8009,0.010314,MIR-1265
GO:0001819,positive regulation of cytokine production,-1.7787,0.012990,MIR-1265
GO:0034612,response to tumor necrosis factor,-1.7728,0.014256,MIR-1265
GO:0002251,organ or tissue specific immune response,1.9026,0.18731,MIR-1265
GO:0035456,response to interferon-beta,3.0778,0.65623,MIR-1286
GO:0048536,spleen development,2.7596,0.88297,MIR-1286
GO:0070671,response to interleukin-12,-0.54384,0.9625,MIR-1286
GO:0002250,adaptive immune response,2.6255,<2.2e-16,MIR-1538
GO:0007159,leukocyte cell-cell adhesion,2.5286,<2.2e-16,MIR-1538
GO:0002694,regulation of leukocyte activation,2.4787,<2.2e-16,MIR-1538
GO:0002764,immune response-regulating signaling pathway,2.4578,<2.2e-16,MIR-1538
GO:0002449,lymphocyte mediated immunity,2.4456,<2.2e-16,MIR-1538
GO:0002697,regulation of immune effector process,2.4208,<2.2e-16,MIR-1538
GO:0001819,positive regulation of cytokine production,2.3856,<2.2e-16,MIR-1538
GO:0001818,negative regulation of cytokine production,2.3746,<2.2e-16,MIR-1538
GO:0002285,lymphocyte activation involved in immune response,2.369,<2.2e-16,MIR-1538
GO:0002440,production of molecular mediator of immune response,2.2904,<2.2e-16,MIR-1538
GO:0002446,neutrophil mediated immunity,2.2878,<2.2e-16,MIR-1538
GO:0002683,negative regulation of immune system process,2.2768,<2.2e-16,MIR-1538
GO:0002521,leukocyte differentiation,2.242,<2.2e-16,MIR-1538
GO:0002507,tolerance induction,2.1147,<2.2e-16,MIR-1538
GO:0002526,acute inflammatory response,2.098,<2.2e-16,MIR-1538
GO:0002532,production of molecular mediator involved in inflammatory response,2.0279,<2.2e-16,MIR-1538
GO:0001818,negative regulation of cytokine production,-2.0674,<2.2e-16,MIR-1276
GO:0002521,leukocyte differentiation,-2.0896,<2.2e-16,MIR-1276
GO:0002532,production of molecular mediator involved in inflammatory response,-2.1182,<2.2e-16,MIR-1276
GO:0002446,neutrophil mediated immunity,-2.1249,<2.2e-16,MIR-1276
GO:0002683,negative regulation of immune system process,-2.1596,<2.2e-16,MIR-1276
GO:0006959,humoral immune response,-2.1942,<2.2e-16,MIR-1276
GO:0002448,mast cell mediated immunity,-2.1978,<2.2e-16,MIR-1276
GO:0002269,leukocyte activation involved in inflammatory response,-2.2097,<2.2e-16,MIR-1276
GO:0002697,regulation of immune effector process,-2.2237,<2.2e-16,MIR-1276
GO:0002526,acute inflammatory response,-2.2578,<2.2e-16,MIR-1276
GO:0002285,lymphocyte activation involved in immune response,-2.2843,<2.2e-16,MIR-1276
GO:0002449,lymphocyte mediated immunity,-2.3928,<2.2e-16,MIR-1276
GO:0002694,regulation of leukocyte activation,-2.4848,<2.2e-16,MIR-1276
GO:0002764,immune response-regulating signaling pathway,-2.5004,<2.2e-16,MIR-1276
GO:0002250,adaptive immune response,-2.5496,<2.2e-16,MIR-1276
GO:0032602,chemokine production,-1.9548,0.033111,MIR-1288
GO:0032637,interleukin-8 production,-1.862,0.047883,MIR-1288
GO:0032612,interleukin-1 production,-1.8226,0.048029,MIR-1288
GO:0032635,interleukin-6 production,-1.903,0.049241,MIR-1288
GO:0070555,response to interleukin-1,-1.793,0.050373,MIR-1288
GO:0032609,interferon-gamma production,-1.7977,0.054760,MIR-1288
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.7497,0.066221,MIR-1288
GO:0042116,macrophage activation,-1.742,0.067147,MIR-1288
GO:0050663,cytokine secretion,-1.7289,0.071315,MIR-1288
GO:0070661,leukocyte proliferation,-1.6904,0.078638,MIR-1288
GO:0034341,response to interferon-gamma,-1.6543,0.089546,MIR-1288
GO:0002269,leukocyte activation involved in inflammatory response,-1.6584,0.090842,MIR-1288
GO:0050727,regulation of inflammatory response,-1.6417,0.091206,MIR-1288
GO:0007159,leukocyte cell-cell adhesion,-1.6431,0.095002,MIR-1288
GO:0050900,leukocyte migration,-1.5882,0.11512,MIR-1288
GO:0035456,response to interferon-beta,-2.0027,0.0039338,MIR-1289-1
GO:0032602,chemokine production,-1.7274,0.033958,MIR-1289-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.1721,<2.2e-16,MIR-1915
GO:0002526,acute inflammatory response,-2.1926,<2.2e-16,MIR-1915
GO:0032602,chemokine production,-2.195,<2.2e-16,MIR-1915
GO:0050663,cytokine secretion,-2.2127,<2.2e-16,MIR-1915
GO:0050900,leukocyte migration,-2.2456,<2.2e-16,MIR-1915
GO:0032637,interleukin-8 production,-2.1117,0.00045229,MIR-1915
GO:0007159,leukocyte cell-cell adhesion,-2.1117,0.00051690,MIR-1915
GO:0032613,interleukin-10 production,-2.1368,0.00060305,MIR-1915
GO:0034341,response to interferon-gamma,-2.0876,0.00072366,MIR-1915
GO:1990868,response to chemokine,-2.0278,0.00096488,MIR-1915
GO:0032615,interleukin-12 production,-2.0347,0.0010338,MIR-1915
GO:0050727,regulation of inflammatory response,-2.0081,0.0010642,MIR-1915
GO:0006959,humoral immune response,-1.996,0.0014071,MIR-1915
GO:0042110,T cell activation,-1.9915,0.0014473,MIR-1915
GO:0070661,leukocyte proliferation,-1.9927,0.0015235,MIR-1915
GO:0035455,response to interferon-alpha,1.7513,0.016430,MIR-1915
GO:0032637,interleukin-8 production,-1.7837,0.039510,MIR-1287
GO:0002526,acute inflammatory response,-1.7224,0.048032,MIR-1287
GO:0032602,chemokine production,-1.6545,0.082218,MIR-1287
GO:0050727,regulation of inflammatory response,-1.5983,0.087312,MIR-1287
GO:0032635,interleukin-6 production,-1.6029,0.095538,MIR-1287
GO:0042110,T cell activation,1.5976,0.11499,MIR-320C-1
GO:0002764,immune response-regulating signaling pathway,1.5874,0.11589,MIR-320C-1
GO:0070661,leukocyte proliferation,1.5698,0.12714,MIR-320C-1
GO:0042113,B cell activation,1.6048,0.12840,MIR-320C-1
GO:0071559,response to transforming growth factor beta,1.5639,0.13011,MIR-320C-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.0159,<2.2e-16,MIR-1914
GO:0032637,interleukin-8 production,-2.0289,<2.2e-16,MIR-1914
GO:0070661,leukocyte proliferation,-2.0554,<2.2e-16,MIR-1914
GO:0002764,immune response-regulating signaling pathway,-2.0625,<2.2e-16,MIR-1914
GO:0002526,acute inflammatory response,-2.0813,<2.2e-16,MIR-1914
GO:0034341,response to interferon-gamma,-2.0834,<2.2e-16,MIR-1914
GO:0042116,macrophage activation,-2.1393,<2.2e-16,MIR-1914
GO:0032635,interleukin-6 production,-2.1927,<2.2e-16,MIR-1914
GO:0032620,interleukin-17 production,-2.0052,0.00020901,MIR-1914
GO:0050663,cytokine secretion,-1.9806,0.00054866,MIR-1914
GO:0032612,interleukin-1 production,-1.9655,0.00061604,MIR-1914
GO:0150076,neuroinflammatory response,-1.9659,0.00065027,MIR-1914
GO:0032609,interferon-gamma production,-1.9634,0.00087786,MIR-1914
GO:0050727,regulation of inflammatory response,-1.9424,0.00093106,MIR-1914
GO:0002269,leukocyte activation involved in inflammatory response,-1.9424,0.00097540,MIR-1914
GO:0036230,granulocyte activation,-2.2217,<2.2e-16,MIR-1292
GO:0002446,neutrophil mediated immunity,-2.2365,<2.2e-16,MIR-1292
GO:0050900,leukocyte migration,-2.4201,<2.2e-16,MIR-1292
GO:0001525,angiogenesis,-2.1077,0.00090828,MIR-1292
GO:0007159,leukocyte cell-cell adhesion,-1.9795,0.0019817,MIR-1292
GO:0034340,response to type I interferon,-2.2031,<2.2e-16,MIR-1913
GO:0034341,response to interferon-gamma,-2.3999,<2.2e-16,MIR-1913
GO:0032606,type I interferon production,-1.9756,0.00051789,MIR-1913
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9763,0.00056105,MIR-1913
GO:0032609,interferon-gamma production,-2.1434,0.00067326,MIR-1913
GO:0042116,macrophage activation,-2.0227,0.00074807,MIR-1913
GO:0035456,response to interferon-beta,-2.0275,0.00084158,MIR-1913
GO:0032615,interleukin-12 production,-2.1085,0.0011221,MIR-1913
GO:0070661,leukocyte proliferation,-1.9526,0.0016832,MIR-1913
GO:0001819,positive regulation of cytokine production,-1.8846,0.0043564,MIR-1913
GO:0035455,response to interferon-alpha,-1.8659,0.0046487,MIR-1913
GO:0007159,leukocyte cell-cell adhesion,-1.8572,0.0050495,MIR-1913
GO:0045088,regulation of innate immune response,-1.8753,0.0050495,MIR-1913
GO:0002764,immune response-regulating signaling pathway,-1.8209,0.0074059,MIR-1913
GO:0035456,response to interferon-beta,-1.4813,0.19584,MIR-1246
GO:0034341,response to interferon-gamma,2.1851,<2.2e-16,MIR-1248
GO:0050900,leukocyte migration,2.131,<2.2e-16,MIR-1248
GO:0001773,myeloid dendritic cell activation,2.0414,0.0015988,MIR-1248
GO:0001525,angiogenesis,2.0247,0.0018652,MIR-1248
GO:0007159,leukocyte cell-cell adhesion,2.008,0.0020984,MIR-1248
GO:0070555,response to interleukin-1,1.9295,0.0042528,MIR-1248
GO:0002449,lymphocyte mediated immunity,-2.1052,<2.2e-16,MIR-1912
GO:0034340,response to type I interferon,-2.1505,<2.2e-16,MIR-1912
GO:0034341,response to interferon-gamma,-2.155,<2.2e-16,MIR-1912
GO:0050727,regulation of inflammatory response,-2.1872,<2.2e-16,MIR-1912
GO:0002250,adaptive immune response,-2.2193,<2.2e-16,MIR-1912
GO:0032623,interleukin-2 production,-2.2197,<2.2e-16,MIR-1912
GO:0006959,humoral immune response,-2.2516,<2.2e-16,MIR-1912
GO:0002526,acute inflammatory response,-2.3985,<2.2e-16,MIR-1912
GO:0032633,interleukin-4 production,-2.0672,0.00036817,MIR-1912
GO:0036230,granulocyte activation,-2.0252,0.00050623,MIR-1912
GO:0050663,cytokine secretion,-2.035,0.00057855,MIR-1912
GO:0007159,leukocyte cell-cell adhesion,-2.0489,0.00062305,MIR-1912
GO:0042116,macrophage activation,-2.0545,0.00067498,MIR-1912
GO:0002446,neutrophil mediated immunity,-1.983,0.00080997,MIR-1912
GO:0050900,leukocyte migration,1.9296,<2.2e-16,MIR-1247
GO:0071706,tumor necrosis factor superfamily cytokine production,1.8951,<2.2e-16,MIR-1247
GO:0001525,angiogenesis,1.888,<2.2e-16,MIR-1247
GO:0050727,regulation of inflammatory response,1.8793,<2.2e-16,MIR-1247
GO:0032637,interleukin-8 production,1.8164,0.00010402,MIR-1247
GO:0032635,interleukin-6 production,1.8189,0.00011032,MIR-1247
GO:0002532,production of molecular mediator involved in inflammatory response,1.8189,0.00011377,MIR-1247
GO:0035456,response to interferon-beta,-1.6664,0.17428,MIR-1263
GO:0010573,vascular endothelial growth factor production,-1.6713,0.18545,MIR-1263
GO:0032602,chemokine production,-1.6302,0.22707,MIR-1263
GO:0035455,response to interferon-alpha,-1.5006,0.39056,MIR-1263
GO:0002250,adaptive immune response,2.2599,<2.2e-16,MIR-1249
GO:0002449,lymphocyte mediated immunity,2.1974,<2.2e-16,MIR-1249
GO:0002285,lymphocyte activation involved in immune response,2.1263,<2.2e-16,MIR-1249
GO:0002694,regulation of leukocyte activation,2.1259,<2.2e-16,MIR-1249
GO:0002764,immune response-regulating signaling pathway,2.0997,<2.2e-16,MIR-1249
GO:0002521,leukocyte differentiation,2.0854,<2.2e-16,MIR-1249
GO:0001819,positive regulation of cytokine production,2.0675,<2.2e-16,MIR-1249
GO:0001773,myeloid dendritic cell activation,2.0533,<2.2e-16,MIR-1249
GO:0002526,acute inflammatory response,2.0486,<2.2e-16,MIR-1249
GO:0002697,regulation of immune effector process,2.0371,<2.2e-16,MIR-1249
GO:0002683,negative regulation of immune system process,2.0018,<2.2e-16,MIR-1249
GO:0002446,neutrophil mediated immunity,1.9895,<2.2e-16,MIR-1249
GO:0002448,mast cell mediated immunity,1.9608,<2.2e-16,MIR-1249
GO:0002532,production of molecular mediator involved in inflammatory response,1.9499,<2.2e-16,MIR-1249
GO:0001818,negative regulation of cytokine production,1.9408,<2.2e-16,MIR-1249
GO:0002507,tolerance induction,1.9202,<2.2e-16,MIR-1249
GO:0002269,leukocyte activation involved in inflammatory response,1.876,<2.2e-16,MIR-1249
GO:0035456,response to interferon-beta,-2.1942,<2.2e-16,MIR-1296
GO:0034341,response to interferon-gamma,-2.2242,<2.2e-16,MIR-1296
GO:0034340,response to type I interferon,-2.6603,<2.2e-16,MIR-1296
GO:0002250,adaptive immune response,-2.0106,0.00057945,MIR-1296
GO:0035455,response to interferon-alpha,-2.0259,0.00069534,MIR-1296
GO:0032620,interleukin-17 production,-1.9808,0.00099334,MIR-1296
GO:0002449,lymphocyte mediated immunity,-1.9026,0.0039982,MIR-1296
GO:0045088,regulation of innate immune response,-1.8875,0.0042010,MIR-1296
GO:0032609,interferon-gamma production,-1.8938,0.0042669,MIR-1296
GO:0032606,type I interferon production,-1.822,0.010564,MIR-1296
GO:0032620,interleukin-17 production,-2.0352,<2.2e-16,MIR-1298
GO:0002269,leukocyte activation involved in inflammatory response,-2.0506,<2.2e-16,MIR-1298
GO:0002448,mast cell mediated immunity,-2.0752,<2.2e-16,MIR-1298
GO:0002285,lymphocyte activation involved in immune response,-2.1083,<2.2e-16,MIR-1298
GO:0002694,regulation of leukocyte activation,-2.1241,<2.2e-16,MIR-1298
GO:0002697,regulation of immune effector process,-2.16,<2.2e-16,MIR-1298
GO:0002764,immune response-regulating signaling pathway,-2.1705,<2.2e-16,MIR-1298
GO:0001819,positive regulation of cytokine production,-2.1747,<2.2e-16,MIR-1298
GO:0001818,negative regulation of cytokine production,-2.1768,<2.2e-16,MIR-1298
GO:0032609,interferon-gamma production,-2.2277,<2.2e-16,MIR-1298
GO:0002449,lymphocyte mediated immunity,-2.24,<2.2e-16,MIR-1298
GO:0032612,interleukin-1 production,-2.2703,<2.2e-16,MIR-1298
GO:0002532,production of molecular mediator involved in inflammatory response,-2.3022,<2.2e-16,MIR-1298
GO:0007159,leukocyte cell-cell adhesion,-2.3111,<2.2e-16,MIR-1298
GO:0002446,neutrophil mediated immunity,-2.4726,<2.2e-16,MIR-1298
GO:0032635,interleukin-6 production,-6.1773,0.30008,MIR-1256
GO:0050663,cytokine secretion,-5.8359,0.44907,MIR-1256
GO:0032602,chemokine production,-6.2449,0.51921,MIR-1256
GO:0002250,adaptive immune response,-0.91458,0.61505,MIR-1256
GO:0002285,lymphocyte activation involved in immune response,-0.9331,0.61575,MIR-1256
GO:0002448,mast cell mediated immunity,-0.93722,0.62063,MIR-1256
GO:0071887,leukocyte apoptotic process,-0.98414,0.62162,MIR-1256
GO:0032615,interleukin-12 production,-2.127,<2.2e-16,MIR-1185-1
GO:0032609,interferon-gamma production,-2.1812,<2.2e-16,MIR-1185-1
GO:0002449,lymphocyte mediated immunity,-2.1816,<2.2e-16,MIR-1185-1
GO:0019882,antigen processing and presentation,-2.1824,<2.2e-16,MIR-1185-1
GO:0060759,regulation of response to cytokine stimulus,-2.2095,<2.2e-16,MIR-1185-1
GO:0032606,type I interferon production,-2.2749,<2.2e-16,MIR-1185-1
GO:0035456,response to interferon-beta,-2.4675,<2.2e-16,MIR-1185-1
GO:0034341,response to interferon-gamma,-2.6503,<2.2e-16,MIR-1185-1
GO:0034340,response to type I interferon,-2.6719,<2.2e-16,MIR-1185-1
GO:0032620,interleukin-17 production,-2.0367,0.0017739,MIR-1185-1
GO:0032623,interleukin-2 production,-2.0187,0.0017925,MIR-1185-1
GO:0007159,leukocyte cell-cell adhesion,-2.0263,0.0018921,MIR-1185-1
GO:0035455,response to interferon-alpha,-1.9733,0.0018921,MIR-1185-1
GO:0002250,adaptive immune response,-2.0159,0.0019867,MIR-1185-1
GO:0034340,response to type I interferon,-1.7991,0.025941,MIR-1231
GO:0034341,response to interferon-gamma,-1.7536,0.030764,MIR-1231
GO:0002251,organ or tissue specific immune response,-1.7282,0.038989,MIR-1231
GO:0032620,interleukin-17 production,-1.6628,0.057347,MIR-1231
GO:0002200,somatic diversification of immune receptors,-1.744,0.052553,MIR-1205
GO:0045088,regulation of innate immune response,0.96198,0.77107,MIR-1205
GO:0002526,acute inflammatory response,0.96287,0.77136,MIR-1205
GO:0070741,response to interleukin-6,-0.95746,0.75305,MIR-1278
GO:0060759,regulation of response to cytokine stimulus,-0.99671,0.75423,MIR-1278
GO:0070670,response to interleukin-4,-1.0099,0.75858,MIR-1278
GO:0032613,interleukin-10 production,-0.93347,0.77128,MIR-1278
GO:0002507,tolerance induction,2.3969,0.90604,MIR-1278
GO:0035455,response to interferon-alpha,-1.8903,0.067128,MIR-2113
GO:0032633,interleukin-4 production,-1.8945,0.086521,MIR-2113
GO:0032609,interferon-gamma production,-1.7462,0.11188,MIR-2113
GO:0001773,myeloid dendritic cell activation,-1.82,0.11367,MIR-2113
GO:0042116,macrophage activation,-1.68,0.12642,MIR-2113
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.6697,0.12899,MIR-2113
GO:0002250,adaptive immune response,-1.6816,0.13306,MIR-2113
GO:0032637,interleukin-8 production,-1.6562,0.13699,MIR-2113
GO:0035456,response to interferon-beta,-1.7803,0.13724,MIR-2113
GO:0032613,interleukin-10 production,-1.6887,0.14493,MIR-2113
GO:0034340,response to type I interferon,-1.5816,0.14496,MIR-2113
GO:0034341,response to interferon-gamma,-1.6158,0.14626,MIR-2113
GO:0034612,response to tumor necrosis factor,-1.6965,0.14731,MIR-2113
GO:0070670,response to interleukin-4,1.7653,0.32694,MIR-1299
GO:0042092,type 2 immune response,1.7026,0.47171,MIR-1299
GO:0008356,asymmetric cell division,1.6344,0.51432,MIR-1299
GO:0002449,lymphocyte mediated immunity,1.5434,0.5304,MIR-1299
GO:0010573,vascular endothelial growth factor production,-1.4485,0.94159,MIR-1299
GO:1903706,regulation of hemopoiesis,-1.4694,0.957,MIR-1299
GO:0071887,leukocyte apoptotic process,-0.7102,0.97492,MIR-1299
GO:0035456,response to interferon-beta,-2.078,<2.2e-16,MIR-1257
GO:0034340,response to type I interferon,-2.1486,<2.2e-16,MIR-1257
GO:0019882,antigen processing and presentation,-2.2681,<2.2e-16,MIR-1257
GO:0034341,response to interferon-gamma,-2.3534,<2.2e-16,MIR-1257
GO:0001773,myeloid dendritic cell activation,-1.8183,0.034669,MIR-1257
GO:0032615,interleukin-12 production,-1.8257,0.035235,MIR-1257
GO:0032606,type I interferon production,-1.8014,0.037200,MIR-1257
GO:0002449,lymphocyte mediated immunity,-1.8322,0.037692,MIR-1257
GO:0042092,type 2 immune response,-1.7916,0.038098,MIR-1257
GO:0070661,leukocyte proliferation,-1.8706,0.039114,MIR-1257
GO:0002507,tolerance induction,-1.8393,0.039509,MIR-1257
GO:0008356,asymmetric cell division,-1.7684,0.042003,MIR-1257
GO:0006925,inflammatory cell apoptotic process,-1.7704,0.043144,MIR-1257
GO:0032609,interferon-gamma production,-1.8398,0.044004,MIR-1257
GO:0035455,response to interferon-alpha,-1.7542,0.044448,MIR-1257
GO:0060759,regulation of response to cytokine stimulus,-1.6991,0.056745,MIR-1257
GO:0036230,granulocyte activation,-2.2277,<2.2e-16,MIR-320D-2
GO:0002446,neutrophil mediated immunity,-2.2395,<2.2e-16,MIR-320D-2
GO:0070671,response to interleukin-12,-1.8708,0.0035962,MIR-320D-2
GO:0035455,response to interferon-alpha,1.8338,0.034752,MIR-320D-2
GO:0034612,response to tumor necrosis factor,1.5489,0.16568,MIR-1258
GO:0050900,leukocyte migration,1.5138,0.16579,MIR-1258
GO:0032635,interleukin-6 production,1.5443,0.16811,MIR-1258
GO:0071706,tumor necrosis factor superfamily cytokine production,1.527,0.16814,MIR-1258
GO:0002697,regulation of immune effector process,1.3921,0.16834,MIR-1258
GO:0002269,leukocyte activation involved in inflammatory response,-1.6648,0.16841,MIR-1307
GO:0150076,neuroinflammatory response,-1.401,0.50798,MIR-1307
GO:0002251,organ or tissue specific immune response,-1.4052,0.52933,MIR-1307
GO:0035456,response to interferon-beta,1.3906,0.37725,MIR-1270
GO:0008356,asymmetric cell division,1.3387,0.51019,MIR-1270
GO:0002250,adaptive immune response,2.1131,<2.2e-16,MIR-1294
GO:0007159,leukocyte cell-cell adhesion,2.0939,<2.2e-16,MIR-1294
GO:0002521,leukocyte differentiation,2.0192,<2.2e-16,MIR-1294
GO:0002449,lymphocyte mediated immunity,1.9969,<2.2e-16,MIR-1294
GO:0002694,regulation of leukocyte activation,1.9941,<2.2e-16,MIR-1294
GO:0002526,acute inflammatory response,1.9931,<2.2e-16,MIR-1294
GO:0002285,lymphocyte activation involved in immune response,1.9878,<2.2e-16,MIR-1294
GO:0001819,positive regulation of cytokine production,1.9796,<2.2e-16,MIR-1294
GO:0002532,production of molecular mediator involved in inflammatory response,1.9616,<2.2e-16,MIR-1294
GO:0002764,immune response-regulating signaling pathway,1.959,<2.2e-16,MIR-1294
GO:0001525,angiogenesis,1.9471,<2.2e-16,MIR-1294
GO:0002683,negative regulation of immune system process,1.9276,<2.2e-16,MIR-1294
GO:0001773,myeloid dendritic cell activation,1.9231,<2.2e-16,MIR-1294
GO:0001818,negative regulation of cytokine production,1.9178,<2.2e-16,MIR-1294
GO:0002269,leukocyte activation involved in inflammatory response,1.9154,<2.2e-16,MIR-1294
GO:0002446,neutrophil mediated immunity,1.893,<2.2e-16,MIR-1294
GO:0002683,negative regulation of immune system process,1.7562,0.20310,MIR-1825
GO:0002200,somatic diversification of immune receptors,1.7583,0.20456,MIR-1825
GO:0042092,type 2 immune response,1.7377,0.20585,MIR-1825
GO:0035455,response to interferon-alpha,1.7646,0.20596,MIR-1825
GO:0030101,natural killer cell activation,1.7596,0.20615,MIR-1825
GO:0002269,leukocyte activation involved in inflammatory response,1.7702,0.21049,MIR-1825
GO:0001773,myeloid dendritic cell activation,1.7243,0.21052,MIR-1825
GO:0032613,interleukin-10 production,1.781,0.21166,MIR-1825
GO:0060759,regulation of response to cytokine stimulus,1.7048,0.21194,MIR-1825
GO:0042116,macrophage activation,1.6985,0.21319,MIR-1825
GO:0032620,interleukin-17 production,1.7825,0.21352,MIR-1825
GO:0002521,leukocyte differentiation,1.7829,0.21580,MIR-1825
GO:1990868,response to chemokine,1.5495,0.36740,MIR-1272
GO:0071559,response to transforming growth factor beta,1.5203,0.36751,MIR-1272
GO:0034340,response to type I interferon,1.5252,0.33681,MIR-1243
GO:0007159,leukocyte cell-cell adhesion,2.0964,<2.2e-16,MIR-1976
GO:0002250,adaptive immune response,2.0947,<2.2e-16,MIR-1976
GO:0002449,lymphocyte mediated immunity,2.0597,<2.2e-16,MIR-1976
GO:0002764,immune response-regulating signaling pathway,2.0406,<2.2e-16,MIR-1976
GO:0002521,leukocyte differentiation,2.0261,<2.2e-16,MIR-1976
GO:0002285,lymphocyte activation involved in immune response,2.0229,<2.2e-16,MIR-1976
GO:0002694,regulation of leukocyte activation,2.0098,<2.2e-16,MIR-1976
GO:0001819,positive regulation of cytokine production,1.9495,<2.2e-16,MIR-1976
GO:0001773,myeloid dendritic cell activation,1.9487,<2.2e-16,MIR-1976
GO:0002526,acute inflammatory response,1.9382,<2.2e-16,MIR-1976
GO:0002697,regulation of immune effector process,1.9339,<2.2e-16,MIR-1976
GO:0002446,neutrophil mediated immunity,1.93,<2.2e-16,MIR-1976
GO:0002440,production of molecular mediator of immune response,1.9163,<2.2e-16,MIR-1976
GO:0002269,leukocyte activation involved in inflammatory response,1.8964,<2.2e-16,MIR-1976
GO:0001818,negative regulation of cytokine production,1.8915,<2.2e-16,MIR-1976
GO:0002507,tolerance induction,1.8828,<2.2e-16,MIR-1976
GO:0002532,production of molecular mediator involved in inflammatory response,1.8771,<2.2e-16,MIR-1976
GO:0002251,organ or tissue specific immune response,-1.7569,0.59573,MIR-548F-1
GO:0032616,interleukin-13 production,-1.531,0.63435,MIR-548F-1
GO:0035456,response to interferon-beta,-1.6411,0.66498,MIR-548F-1
GO:0032606,type I interferon production,-1.5649,0.71275,MIR-548F-1
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.1786,0.90744,MIR-548F-1
GO:0002437,inflammatory response to antigenic stimulus,1.1712,0.91532,MIR-548F-1
GO:0002449,lymphocyte mediated immunity,1.4871,0.25425,MIR-1255A
GO:0002250,adaptive immune response,1.4659,0.25666,MIR-1255A
GO:0036230,granulocyte activation,-2.2757,<2.2e-16,MIR-320C-2
GO:0002446,neutrophil mediated immunity,-2.3107,<2.2e-16,MIR-320C-2
GO:0019882,antigen processing and presentation,-1.9799,0.0014458,MIR-320C-2
GO:0035455,response to interferon-alpha,1.4029,0.30695,MIR-320C-2
GO:0008356,asymmetric cell division,1.4039,0.31379,MIR-320C-2
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1.8713,0.13343,MIR-1234
GO:0035455,response to interferon-alpha,1.877,0.13683,MIR-1234
GO:0001525,angiogenesis,1.8367,0.15553,MIR-1234
GO:0043276,anoikis,1.9535,0.16487,MIR-1234
GO:0034340,response to type I interferon,1.741,0.17893,MIR-1234
GO:0007159,leukocyte cell-cell adhesion,1.8193,0.18243,MIR-1234
GO:0002250,adaptive immune response,1.8119,0.18481,MIR-1234
GO:0098760,response to interleukin-7,1.9101,0.0086349,MIR-1306
GO:0032620,interleukin-17 production,-1.5035,0.19729,MIR-1306
GO:0002251,organ or tissue specific immune response,-1.4276,0.23134,MIR-1306
GO:0001525,angiogenesis,2.2361,<2.2e-16,MIR-1228
GO:0007159,leukocyte cell-cell adhesion,2.2021,<2.2e-16,MIR-1228
GO:0002250,adaptive immune response,2.1817,<2.2e-16,MIR-1228
GO:0002521,leukocyte differentiation,2.133,<2.2e-16,MIR-1228
GO:0002449,lymphocyte mediated immunity,2.0683,<2.2e-16,MIR-1228
GO:0002446,neutrophil mediated immunity,2.0676,<2.2e-16,MIR-1228
GO:0002683,negative regulation of immune system process,2.0598,<2.2e-16,MIR-1228
GO:0002285,lymphocyte activation involved in immune response,2.0584,<2.2e-16,MIR-1228
GO:0002694,regulation of leukocyte activation,2.0557,<2.2e-16,MIR-1228
GO:0002764,immune response-regulating signaling pathway,2.0522,<2.2e-16,MIR-1228
GO:0001818,negative regulation of cytokine production,2.0483,<2.2e-16,MIR-1228
GO:0070671,response to interleukin-12,2.1624,<2.2e-16,MIR-1266
GO:0002449,lymphocyte mediated immunity,2.1601,<2.2e-16,MIR-1266
GO:0071559,response to transforming growth factor beta,-1.8606,0.00029051,MIR-1266
GO:0002250,adaptive immune response,2.0698,0.0010734,MIR-1266
GO:0032606,type I interferon production,2.0239,0.0031308,MIR-1266
GO:0034340,response to type I interferon,1.9807,0.0037885,MIR-1266
GO:0035456,response to interferon-beta,1.9815,0.0040253,MIR-1266
GO:0002532,production of molecular mediator involved in inflammatory response,-1.4712,0.62678,MIR-1283-2
GO:0002448,mast cell mediated immunity,-1.5186,0.64079,MIR-1283-2
GO:0030101,natural killer cell activation,-1.3223,0.7182,MIR-1283-2
GO:0043276,anoikis,-1.3446,0.74017,MIR-1283-2
GO:0045576,mast cell activation,-1.5615,0.81177,MIR-1283-2
GO:0002269,leukocyte activation involved in inflammatory response,-1.238,0.87603,MIR-1283-2
GO:0035456,response to interferon-beta,-1.9165,0.088305,MIR-1185-2
GO:0034341,response to interferon-gamma,-1.8338,0.14616,MIR-1185-2
GO:0034340,response to type I interferon,-1.761,0.19488,MIR-1185-2
GO:0035455,response to interferon-alpha,-1.6826,0.28725,MIR-1185-2
GO:0045576,mast cell activation,-1.4434,0.30434,MIR-1185-2
GO:0032606,type I interferon production,-1.4964,0.31424,MIR-1185-2
GO:0035924,cellular response to vascular endothelial growth factor stimulus,2.2307,0.0019450,MIR-1909
GO:0001525,angiogenesis,2.2026,0.0021881,MIR-1909
GO:0034341,response to interferon-gamma,-2.4694,<2.2e-16,MIR-1203
GO:0002764,immune response-regulating signaling pathway,-2.4817,<2.2e-16,MIR-1203
GO:0032609,interferon-gamma production,-2.5568,<2.2e-16,MIR-1203
GO:0032633,interleukin-4 production,-2.2509,0.0013079,MIR-1203
GO:0007159,leukocyte cell-cell adhesion,-2.3857,0.0013079,MIR-1203
GO:0032637,interleukin-8 production,-2.2627,0.0014268,MIR-1203
GO:0002446,neutrophil mediated immunity,-2.2014,0.0014714,MIR-1203
GO:0070661,leukocyte proliferation,-2.3105,0.0015695,MIR-1203
GO:0032613,interleukin-10 production,-2.2078,0.0015695,MIR-1203
GO:0042092,type 2 immune response,-2.1802,0.0016521,MIR-1203
GO:0036230,granulocyte activation,-2.2096,0.0016816,MIR-1203
GO:0032615,interleukin-12 production,-2.189,0.0017439,MIR-1203
GO:0002449,lymphocyte mediated immunity,-2.3386,0.0017439,MIR-1203
GO:0042116,macrophage activation,-2.2099,0.0018110,MIR-1203
GO:0032623,interleukin-2 production,-2.3395,0.0019619,MIR-1203
GO:0002250,adaptive immune response,-2.4053,0.0019619,MIR-1203
GO:0002683,negative regulation of immune system process,-2.1298,0.0035671,MIR-1203
GO:0034340,response to type I interferon,2.4178,<2.2e-16,MIR-1181
GO:0035455,response to interferon-alpha,2.0623,0.0022800,MIR-1181
GO:0032606,type I interferon production,1.9903,0.0035177,MIR-1181
GO:0034341,response to interferon-gamma,1.9714,0.0039085,MIR-1181
GO:0006959,humoral immune response,-1.6446,0.38236,MIR-1277
GO:0008356,asymmetric cell division,-2.6799,0.71757,MIR-1285-1
GO:0070555,response to interleukin-1,-1.289,0.72667,MIR-1285-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.2378,0.73109,MIR-1285-1
GO:1990868,response to chemokine,-1.2215,0.73339,MIR-1285-1
GO:0002446,neutrophil mediated immunity,1.8867,0.0025906,MIR-1293
GO:0036230,granulocyte activation,1.8302,0.0068003,MIR-1293
GO:0019882,antigen processing and presentation,1.7707,0.013693,MIR-1293
GO:0035455,response to interferon-alpha,-1.4995,0.34619,MIR-1293
GO:0150076,neuroinflammatory response,-1.4563,0.38341,MIR-1293
GO:0006959,humoral immune response,-1.4701,0.39085,MIR-1293
GO:0002251,organ or tissue specific immune response,1.9353,0.0080812,MIR-1291
GO:0034612,response to tumor necrosis factor,1.7188,0.041832,MIR-1291
GO:0006959,humoral immune response,1.7234,0.042273,MIR-1291
GO:0070670,response to interleukin-4,1.6744,0.062837,MIR-1291
GO:0034341,response to interferon-gamma,1.6542,0.065175,MIR-1291
GO:0032609,interferon-gamma production,1.6201,0.071899,MIR-1291
GO:0032602,chemokine production,-2.2753,<2.2e-16,MIR-1911
GO:0032635,interleukin-6 production,-2.2791,<2.2e-16,MIR-1911
GO:0002285,lymphocyte activation involved in immune response,-2.286,<2.2e-16,MIR-1911
GO:0006959,humoral immune response,-2.311,<2.2e-16,MIR-1911
GO:0032633,interleukin-4 production,-2.3388,<2.2e-16,MIR-1911
GO:0002694,regulation of leukocyte activation,-2.3611,<2.2e-16,MIR-1911
GO:0001818,negative regulation of cytokine production,-2.3702,<2.2e-16,MIR-1911
GO:0032613,interleukin-10 production,-2.3747,<2.2e-16,MIR-1911
GO:0001819,positive regulation of cytokine production,-2.3798,<2.2e-16,MIR-1911
GO:0032623,interleukin-2 production,-2.4026,<2.2e-16,MIR-1911
GO:0002449,lymphocyte mediated immunity,-2.415,<2.2e-16,MIR-1911
GO:0002764,immune response-regulating signaling pathway,-2.4219,<2.2e-16,MIR-1911
GO:0002446,neutrophil mediated immunity,-2.4559,<2.2e-16,MIR-1911
GO:0032612,interleukin-1 production,-2.473,<2.2e-16,MIR-1911
GO:0002532,production of molecular mediator involved in inflammatory response,-2.4847,<2.2e-16,MIR-1911
GO:0036230,granulocyte activation,-2.5002,<2.2e-16,MIR-1911
GO:0007159,leukocyte cell-cell adhesion,-2.5346,<2.2e-16,MIR-1911
GO:0002250,adaptive immune response,-2.6303,<2.2e-16,MIR-1911
GO:0034341,response to interferon-gamma,-2.6338,<2.2e-16,MIR-1911
GO:0007159,leukocyte cell-cell adhesion,2.4103,<2.2e-16,MIR-2110
GO:0002764,immune response-regulating signaling pathway,2.2712,<2.2e-16,MIR-2110
GO:0002526,acute inflammatory response,2.245,<2.2e-16,MIR-2110
GO:0002250,adaptive immune response,2.2168,<2.2e-16,MIR-2110
GO:0032612,interleukin-1 production,2.2086,<2.2e-16,MIR-2110
GO:0006959,humoral immune response,2.1963,<2.2e-16,MIR-2110
GO:0032635,interleukin-6 production,2.192,<2.2e-16,MIR-2110
GO:0001819,positive regulation of cytokine production,2.1366,<2.2e-16,MIR-2110
GO:0002449,lymphocyte mediated immunity,2.1019,<2.2e-16,MIR-2110
GO:0002697,regulation of immune effector process,2.0881,<2.2e-16,MIR-2110
GO:0002521,leukocyte differentiation,2.0603,<2.2e-16,MIR-2110
GO:0034341,response to interferon-gamma,-2.026,0.0054301,MIR-1238
GO:0050663,cytokine secretion,-1.8951,0.035296,MIR-1238
GO:0002532,production of molecular mediator involved in inflammatory response,-1.9047,0.042234,MIR-1238
GO:0002526,acute inflammatory response,-1.7419,0.048509,MIR-1238
GO:0034612,response to tumor necrosis factor,-1.7702,0.049694,MIR-1238
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.7746,0.049957,MIR-1238
GO:0050727,regulation of inflammatory response,-1.8009,0.050228,MIR-1238
GO:0002269,leukocyte activation involved in inflammatory response,-1.8309,0.054301,MIR-1238
GO:0060759,regulation of response to cytokine stimulus,-1.7227,0.054527,MIR-1238
GO:0030101,natural killer cell activation,-1.7586,0.055206,MIR-1238
GO:0001819,positive regulation of cytokine production,-1.8017,0.055852,MIR-1238
GO:1990868,response to chemokine,-1.8023,0.063954,MIR-1238
GO:0032635,interleukin-6 production,-1.6803,0.065542,MIR-1238
GO:0032612,interleukin-1 production,-1.6532,0.070333,MIR-1238
GO:0050900,leukocyte migration,-1.6562,0.071496,MIR-1238
GO:0070661,leukocyte proliferation,-2.2379,<2.2e-16,MIR-1250
GO:0032637,interleukin-8 production,-2.2443,<2.2e-16,MIR-1250
GO:0032609,interferon-gamma production,-2.248,<2.2e-16,MIR-1250
GO:0050663,cytokine secretion,-2.2672,<2.2e-16,MIR-1250
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.323,<2.2e-16,MIR-1250
GO:0001819,positive regulation of cytokine production,-2.3354,<2.2e-16,MIR-1250
GO:0032635,interleukin-6 production,-2.3572,<2.2e-16,MIR-1250
GO:0002764,immune response-regulating signaling pathway,-2.4359,<2.2e-16,MIR-1250
GO:0034340,response to type I interferon,-2.4545,<2.2e-16,MIR-1250
GO:0002250,adaptive immune response,-2.4846,<2.2e-16,MIR-1250
GO:0034341,response to interferon-gamma,-2.5464,<2.2e-16,MIR-1250
GO:0002285,lymphocyte activation involved in immune response,-2.1178,0.00017344,MIR-1250
GO:0032623,interleukin-2 production,-2.136,0.00018211,MIR-1250
GO:0042110,T cell activation,-2.1486,0.00019170,MIR-1250
GO:0032633,interleukin-4 production,-2.1581,0.00020235,MIR-1250
GO:0045088,regulation of innate immune response,-2.1593,0.00021425,MIR-1250
GO:0050727,regulation of inflammatory response,-2.161,0.00022764,MIR-1250
GO:0002694,regulation of leukocyte activation,-1.9992,0.00038748,MIR-1250
GO:0002532,production of molecular mediator involved in inflammatory response,-2.0994,<2.2e-16,MIR-1226
GO:0032612,interleukin-1 production,-2.1184,<2.2e-16,MIR-1226
GO:0002683,negative regulation of immune system process,-2.1412,<2.2e-16,MIR-1226
GO:0032613,interleukin-10 production,-2.1566,<2.2e-16,MIR-1226
GO:0002526,acute inflammatory response,-2.1618,<2.2e-16,MIR-1226
GO:0002697,regulation of immune effector process,-2.1729,<2.2e-16,MIR-1226
GO:0032606,type I interferon production,-2.1747,<2.2e-16,MIR-1226
GO:0032615,interleukin-12 production,-2.1827,<2.2e-16,MIR-1226
GO:0032637,interleukin-8 production,-2.2411,<2.2e-16,MIR-1226
GO:0002694,regulation of leukocyte activation,-2.2545,<2.2e-16,MIR-1226
GO:0002269,leukocyte activation involved in inflammatory response,-2.2702,<2.2e-16,MIR-1226
GO:0032635,interleukin-6 production,-2.309,<2.2e-16,MIR-1226
GO:0002449,lymphocyte mediated immunity,-2.3836,<2.2e-16,MIR-1226
GO:0001819,positive regulation of cytokine production,-2.3949,<2.2e-16,MIR-1226
GO:0007159,leukocyte cell-cell adhesion,-2.436,<2.2e-16,MIR-1226
GO:0002764,immune response-regulating signaling pathway,-2.4092,<2.2e-16,MIR-1226
GO:0002250,adaptive immune response,-2.4226,<2.2e-16,MIR-1226
GO:0002285,lymphocyte activation involved in immune response,0.14504,0.95481,MIR-1179
GO:0032623,interleukin-2 production,2.429,<2.2e-16,MIR-1304
GO:0032612,interleukin-1 production,2.3463,<2.2e-16,MIR-1304
GO:0002250,adaptive immune response,2.3289,<2.2e-16,MIR-1304
GO:0007159,leukocyte cell-cell adhesion,2.323,<2.2e-16,MIR-1304
GO:0032609,interferon-gamma production,2.3207,<2.2e-16,MIR-1304
GO:0001819,positive regulation of cytokine production,2.2833,<2.2e-16,MIR-1304
GO:0050900,leukocyte migration,2.2311,<2.2e-16,MIR-1304
GO:0070661,leukocyte proliferation,2.1183,0.00021053,MIR-1304
GO:0070555,response to interleukin-1,2.1384,0.00023685,MIR-1304
GO:0070671,response to interleukin-12,2.1533,0.00025264,MIR-1304
GO:0002764,immune response-regulating signaling pathway,2.1558,0.00027068,MIR-1304
GO:0071887,leukocyte apoptotic process,2.1722,0.00029150,MIR-1304
GO:0050663,cytokine secretion,2.1842,0.00031580,MIR-1304
GO:0042110,T cell activation,2.0777,0.00068901,MIR-1304
GO:0002521,leukocyte differentiation,2.0826,0.00072182,MIR-1304
GO:0032609,interferon-gamma production,-2.0681,<2.2e-16,MIR-1236
GO:0032637,interleukin-8 production,-2.0805,<2.2e-16,MIR-1236
GO:0070661,leukocyte proliferation,-2.0868,<2.2e-16,MIR-1236
GO:0007159,leukocyte cell-cell adhesion,-2.1059,<2.2e-16,MIR-1236
GO:0050900,leukocyte migration,-2.1531,<2.2e-16,MIR-1236
GO:0032635,interleukin-6 production,-2.1641,<2.2e-16,MIR-1236
GO:1990868,response to chemokine,-2.1691,<2.2e-16,MIR-1236
GO:0034341,response to interferon-gamma,-2.3939,<2.2e-16,MIR-1236
GO:0001819,positive regulation of cytokine production,-1.9903,0.00018458,MIR-1236
GO:0050727,regulation of inflammatory response,-2.006,0.00020919,MIR-1236
GO:0042116,macrophage activation,-2.0115,0.00022413,MIR-1236
GO:0002764,immune response-regulating signaling pathway,-1.9717,0.00082575,MIR-1236
GO:0032620,interleukin-17 production,-1.9515,0.00085578,MIR-1236
GO:0002526,acute inflammatory response,-1.9732,0.00087162,MIR-1236
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.9365,0.00095500,MIR-1236
GO:0032635,interleukin-6 production,-1.9366,0.0060182,MIR-1301
GO:1990868,response to chemokine,-1.8345,0.022067,MIR-1301
GO:0042116,macrophage activation,-1.7604,0.037614,MIR-1301
GO:0002532,production of molecular mediator involved in inflammatory response,-1.7712,0.038173,MIR-1301
GO:0032637,interleukin-8 production,-1.7662,0.038838,MIR-1301
GO:0002269,leukocyte activation involved in inflammatory response,-1.712,0.039094,MIR-1301
GO:0002764,immune response-regulating signaling pathway,-2.1193,<2.2e-16,MIR-1197
GO:0032606,type I interferon production,-2.242,<2.2e-16,MIR-1197
GO:0045088,regulation of innate immune response,-2.2446,<2.2e-16,MIR-1197
GO:0032609,interferon-gamma production,-2.2559,<2.2e-16,MIR-1197
GO:0035456,response to interferon-beta,-2.2679,<2.2e-16,MIR-1197
GO:0002449,lymphocyte mediated immunity,-2.2831,<2.2e-16,MIR-1197
GO:0002250,adaptive immune response,-2.3665,<2.2e-16,MIR-1197
GO:0034341,response to interferon-gamma,-2.4941,<2.2e-16,MIR-1197
GO:0034340,response to type I interferon,-2.7122,<2.2e-16,MIR-1197
GO:0032633,interleukin-4 production,-2.013,0.00016903,MIR-1197
GO:0019882,antigen processing and presentation,-2.0185,0.00017607,MIR-1197
GO:0032635,interleukin-6 production,-2.0311,0.00018373,MIR-1197
GO:0032615,interleukin-12 production,-2.0472,0.00020122,MIR-1197
GO:0001819,positive regulation of cytokine production,-2.0546,0.00023476,MIR-1197
GO:0002521,leukocyte differentiation,-2.0454,<2.2e-16,MIR-1264
GO:0030101,natural killer cell activation,-2.0527,<2.2e-16,MIR-1264
GO:0001818,negative regulation of cytokine production,-2.0936,<2.2e-16,MIR-1264
GO:0002437,inflammatory response to antigenic stimulus,-2.1172,<2.2e-16,MIR-1264
GO:0002683,negative regulation of immune system process,-2.1243,<2.2e-16,MIR-1264
GO:0002269,leukocyte activation involved in inflammatory response,-2.1348,<2.2e-16,MIR-1264
GO:0019882,antigen processing and presentation,-2.1502,<2.2e-16,MIR-1264
GO:0002285,lymphocyte activation involved in immune response,-2.1704,<2.2e-16,MIR-1264
GO:0002446,neutrophil mediated immunity,-2.2326,<2.2e-16,MIR-1264
GO:0002526,acute inflammatory response,-2.2472,<2.2e-16,MIR-1264
GO:0002697,regulation of immune effector process,-2.2688,<2.2e-16,MIR-1264
GO:0001819,positive regulation of cytokine production,-2.2895,<2.2e-16,MIR-1264
GO:0002694,regulation of leukocyte activation,-2.344,<2.2e-16,MIR-1264
GO:0002449,lymphocyte mediated immunity,-2.4715,<2.2e-16,MIR-1264
GO:0002764,immune response-regulating signaling pathway,-2.348,<2.2e-16,MIR-1264
GO:0002250,adaptive immune response,-2.4969,<2.2e-16,MIR-1264
GO:0033028,myeloid cell apoptotic process,3.6323,0.5555,MIR-1282
GO:0070670,response to interleukin-4,3.5687,0.62569,MIR-1282
GO:0042092,type 2 immune response,3.6603,0.9109,MIR-1282
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1.2892,0.50876,MIR-1323
GO:0001773,myeloid dendritic cell activation,-2.1631,<2.2e-16,MIR-1180
GO:0030101,natural killer cell activation,-2.2011,<2.2e-16,MIR-1180
GO:0002269,leukocyte activation involved in inflammatory response,-2.2233,<2.2e-16,MIR-1180
GO:0002683,negative regulation of immune system process,-2.263,<2.2e-16,MIR-1180
GO:0019882,antigen processing and presentation,-2.2803,<2.2e-16,MIR-1180
GO:0002521,leukocyte differentiation,-2.2954,<2.2e-16,MIR-1180
GO:0002526,acute inflammatory response,-2.3004,<2.2e-16,MIR-1180
GO:0006959,humoral immune response,-2.3227,<2.2e-16,MIR-1180
GO:0002697,regulation of immune effector process,-2.3568,<2.2e-16,MIR-1180
GO:0001818,negative regulation of cytokine production,-2.3617,<2.2e-16,MIR-1180
GO:0002285,lymphocyte activation involved in immune response,-2.4024,<2.2e-16,MIR-1180
GO:0001819,positive regulation of cytokine production,-2.4446,<2.2e-16,MIR-1180
GO:0002449,lymphocyte mediated immunity,-2.6074,<2.2e-16,MIR-1180
GO:0002764,immune response-regulating signaling pathway,-2.8252,<2.2e-16,MIR-1180
GO:0002250,adaptive immune response,1.9472,0.06849,MIR-1539
GO:0034340,response to type I interferon,1.7427,0.19246,MIR-1539
GO:0042113,B cell activation,1.7233,0.19794,MIR-1539
GO:0002200,somatic diversification of immune receptors,1.6847,0.22127,MIR-1539
GO:0042110,T cell activation,1.5378,0.2329,MIR-1539
GO:0002437,inflammatory response to antigenic stimulus,1.5188,0.23396,MIR-1539
GO:0002449,lymphocyte mediated immunity,1.5824,0.23432,MIR-1539
GO:0045088,regulation of innate immune response,1.4789,0.23492,MIR-1539
GO:0032634,interleukin-5 production,1.9326,0.52324,MIR-1469
GO:0032616,interleukin-13 production,1.8754,0.57835,MIR-1469
GO:0048536,spleen development,-2.7181,0.69466,MIR-1469
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-2.7565,0.69974,MIR-1469
GO:0002526,acute inflammatory response,1.3643,0.761,MIR-1469
GO:0043276,anoikis,-1.1949,0.76204,MIR-1469
GO:0006959,humoral immune response,1.3645,0.76761,MIR-1469
GO:0001773,myeloid dendritic cell activation,-2.1366,<2.2e-16,MIR-1910
GO:0002269,leukocyte activation involved in inflammatory response,-2.1532,<2.2e-16,MIR-1910
GO:0002448,mast cell mediated immunity,-2.1537,<2.2e-16,MIR-1910
GO:0006959,humoral immune response,-2.1742,<2.2e-16,MIR-1910
GO:0002532,production of molecular mediator involved in inflammatory response,-2.1964,<2.2e-16,MIR-1910
GO:0002446,neutrophil mediated immunity,-2.2559,<2.2e-16,MIR-1910
GO:0002683,negative regulation of immune system process,-2.2609,<2.2e-16,MIR-1910
GO:0002285,lymphocyte activation involved in immune response,-2.281,<2.2e-16,MIR-1910
GO:0001818,negative regulation of cytokine production,-2.3051,<2.2e-16,MIR-1910
GO:0002521,leukocyte differentiation,-2.3282,<2.2e-16,MIR-1910
GO:0002526,acute inflammatory response,-2.4226,<2.2e-16,MIR-1910
GO:0002449,lymphocyte mediated immunity,-2.4276,<2.2e-16,MIR-1910
GO:0002697,regulation of immune effector process,-2.462,<2.2e-16,MIR-1910
GO:0002694,regulation of leukocyte activation,-2.5748,<2.2e-16,MIR-1910
GO:0002250,adaptive immune response,-2.6622,<2.2e-16,MIR-1910
GO:0002764,immune response-regulating signaling pathway,-2.7707,<2.2e-16,MIR-1910
GO:0035455,response to interferon-alpha,-1.636,0.076455,MIR-1908
GO:0035456,response to interferon-beta,-1.3887,0.26844,MIR-1908
GO:0032620,interleukin-17 production,-1.3611,0.27354,MIR-1908
GO:0034340,response to type I interferon,-1.3709,0.27639,MIR-1908
GO:0002448,mast cell mediated immunity,-1.531,0.29716,MIR-1283-1
GO:0006959,humoral immune response,-1.5362,0.30652,MIR-1283-1
GO:0035924,cellular response to vascular endothelial growth factor stimulus,-1.5362,0.32985,MIR-1283-1
GO:0071706,tumor necrosis factor superfamily cytokine production,-1.506,0.33638,MIR-1283-1
GO:0042116,macrophage activation,-1.5863,0.35815,MIR-1283-1
GO:0045576,mast cell activation,-1.4423,0.41887,MIR-1283-1
GO:0048536,spleen development,1.2039,0.75243,MIR-1283-1
GO:0032606,type I interferon production,1.2649,0.50481,MIR-1305
GO:0043276,anoikis,-1.2959,0.80928,MIR-548L
GO:0002694,regulation of leukocyte activation,1.0447,0.96774,MIR-548L
GO:0002440,production of molecular mediator of immune response,1.0597,0.97594,MIR-548L
GO:0001819,positive regulation of cytokine production,1.0726,0.98321,MIR-548L
GO:0006959,humoral immune response,2.2703,0.99339,MIR-548L
GO:0150076,neuroinflammatory response,-2.1093,0.00076389,MIR-1290
GO:0019882,antigen processing and presentation,-2.1167,0.00095487,MIR-1290
GO:0002446,neutrophil mediated immunity,-2.0533,0.0011458,MIR-1290
GO:0036230,granulocyte activation,-2.1001,0.0012732,MIR-1290
GO:0002269,leukocyte activation involved in inflammatory response,-2.0584,0.0014323,MIR-1290
GO:0002764,immune response-regulating signaling pathway,-2.1299,0.0019097,MIR-1290
GO:0032635,interleukin-6 production,-2.0088,0.0020833,MIR-1290
GO:0007159,leukocyte cell-cell adhesion,-1.9832,0.0032319,MIR-1290
GO:0042110,T cell activation,-1.9787,0.0033102,MIR-1290
GO:0050727,regulation of inflammatory response,-1.9498,0.0044561,MIR-1290
GO:0034341,response to interferon-gamma,-1.9553,0.0045356,MIR-1290
GO:0002521,leukocyte differentiation,-1.94,0.0046236,MIR-1290
GO:0001819,positive regulation of cytokine production,-1.931,0.0046875,MIR-1290
GO:0050900,leukocyte migration,-2.2206,<2.2e-16,MIR-1262
GO:0002521,leukocyte differentiation,-2.2215,<2.2e-16,MIR-1262
GO:0007159,leukocyte cell-cell adhesion,-2.2235,<2.2e-16,MIR-1262
GO:0071706,tumor necrosis factor superfamily cytokine production,-2.2313,<2.2e-16,MIR-1262
GO:1990868,response to chemokine,-2.2431,<2.2e-16,MIR-1262
GO:0042110,T cell activation,-2.2834,<2.2e-16,MIR-1262
GO:0032609,interferon-gamma production,-2.2899,<2.2e-16,MIR-1262
GO:0002250,adaptive immune response,-2.3328,<2.2e-16,MIR-1262
GO:0002449,lymphocyte mediated immunity,-2.337,<2.2e-16,MIR-1262
GO:0036230,granulocyte activation,-2.0642,0.00014066,MIR-1262
GO:0019882,antigen processing and presentation,-2.0778,0.00014770,MIR-1262
GO:0002694,regulation of leukocyte activation,-2.0986,0.00015547,MIR-1262
GO:0034341,response to interferon-gamma,-2.1181,0.00016411,MIR-1262
GO:0002764,immune response-regulating signaling pathway,-2.1229,0.00017376,MIR-1262
GO:0032615,interleukin-12 production,-2.1286,0.00018462,MIR-1262
GO:0032613,interleukin-10 production,-2.1385,0.00019693,MIR-1262
GO:0032637,interleukin-8 production,-2.1472,0.00021100,MIR-1262
GO:0002697,regulation of immune effector process,-2.0441,0.00038530,MIR-1262
GO:0045576,mast cell activation,-1.3275,0.77735,MIR-1237
GO:0010573,vascular endothelial growth factor production,-1.2487,0.93496,MIR-1237
GO:0032623,interleukin-2 production,-1.2522,0.96656,MIR-1237
GO:0002683,negative regulation of immune system process,-1.163,1.0,MIR-1237
GO:0034341,response to interferon-gamma,-2.0849,<2.2e-16,MIR-1227
GO:0007159,leukocyte cell-cell adhesion,-1.9216,0.011528,MIR-1227
GO:0070661,leukocyte proliferation,-1.877,0.011955,MIR-1227
GO:0002526,acute inflammatory response,-1.8878,0.012077,MIR-1227
GO:0002251,organ or tissue specific immune response,-1.8563,0.016907,MIR-1227
GO:0001819,positive regulation of cytokine production,-1.7596,0.026706,MIR-1227
GO:0032602,chemokine production,-1.7643,0.027505,MIR-1227
GO:0002269,leukocyte activation involved in inflammatory response,-1.7677,0.027752,MIR-1227
GO:1990868,response to chemokine,-1.7515,0.027813,MIR-1227
GO:0032620,interleukin-17 production,-1.7918,0.028545,MIR-1227
GO:0032637,interleukin-8 production,-1.7685,0.028706,MIR-1227
GO:0050900,leukocyte migration,-1.7853,0.029972,MIR-1227
GO:0042092,type 2 immune response,-1.7167,0.031594,MIR-1227
GO:0070741,response to interleukin-6,-1.6584,0.51083,MIR-1303
GO:0002251,organ or tissue specific immune response,-1.704,0.6264,MIR-1303
GO:0034341,response to interferon-gamma,-1.6185,0.63746,MIR-1303
GO:0035456,response to interferon-beta,-1.2834,0.65719,MIR-1303
GO:0035455,response to interferon-alpha,-1.4963,0.66415,MIR-1303
GO:0050900,leukocyte migration,-1.2839,0.66586,MIR-1303
GO:0030101,natural killer cell activation,-1.3403,0.6831,MIR-1303
GO:0050663,cytokine secretion,-1.4767,0.44294,MIR-1267
GO:0006925,inflammatory cell apoptotic process,-1.4404,0.49934,MIR-1267
GO:0002440,production of molecular mediator of immune response,-1.4412,0.51386,MIR-1267
GO:0002448,mast cell mediated immunity,0.18379,0.99687,MIR-1267
GO:0035455,response to interferon-alpha,0.25406,0.99761,MIR-1267
GO:0002244,hematopoietic progenitor cell differentiation,1.2256,1.0,MIR-1267
GO:0034341,response to interferon-gamma,1.1939,1.0,MIR-1267
GO:0001773,myeloid dendritic cell activation,-2.0808,<2.2e-16,MIR-1251
GO:0002440,production of molecular mediator of immune response,-2.1042,<2.2e-16,MIR-1251
GO:0002269,leukocyte activation involved in inflammatory response,-2.1447,<2.2e-16,MIR-1251
GO:0006959,humoral immune response,-2.1894,<2.2e-16,MIR-1251
GO:0002507,tolerance induction,-2.2163,<2.2e-16,MIR-1251
GO:0002285,lymphocyte activation involved in immune response,-2.2975,<2.2e-16,MIR-1251
GO:0002521,leukocyte differentiation,-2.3315,<2.2e-16,MIR-1251
GO:0001818,negative regulation of cytokine production,-2.3476,<2.2e-16,MIR-1251
GO:0002697,regulation of immune effector process,-2.3629,<2.2e-16,MIR-1251
GO:0002683,negative regulation of immune system process,-2.3668,<2.2e-16,MIR-1251
GO:0002532,production of molecular mediator involved in inflammatory response,-2.4167,<2.2e-16,MIR-1251
GO:0002694,regulation of leukocyte activation,-2.4699,<2.2e-16,MIR-1251
GO:0002446,neutrophil mediated immunity,-2.4932,<2.2e-16,MIR-1251
GO:0002449,lymphocyte mediated immunity,-2.5285,<2.2e-16,MIR-1251
GO:0002764,immune response-regulating signaling pathway,-2.5894,<2.2e-16,MIR-1251
GO:0002250,adaptive immune response,-2.6641,<2.2e-16,MIR-1251
GO:0034340,response to type I interferon,2.3128,<2.2e-16,MIR-320B-2
GO:0032606,type I interferon production,2.1685,0.00085427,MIR-320B-2
GO:0034341,response to interferon-gamma,1.97,0.0026849,MIR-320B-2
GO:0035455,response to interferon-alpha,1.9507,0.0029900,MIR-320B-2
GO:0002200,somatic diversification of immune receptors,1.8051,0.017313,MIR-320B-2
GO:0060759,regulation of response to cytokine stimulus,1.8084,0.017940,MIR-320B-2
GO:0070741,response to interleukin-6,1.7358,0.025365,MIR-320B-2
GO:0050663,cytokine secretion,-1.032,0.92493,MIR-548K
GO:0006925,inflammatory cell apoptotic process,1.3239,1.0,MIR-548K
GO:0002446,neutrophil mediated immunity,-2.095,<2.2e-16,MIR-513B
GO:0002764,immune response-regulating signaling pathway,-2.1177,<2.2e-16,MIR-513B
GO:0032615,interleukin-12 production,-2.1194,<2.2e-16,MIR-513B
GO:0002440,production of molecular mediator of immune response,-2.1206,<2.2e-16,MIR-513B
GO:0032609,interferon-gamma production,-2.1293,<2.2e-16,MIR-513B
GO:0002521,leukocyte differentiation,-2.1389,<2.2e-16,MIR-513B
GO:0002694,regulation of leukocyte activation,-2.1706,<2.2e-16,MIR-513B
GO:0036230,granulocyte activation,-2.1844,<2.2e-16,MIR-513B
GO:0071887,leukocyte apoptotic process,-2.2017,<2.2e-16,MIR-513B
GO:0002449,lymphocyte mediated immunity,-2.2345,<2.2e-16,MIR-513B
GO:0042113,B cell activation,-2.2404,<2.2e-16,MIR-513B
GO:1990868,response to chemokine,-2.2556,<2.2e-16,MIR-513B
GO:0007159,leukocyte cell-cell adhesion,-2.2939,<2.2e-16,MIR-513B
GO:0050900,leukocyte migration,-2.3104,<2.2e-16,MIR-513B
GO:0042110,T cell activation,-2.3676,<2.2e-16,MIR-513B
GO:0002250,adaptive immune response,-2.4922,<2.2e-16,MIR-513B
GO:0034341,response to interferon-gamma,2.4891,<2.2e-16,MIR-663B
GO:0032602,chemokine production,2.3701,<2.2e-16,MIR-663B
GO:0007159,leukocyte cell-cell adhesion,2.3461,<2.2e-16,MIR-663B
GO:0019882,antigen processing and presentation,2.3005,<2.2e-16,MIR-663B
GO:0032609,interferon-gamma production,2.263,<2.2e-16,MIR-663B
GO:0032637,interleukin-8 production,2.2594,<2.2e-16,MIR-663B
GO:0042110,T cell activation,2.2579,<2.2e-16,MIR-663B
GO:0002250,adaptive immune response,2.2313,<2.2e-16,MIR-663B
GO:0036230,granulocyte activation,2.2197,<2.2e-16,MIR-663B
GO:0001819,positive regulation of cytokine production,2.2123,<2.2e-16,MIR-663B
GO:0002446,neutrophil mediated immunity,2.1619,<2.2e-16,MIR-663B
GO:0002764,immune response-regulating signaling pathway,2.1579,<2.2e-16,MIR-663B
GO:0034340,response to type I interferon,2.1282,<2.2e-16,MIR-663B
GO:0002697,regulation of immune effector process,2.1222,<2.2e-16,MIR-663B
GO:0002440,production of molecular mediator of immune response,2.1093,<2.2e-16,MIR-663B
GO:0032635,interleukin-6 production,2.1054,<2.2e-16,MIR-663B
GO:0002449,lymphocyte mediated immunity,2.0919,<2.2e-16,MIR-663B
GO:0002521,leukocyte differentiation,2.0505,<2.2e-16,MIR-663B
GO:0002250,adaptive immune response,2.6075,<2.2e-16,MIR-548O
GO:0002449,lymphocyte mediated immunity,2.5126,<2.2e-16,MIR-548O
GO:0002764,immune response-regulating signaling pathway,2.4798,<2.2e-16,MIR-548O
GO:0007159,leukocyte cell-cell adhesion,2.4738,<2.2e-16,MIR-548O
GO:0002526,acute inflammatory response,2.4573,<2.2e-16,MIR-548O
GO:0002446,neutrophil mediated immunity,2.4527,<2.2e-16,MIR-548O
GO:0001819,positive regulation of cytokine production,2.4414,<2.2e-16,MIR-548O
GO:0002697,regulation of immune effector process,2.4271,<2.2e-16,MIR-548O
GO:0002694,regulation of leukocyte activation,2.4232,<2.2e-16,MIR-548O
GO:0002285,lymphocyte activation involved in immune response,2.4035,<2.2e-16,MIR-548O
GO:0002521,leukocyte differentiation,2.3279,<2.2e-16,MIR-548O
GO:0001818,negative regulation of cytokine production,2.2962,<2.2e-16,MIR-548O
GO:0002683,negative regulation of immune system process,2.2737,<2.2e-16,MIR-548O
GO:0002440,production of molecular mediator of immune response,2.2649,<2.2e-16,MIR-548O
GO:0002532,production of molecular mediator involved in inflammatory response,2.2595,<2.2e-16,MIR-548O
GO:0006959,humoral immune response,2.2371,<2.2e-16,MIR-548O
GO:0002448,mast cell mediated immunity,2.0683,<2.2e-16,MIR-548O
GO:0001773,myeloid dendritic cell activation,1.9811,<2.2e-16,MIR-548O
GO:0036230,granulocyte activation,-2.0866,0.00037414,MIR-320D-1
GO:0002446,neutrophil mediated immunity,-2.117,0.00074828,MIR-320D-1
GO:0019882,antigen processing and presentation,-1.801,0.0067345,MIR-320D-1
GO:0035455,response to interferon-alpha,1.7463,0.065013,MIR-320D-1
GO:0032606,type I interferon production,1.4558,0.26122,MIR-320D-1
GO:0002250,adaptive immune response,2.8201,<2.2e-16,MIR-548J
GO:0002449,lymphocyte mediated immunity,2.6824,<2.2e-16,MIR-548J
GO:0007159,leukocyte cell-cell adhesion,2.6066,<2.2e-16,MIR-548J
GO:0042110,T cell activation,2.4546,<2.2e-16,MIR-548J
GO:0032609,interferon-gamma production,2.4327,<2.2e-16,MIR-548J
GO:0002764,immune response-regulating signaling pathway,2.4206,<2.2e-16,MIR-548J
GO:0002697,regulation of immune effector process,2.4104,<2.2e-16,MIR-548J
GO:0032615,interleukin-12 production,2.4006,<2.2e-16,MIR-548J
GO:0045088,regulation of innate immune response,2.4003,<2.2e-16,MIR-548J
GO:0034341,response to interferon-gamma,2.3864,<2.2e-16,MIR-548J
GO:0002526,acute inflammatory response,2.3775,<2.2e-16,MIR-548J
GO:0036230,granulocyte activation,2.3457,<2.2e-16,MIR-548J
GO:0034612,response to tumor necrosis factor,2.342,<2.2e-16,MIR-548J
GO:0002446,neutrophil mediated immunity,2.3338,<2.2e-16,MIR-548J
GO:0042092,type 2 immune response,2.3195,<2.2e-16,MIR-548J
GO:0002694,regulation of leukocyte activation,2.2965,<2.2e-16,MIR-548J
GO:0001819,positive regulation of cytokine production,2.2853,<2.2e-16,MIR-548J
GO:0002448,mast cell mediated immunity,5.0105,0.36381,MIR-548E
GO:0150076,neuroinflammatory response,5.0439,0.38247,MIR-548E
GO:0002200,somatic diversification of immune receptors,5.0715,0.41254,MIR-548E
GO:0002269,leukocyte activation involved in inflammatory response,5.0844,0.52092,MIR-548E
GO:0032620,interleukin-17 production,4.5946,0.77224,MIR-548E
GO:0045576,mast cell activation,4.4866,0.7879,MIR-548E
GO:0032637,interleukin-8 production,0.67456,0.80443,MIR-548E
GO:0002269,leukocyte activation involved in inflammatory response,-2.027,<2.2e-16,MIR-181A-2
GO:0002507,tolerance induction,-2.0294,<2.2e-16,MIR-181A-2
GO:0001818,negative regulation of cytokine production,-2.1729,<2.2e-16,MIR-181A-2
GO:0002440,production of molecular mediator of immune response,-2.2172,<2.2e-16,MIR-181A-2
GO:0002285,lymphocyte activation involved in immune response,-2.2648,<2.2e-16,MIR-181A-2
GO:0002521,leukocyte differentiation,-2.2685,<2.2e-16,MIR-181A-2
GO:0002683,negative regulation of immune system process,-2.2791,<2.2e-16,MIR-181A-2
GO:0001773,myeloid dendritic cell activation,-2.3025,<2.2e-16,MIR-181A-2
GO:0002532,production of molecular mediator involved in inflammatory response,-2.3668,<2.2e-16,MIR-181A-2
GO:0002694,regulation of leukocyte activation,-2.4463,<2.2e-16,MIR-181A-2
GO:0002526,acute inflammatory response,-2.4975,<2.2e-16,MIR-181A-2
GO:0002446,neutrophil mediated immunity,-2.509,<2.2e-16,MIR-181A-2
GO:0006959,humoral immune response,-2.5139,<2.2e-16,MIR-181A-2
GO:0002449,lymphocyte mediated immunity,-2.5906,<2.2e-16,MIR-181A-2
GO:0002764,immune response-regulating signaling pathway,-2.5266,<2.2e-16,MIR-181A-2
GO:0002250,adaptive immune response,-2.7442,<2.2e-16,MIR-181A-2
GO:0098760,response to interleukin-7,-1.4828,0.10976,MIR-210
GO:0035456,response to interferon-beta,1.6045,0.15978,MIR-497
GO:1990868,response to chemokine,-2.1084,<2.2e-16,MIR-202
GO:0019882,antigen processing and presentation,-2.1287,<2.2e-16,MIR-202
GO:0002285,lymphocyte activation involved in immune response,-2.1331,<2.2e-16,MIR-202
GO:0002250,adaptive immune response,-2.1583,<2.2e-16,MIR-202
GO:0050900,leukocyte migration,-2.1607,<2.2e-16,MIR-202
GO:0007159,leukocyte cell-cell adhesion,-2.2282,<2.2e-16,MIR-202
GO:0042110,T cell activation,-2.2385,<2.2e-16,MIR-202
GO:0071887,leukocyte apoptotic process,-1.9963,0.00020296,MIR-202
GO:0042092,type 2 immune response,-1.956,0.00026474,MIR-202
GO:0002521,leukocyte differentiation,-1.957,0.00027677,MIR-202
GO:0042113,B cell activation,-1.9609,0.00028995,MIR-202
GO:0002694,regulation of leukocyte activation,-1.9831,0.00032047,MIR-202
GO:0036230,granulocyte activation,-1.9891,0.00035817,MIR-202
GO:0035455,response to interferon-alpha,1.7637,0.17957,MIR-202
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1.7691,<2.2e-16,MIR-133A-1
GO:0001525,angiogenesis,1.7637,<2.2e-16,MIR-133A-1
GO:0050900,leukocyte migration,1.736,0.00048386,MIR-133A-1
GO:0035456,response to interferon-beta,1.9782,0.0046367,MIR-30D
GO:0034340,response to type I interferon,1.9174,0.0076505,MIR-30D
GO:0035455,response to interferon-alpha,1.7158,0.056747,MIR-30D
GO:0034341,response to interferon-gamma,1.5405,0.14469,MIR-30D
GO:0032615,interleukin-12 production,1.9295,<2.2e-16,MIR-217
GO:0050900,leukocyte migration,1.8924,<2.2e-16,MIR-217
GO:0001525,angiogenesis,1.8828,<2.2e-16,MIR-217
GO:0002250,adaptive immune response,1.8724,<2.2e-16,MIR-217
GO:1990868,response to chemokine,1.8654,<2.2e-16,MIR-217
GO:0032609,interferon-gamma production,1.838,<2.2e-16,MIR-217
GO:0007159,leukocyte cell-cell adhesion,2.4271,<2.2e-16,MIR-222
GO:0002250,adaptive immune response,2.398,<2.2e-16,MIR-222
GO:0002764,immune response-regulating signaling pathway,2.3182,<2.2e-16,MIR-222
GO:0002694,regulation of leukocyte activation,2.273,<2.2e-16,MIR-222
GO:0002449,lymphocyte mediated immunity,2.2633,<2.2e-16,MIR-222
GO:0002697,regulation of immune effector process,2.2471,<2.2e-16,MIR-222
GO:0002285,lymphocyte activation involved in immune response,2.2206,<2.2e-16,MIR-222
GO:0001819,positive regulation of cytokine production,2.2187,<2.2e-16,MIR-222
GO:0002521,leukocyte differentiation,2.2186,<2.2e-16,MIR-222
GO:0002532,production of molecular mediator involved in inflammatory response,2.1744,<2.2e-16,MIR-222
GO:0006959,humoral immune response,2.1722,<2.2e-16,MIR-222
GO:0001818,negative regulation of cytokine production,2.1543,<2.2e-16,MIR-222
GO:0002683,negative regulation of immune system process,2.1539,<2.2e-16,MIR-222
GO:0002526,acute inflammatory response,2.1096,<2.2e-16,MIR-222
GO:0002446,neutrophil mediated immunity,2.0952,<2.2e-16,MIR-222
GO:0001525,angiogenesis,2.0301,<2.2e-16,MIR-222
GO:0001525,angiogenesis,-2.0224,0.00054432,MIR-194-2
GO:0034340,response to type I interferon,1.7257,0.043402,MIR-194-2
GO:0070670,response to interleukin-4,1.5813,0.11427,MIR-194-2
GO:0032606,type I interferon production,1.4768,0.12447,MIR-194-2
GO:0001525,angiogenesis,-2.0606,<2.2e-16,MIR-200C
GO:0034340,response to type I interferon,1.8902,0.015541,MIR-200C
GO:0032606,type I interferon production,1.6381,0.11494,MIR-200C
GO:0007159,leukocyte cell-cell adhesion,2.2629,<2.2e-16,MIR-34A
GO:0034341,response to interferon-gamma,2.2286,<2.2e-16,MIR-34A
GO:0002250,adaptive immune response,2.2048,<2.2e-16,MIR-34A
GO:0002449,lymphocyte mediated immunity,2.1308,<2.2e-16,MIR-34A
GO:0032637,interleukin-8 production,2.1284,<2.2e-16,MIR-34A
GO:0001819,positive regulation of cytokine production,2.1265,<2.2e-16,MIR-34A
GO:0002697,regulation of immune effector process,2.1038,<2.2e-16,MIR-34A
GO:0002694,regulation of leukocyte activation,2.1001,<2.2e-16,MIR-34A
GO:0032609,interferon-gamma production,2.0996,<2.2e-16,MIR-34A
GO:0002526,acute inflammatory response,2.0828,<2.2e-16,MIR-34A
GO:0002764,immune response-regulating signaling pathway,2.0696,<2.2e-16,MIR-34A
GO:0002269,leukocyte activation involved in inflammatory response,2.0645,<2.2e-16,MIR-34A
GO:0032635,interleukin-6 production,2.0579,<2.2e-16,MIR-34A
GO:0002285,lymphocyte activation involved in immune response,2.0545,<2.2e-16,MIR-34A
GO:0001525,angiogenesis,2.006,<2.2e-16,MIR-34A
GO:0002521,leukocyte differentiation,2.029,<2.2e-16,MIR-34A
GO:0002200,somatic diversification of immune receptors,-1.1344,0.82228,MIR-302C
GO:0008356,asymmetric cell division,-1.1676,0.84111,MIR-302C
GO:0070671,response to interleukin-12,-1.1744,0.84841,MIR-302C
GO:0002269,leukocyte activation involved in inflammatory response,0.20624,0.99833,MIR-302C
GO:0030101,natural killer cell activation,1.3756,1.0,MIR-302C
GO:0002285,lymphocyte activation involved in immune response,1.3184,1.0,MIR-302C
GO:0070661,leukocyte proliferation,1.2838,1.0,MIR-302C
GO:0034340,response to type I interferon,-2.0647,0.0012662,MIR-122
GO:0035456,response to interferon-beta,-1.9978,0.0026860,MIR-122
GO:0034341,response to interferon-gamma,-1.8413,0.025061,MIR-122
GO:0007159,leukocyte cell-cell adhesion,1.8336,<2.2e-16,MIR-223
GO:0002250,adaptive immune response,1.8219,<2.2e-16,MIR-223
GO:0002449,lymphocyte mediated immunity,1.808,<2.2e-16,MIR-223
GO:0002269,leukocyte activation involved in inflammatory response,1.8034,<2.2e-16,MIR-223
GO:0002764,immune response-regulating signaling pathway,1.7885,<2.2e-16,MIR-223
GO:0002694,regulation of leukocyte activation,1.7774,<2.2e-16,MIR-223
GO:0006959,humoral immune response,1.7763,<2.2e-16,MIR-223
GO:0002526,acute inflammatory response,1.7752,<2.2e-16,MIR-223
GO:0001773,myeloid dendritic cell activation,1.7733,<2.2e-16,MIR-223
GO:0002285,lymphocyte activation involved in immune response,1.7696,<2.2e-16,MIR-223
GO:0001819,positive regulation of cytokine production,1.7641,<2.2e-16,MIR-223
GO:0002507,tolerance induction,1.7571,<2.2e-16,MIR-223
GO:0002532,production of molecular mediator involved in inflammatory response,1.7528,<2.2e-16,MIR-223
GO:0002446,neutrophil mediated immunity,1.7522,<2.2e-16,MIR-223
GO:0002250,adaptive immune response,2.2518,<2.2e-16,LET-7I
GO:0007159,leukocyte cell-cell adhesion,2.1765,<2.2e-16,LET-7I
GO:0002449,lymphocyte mediated immunity,2.1677,<2.2e-16,LET-7I
GO:0002764,immune response-regulating signaling pathway,2.1326,<2.2e-16,LET-7I
GO:0001819,positive regulation of cytokine production,2.1324,<2.2e-16,LET-7I
GO:0002697,regulation of immune effector process,2.1317,<2.2e-16,LET-7I
GO:0002694,regulation of leukocyte activation,2.1279,<2.2e-16,LET-7I
GO:0002285,lymphocyte activation involved in immune response,2.1101,<2.2e-16,LET-7I
GO:0002683,negative regulation of immune system process,2.068,<2.2e-16,LET-7I
GO:0002532,production of molecular mediator involved in inflammatory response,2.0375,<2.2e-16,LET-7I
GO:0001818,negative regulation of cytokine production,2.0362,<2.2e-16,LET-7I
GO:0002440,production of molecular mediator of immune response,2.0293,<2.2e-16,LET-7I
GO:0002521,leukocyte differentiation,2.0009,<2.2e-16,LET-7I
GO:0006959,humoral immune response,1.9821,<2.2e-16,LET-7I
GO:0002446,neutrophil mediated immunity,1.9705,<2.2e-16,LET-7I
GO:0002448,mast cell mediated immunity,1.9559,<2.2e-16,LET-7I
GO:0002269,leukocyte activation involved in inflammatory response,1.9395,<2.2e-16,LET-7I
GO:0001773,myeloid dendritic cell activation,1.9182,<2.2e-16,LET-7I
GO:0032637,interleukin-8 production,-2.1238,<2.2e-16,MIR-130A
GO:0050900,leukocyte migration,-2.1572,<2.2e-16,MIR-130A
GO:0002526,acute inflammatory response,-2.1671,<2.2e-16,MIR-130A
GO:0002446,neutrophil mediated immunity,-2.6428,<2.2e-16,MIR-130A
GO:0036230,granulocyte activation,-2.6428,<2.2e-16,MIR-130A
GO:0045576,mast cell activation,-2.0612,0.00049383,MIR-130A
GO:0001525,angiogenesis,-1.998,0.0018855,MIR-130A
GO:0042092,type 2 immune response,-2.0015,0.0019753,MIR-130A
GO:0050727,regulation of inflammatory response,-1.9688,0.0020513,MIR-130A
GO:0035455,response to interferon-alpha,-2.0625,<2.2e-16,MIR-493
GO:0032606,type I interferon production,-2.0743,<2.2e-16,MIR-493
GO:0035456,response to interferon-beta,-2.389,<2.2e-16,MIR-493
GO:0034340,response to type I interferon,-2.7683,<2.2e-16,MIR-493
GO:0002250,adaptive immune response,1.9759,<2.2e-16,MIR-142
GO:0002449,lymphocyte mediated immunity,1.9653,<2.2e-16,MIR-142
GO:0002285,lymphocyte activation involved in immune response,1.919,<2.2e-16,MIR-142
GO:0007159,leukocyte cell-cell adhesion,1.8909,<2.2e-16,MIR-142
GO:0002764,immune response-regulating signaling pathway,1.8786,<2.2e-16,MIR-142
GO:0002694,regulation of leukocyte activation,1.8698,<2.2e-16,MIR-142
GO:0002521,leukocyte differentiation,1.8514,<2.2e-16,MIR-142
GO:0001819,positive regulation of cytokine production,1.8176,<2.2e-16,MIR-142
GO:0019882,antigen processing and presentation,1.8129,<2.2e-16,MIR-142
GO:0002697,regulation of immune effector process,1.8065,<2.2e-16,MIR-142
GO:0002446,neutrophil mediated immunity,1.8002,<2.2e-16,MIR-142
GO:0002440,production of molecular mediator of immune response,1.7939,<2.2e-16,MIR-142
GO:0001773,myeloid dendritic cell activation,1.7897,<2.2e-16,MIR-142
GO:0001818,negative regulation of cytokine production,1.7826,<2.2e-16,MIR-142
GO:0002683,negative regulation of immune system process,1.7811,<2.2e-16,MIR-142
GO:0002448,mast cell mediated immunity,1.7769,<2.2e-16,MIR-142
GO:0002526,acute inflammatory response,1.7689,<2.2e-16,MIR-142
